| 
GO:0022625 cytosolic large
ribosomal subunit
 | 
40
 | 
9.25e-18
 | 
7.84e-01
 | 
8.18e-15
 | 
| 
GO:0035145 exon-exon junction
complex
 | 
10
 | 
5.17e-05
 | 
-7.39e-01
 | 
6.09e-03
 | 
| 
GO:0002181 cytoplasmic translation
 | 
27
 | 
3.22e-11
 | 
7.38e-01
 | 
1.42e-08
 | 
| 
GO:0022627 cytosolic small
ribosomal subunit
 | 
25
 | 
4.25e-10
 | 
7.21e-01
 | 
1.50e-07
 | 
| 
GO:1905564 positive regulation of
vascular endothelial cell proliferation
 | 
10
 | 
4.73e-04
 | 
6.38e-01
 | 
2.99e-02
 | 
| 
GO:0036121 double-stranded DNA
helicase activity
 | 
11
 | 
3.01e-04
 | 
-6.29e-01
 | 
2.32e-02
 | 
| 
GO:0004683
calcium/calmodulin-dependent protein kinase activity
 | 
11
 | 
6.66e-04
 | 
5.93e-01
 | 
3.46e-02
 | 
| 
GO:0004602 glutathione peroxidase
activity
 | 
12
 | 
6.05e-04
 | 
5.72e-01
 | 
3.28e-02
 | 
| 
GO:1990391 DNA repair complex
 | 
10
 | 
3.55e-03
 | 
-5.32e-01
 | 
9.10e-02
 | 
| 
GO:0140662 ATP-dependent protein
folding chaperone
 | 
23
 | 
1.17e-05
 | 
-5.28e-01
 | 
2.07e-03
 | 
| 
GO:0006623 protein targeting to
vacuole
 | 
11
 | 
2.78e-03
 | 
-5.21e-01
 | 
7.94e-02
 | 
| 
GO:0035925 mRNA 3’-UTR AU-rich
region binding
 | 
13
 | 
1.41e-03
 | 
5.11e-01
 | 
5.34e-02
 | 
| 
GO:0003735 structural constituent
of ribosome
 | 
118
 | 
1.19e-21
 | 
5.09e-01
 | 
2.10e-18
 | 
| 
GO:2000648 positive regulation of
stem cell proliferation
 | 
12
 | 
2.45e-03
 | 
5.05e-01
 | 
7.37e-02
 | 
| 
GO:0030127 COPII vesicle coat
 | 
10
 | 
5.88e-03
 | 
5.03e-01
 | 
1.18e-01
 | 
| 
GO:0009378 four-way junction
helicase activity
 | 
13
 | 
1.81e-03
 | 
-5.00e-01
 | 
5.83e-02
 | 
| 
GO:0003724 RNA helicase activity
 | 
37
 | 
2.26e-07
 | 
-4.92e-01
 | 
5.83e-05
 | 
| 
GO:0008593 regulation of Notch
signaling pathway
 | 
10
 | 
7.23e-03
 | 
4.91e-01
 | 
1.29e-01
 | 
| 
GO:1990518 single-stranded 3’-5’
DNA helicase activity
 | 
11
 | 
5.38e-03
 | 
-4.85e-01
 | 
1.14e-01
 | 
| 
GO:0140861 DNA repair-dependent
chromatin remodeling
 | 
14
 | 
1.73e-03
 | 
-4.84e-01
 | 
5.69e-02
 | 
| 
GO:0003678 DNA helicase activity
 | 
20
 | 
1.96e-04
 | 
-4.81e-01
 | 
1.82e-02
 | 
| 
GO:0097038 perinuclear endoplasmic
reticulum
 | 
10
 | 
8.92e-03
 | 
4.78e-01
 | 
1.43e-01
 | 
| 
GO:0005544 calcium-dependent
phospholipid binding
 | 
21
 | 
1.69e-04
 | 
4.74e-01
 | 
1.66e-02
 | 
| 
GO:0007042 lysosomal lumen
acidification
 | 
10
 | 
9.47e-03
 | 
4.74e-01
 | 
1.47e-01
 | 
| 
GO:0042474 middle ear morphogenesis
 | 
10
 | 
9.50e-03
 | 
4.74e-01
 | 
1.47e-01
 | 
| 
GO:0061749 forked DNA-dependent
helicase activity
 | 
10
 | 
9.86e-03
 | 
-4.71e-01
 | 
1.48e-01
 | 
| 
GO:0060216 definitive hemopoiesis
 | 
10
 | 
1.16e-02
 | 
4.61e-01
 | 
1.63e-01
 | 
| 
GO:0001819 positive regulation of
cytokine production
 | 
13
 | 
4.38e-03
 | 
4.56e-01
 | 
1.01e-01
 | 
| 
GO:0070034 telomerase RNA binding
 | 
12
 | 
6.27e-03
 | 
-4.56e-01
 | 
1.22e-01
 | 
| 
GO:0090110 COPII-coated vesicle
cargo loading
 | 
10
 | 
1.45e-02
 | 
4.47e-01
 | 
1.83e-01
 | 
| 
GO:0070182 DNA polymerase binding
 | 
13
 | 
5.41e-03
 | 
-4.46e-01
 | 
1.14e-01
 | 
| 
GO:0012506 vesicle membrane
 | 
15
 | 
3.40e-03
 | 
4.37e-01
 | 
9.10e-02
 | 
| 
GO:0000245 spliceosomal complex
assembly
 | 
10
 | 
1.69e-02
 | 
-4.36e-01
 | 
1.92e-01
 | 
| 
GO:0030020 extracellular matrix
structural constituent conferring tensile strength
 | 
17
 | 
1.93e-03
 | 
4.34e-01
 | 
6.09e-02
 | 
| 
GO:0030992 intraciliary transport
particle B
 | 
15
 | 
3.66e-03
 | 
4.33e-01
 | 
9.10e-02
 | 
| 
GO:0009888 tissue development
 | 
18
 | 
1.57e-03
 | 
-4.30e-01
 | 
5.44e-02
 | 
| 
GO:0007099 centriole replication
 | 
13
 | 
7.89e-03
 | 
4.26e-01
 | 
1.37e-01
 | 
| 
GO:0006412 translation
 | 
96
 | 
6.35e-13
 | 
4.25e-01
 | 
3.74e-10
 | 
| 
GO:0004364 glutathione transferase
activity
 | 
10
 | 
2.04e-02
 | 
4.23e-01
 | 
2.21e-01
 | 
| 
GO:0141198 protein branched
polyubiquitination
 | 
13
 | 
8.57e-03
 | 
-4.21e-01
 | 
1.40e-01
 | 
| 
GO:0005791 rough endoplasmic
reticulum
 | 
12
 | 
1.19e-02
 | 
-4.19e-01
 | 
1.63e-01
 | 
| 
GO:0000774 adenyl-nucleotide
exchange factor activity
 | 
12
 | 
1.20e-02
 | 
-4.19e-01
 | 
1.63e-01
 | 
| 
GO:0051642 centrosome localization
 | 
14
 | 
6.70e-03
 | 
4.19e-01
 | 
1.29e-01
 | 
| 
GO:0070507 regulation of
microtubule cytoskeleton organization
 | 
14
 | 
6.98e-03
 | 
4.16e-01
 | 
1.29e-01
 | 
| 
GO:0045292 mRNA cis splicing, via
spliceosome
 | 
13
 | 
9.67e-03
 | 
-4.15e-01
 | 
1.47e-01
 | 
| 
GO:0010971 positive regulation of
G2/M transition of mitotic cell cycle
 | 
14
 | 
7.50e-03
 | 
-4.13e-01
 | 
1.33e-01
 | 
| 
GO:0032924 activin receptor
signaling pathway
 | 
12
 | 
1.43e-02
 | 
-4.08e-01
 | 
1.82e-01
 | 
| 
GO:0061775 cohesin loader activity
 | 
24
 | 
5.36e-04
 | 
-4.08e-01
 | 
3.16e-02
 | 
| 
GO:0140588 chromatin looping
 | 
27
 | 
2.55e-04
 | 
-4.07e-01
 | 
2.06e-02
 | 
| 
GO:0048041 focal adhesion assembly
 | 
14
 | 
8.50e-03
 | 
-4.06e-01
 | 
1.40e-01
 | 
| 
GO:0140584 chromatin extrusion
motor activity
 | 
23
 | 
7.56e-04
 | 
-4.06e-01
 | 
3.52e-02
 | 
| 
GO:0140665 ATP-dependent H3-H4
histone complex chaperone activity
 | 
23
 | 
7.56e-04
 | 
-4.06e-01
 | 
3.52e-02
 | 
| 
GO:0140849 ATP-dependent H2AZ
histone chaperone activity
 | 
23
 | 
7.56e-04
 | 
-4.06e-01
 | 
3.52e-02
 | 
| 
GO:0017056 structural constituent
of nuclear pore
 | 
19
 | 
2.28e-03
 | 
-4.04e-01
 | 
7.08e-02
 | 
| 
GO:0043995 histone H4K5
acetyltransferase activity
 | 
10
 | 
2.71e-02
 | 
-4.04e-01
 | 
2.42e-01
 | 
| 
GO:0043996 histone H4K8
acetyltransferase activity
 | 
10
 | 
2.71e-02
 | 
-4.04e-01
 | 
2.42e-01
 | 
| 
GO:2001244 positive regulation of
intrinsic apoptotic signaling pathway
 | 
11
 | 
2.16e-02
 | 
4.00e-01
 | 
2.26e-01
 | 
| 
GO:0008630 intrinsic apoptotic
signaling pathway in response to DNA damage
 | 
24
 | 
7.17e-04
 | 
-3.99e-01
 | 
3.52e-02
 | 
| 
GO:0002218 activation of innate
immune response
 | 
17
 | 
4.60e-03
 | 
-3.97e-01
 | 
1.02e-01
 | 
| 
GO:0006749 glutathione metabolic
process
 | 
15
 | 
8.08e-03
 | 
3.95e-01
 | 
1.39e-01
 | 
| 
GO:0070577 lysine-acetylated
histone binding
 | 
16
 | 
6.25e-03
 | 
-3.95e-01
 | 
1.22e-01
 | 
| 
GO:0005852 eukaryotic translation
initiation factor 3 complex
 | 
10
 | 
3.20e-02
 | 
3.92e-01
 | 
2.63e-01
 | 
| 
GO:1903076 regulation of protein
localization to plasma membrane
 | 
18
 | 
4.04e-03
 | 
3.91e-01
 | 
9.40e-02
 | 
| 
GO:0038202 TORC1 signaling
 | 
12
 | 
1.92e-02
 | 
3.90e-01
 | 
2.12e-01
 | 
| 
GO:0034727 piecemeal microautophagy
of the nucleus
 | 
13
 | 
1.50e-02
 | 
3.90e-01
 | 
1.87e-01
 | 
| 
GO:0030665 clathrin-coated vesicle
membrane
 | 
11
 | 
2.53e-02
 | 
3.90e-01
 | 
2.34e-01
 | 
| 
GO:2000352 negative regulation of
endothelial cell apoptotic process
 | 
14
 | 
1.17e-02
 | 
3.89e-01
 | 
1.63e-01
 | 
| 
GO:0031982 vesicle
 | 
26
 | 
6.13e-04
 | 
3.88e-01
 | 
3.28e-02
 | 
| 
GO:0005840 ribosome
 | 
43
 | 
1.10e-05
 | 
3.88e-01
 | 
2.07e-03
 | 
| 
GO:0016442 RISC complex
 | 
11
 | 
2.61e-02
 | 
-3.87e-01
 | 
2.38e-01
 | 
| 
GO:0006120 mitochondrial electron
transport, NADH to ubiquinone
 | 
19
 | 
3.94e-03
 | 
3.82e-01
 | 
9.40e-02
 | 
| 
GO:0098869 cellular oxidant
detoxification
 | 
28
 | 
4.99e-04
 | 
3.80e-01
 | 
3.04e-02
 | 
| 
GO:0001675 acrosome assembly
 | 
11
 | 
2.91e-02
 | 
3.80e-01
 | 
2.50e-01
 | 
| 
GO:0032585 multivesicular body
membrane
 | 
12
 | 
2.31e-02
 | 
3.79e-01
 | 
2.30e-01
 | 
| 
GO:0001725 stress fiber
 | 
42
 | 
2.40e-05
 | 
-3.77e-01
 | 
3.54e-03
 | 
| 
GO:0045116 protein neddylation
 | 
10
 | 
3.92e-02
 | 
3.77e-01
 | 
2.85e-01
 | 
| 
GO:0042026 protein refolding
 | 
12
 | 
2.41e-02
 | 
-3.76e-01
 | 
2.33e-01
 | 
| 
GO:0000380 alternative mRNA
splicing, via spliceosome
 | 
16
 | 
9.59e-03
 | 
-3.74e-01
 | 
1.47e-01
 | 
| 
GO:0090128 regulation of synapse
maturation
 | 
10
 | 
4.07e-02
 | 
3.74e-01
 | 
2.92e-01
 | 
| 
GO:1904646 cellular response to
amyloid-beta
 | 
11
 | 
3.20e-02
 | 
3.73e-01
 | 
2.63e-01
 | 
| 
GO:0060170 ciliary membrane
 | 
20
 | 
3.87e-03
 | 
3.73e-01
 | 
9.40e-02
 | 
| 
GO:0051453 regulation of
intracellular pH
 | 
14
 | 
1.61e-02
 | 
3.72e-01
 | 
1.92e-01
 | 
| 
GO:0060395 SMAD protein signal
transduction
 | 
14
 | 
1.66e-02
 | 
-3.70e-01
 | 
1.92e-01
 | 
| 
GO:0045943 positive regulation of
transcription by RNA polymerase I
 | 
11
 | 
3.39e-02
 | 
-3.69e-01
 | 
2.71e-01
 | 
| 
GO:0046961 proton-transporting
ATPase activity, rotational mechanism
 | 
14
 | 
1.68e-02
 | 
3.69e-01
 | 
1.92e-01
 | 
| 
GO:0060349 bone morphogenesis
 | 
12
 | 
2.79e-02
 | 
3.67e-01
 | 
2.47e-01
 | 
| 
GO:0000423 mitophagy
 | 
31
 | 
4.18e-04
 | 
3.66e-01
 | 
2.96e-02
 | 
| 
GO:0042056 chemoattractant activity
 | 
11
 | 
3.60e-02
 | 
3.65e-01
 | 
2.74e-01
 | 
| 
GO:0055074 calcium ion homeostasis
 | 
18
 | 
7.62e-03
 | 
3.63e-01
 | 
1.33e-01
 | 
| 
GO:0035269 protein O-linked
mannosylation
 | 
13
 | 
2.36e-02
 | 
-3.63e-01
 | 
2.33e-01
 | 
| 
GO:0000462 maturation of SSU-rRNA
from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
 | 
13
 | 
2.44e-02
 | 
-3.61e-01
 | 
2.33e-01
 | 
| 
GO:0044295 axonal growth cone
 | 
11
 | 
3.84e-02
 | 
-3.61e-01
 | 
2.83e-01
 | 
| 
GO:0042073 intraciliary transport
 | 
16
 | 
1.29e-02
 | 
3.59e-01
 | 
1.70e-01
 | 
| 
GO:0030904 retromer complex
 | 
15
 | 
1.72e-02
 | 
3.55e-01
 | 
1.93e-01
 | 
| 
GO:0008137 NADH dehydrogenase
(ubiquinone) activity
 | 
10
 | 
5.18e-02
 | 
3.55e-01
 | 
3.19e-01
 | 
| 
GO:0061952 midbody abscission
 | 
14
 | 
2.15e-02
 | 
3.55e-01
 | 
2.26e-01
 | 
| 
GO:0044458 motile cilium assembly
 | 
12
 | 
3.51e-02
 | 
3.51e-01
 | 
2.72e-01
 | 
| 
GO:2000377 regulation of reactive
oxygen species metabolic process
 | 
10
 | 
5.47e-02
 | 
3.51e-01
 | 
3.26e-01
 | 
| 
GO:1904294 positive regulation of
ERAD pathway
 | 
10
 | 
5.61e-02
 | 
3.49e-01
 | 
3.28e-01
 | 
| 
GO:0007017 microtubule-based
process
 | 
11
 | 
4.64e-02
 | 
3.47e-01
 | 
3.08e-01
 | 
| 
GO:0006406 mRNA export from nucleus
 | 
28
 | 
1.53e-03
 | 
-3.46e-01
 | 
5.42e-02
 | 
| 
GO:0030031 cell projection assembly
 | 
10
 | 
5.84e-02
 | 
3.46e-01
 | 
3.35e-01
 | 
| 
GO:0005680 anaphase-promoting
complex
 | 
13
 | 
3.15e-02
 | 
-3.45e-01
 | 
2.63e-01
 | 
| 
GO:0071897 DNA biosynthetic process
 | 
12
 | 
3.90e-02
 | 
-3.44e-01
 | 
2.85e-01
 | 
| 
GO:0050829 defense response to
Gram-negative bacterium
 | 
12
 | 
3.94e-02
 | 
3.43e-01
 | 
2.86e-01
 | 
| 
GO:0016829 lyase activity
 | 
15
 | 
2.30e-02
 | 
3.39e-01
 | 
2.30e-01
 | 
| 
GO:1903077 negative regulation of
protein localization to plasma membrane
 | 
14
 | 
2.81e-02
 | 
3.39e-01
 | 
2.47e-01
 | 
| 
GO:0022604 regulation of cell
morphogenesis
 | 
14
 | 
2.90e-02
 | 
-3.37e-01
 | 
2.50e-01
 | 
| 
GO:0071108 protein K48-linked
deubiquitination
 | 
15
 | 
2.39e-02
 | 
-3.37e-01
 | 
2.33e-01
 | 
| 
GO:0005902 microvillus
 | 
29
 | 
1.74e-03
 | 
3.36e-01
 | 
5.69e-02
 | 
| 
GO:0051393 alpha-actinin binding
 | 
10
 | 
6.66e-02
 | 
-3.35e-01
 | 
3.47e-01
 | 
| 
GO:0045271 respiratory chain
complex I
 | 
31
 | 
1.26e-03
 | 
3.35e-01
 | 
5.05e-02
 | 
| 
GO:0051603 proteolysis involved in
protein catabolic process
 | 
23
 | 
5.64e-03
 | 
3.33e-01
 | 
1.17e-01
 | 
| 
GO:0008139 nuclear localization
sequence binding
 | 
13
 | 
3.77e-02
 | 
-3.33e-01
 | 
2.79e-01
 | 
| 
GO:0030100 regulation of
endocytosis
 | 
12
 | 
4.61e-02
 | 
3.32e-01
 | 
3.08e-01
 | 
| 
GO:0031145 anaphase-promoting
complex-dependent catabolic process
 | 
14
 | 
3.23e-02
 | 
-3.31e-01
 | 
2.63e-01
 | 
| 
GO:0016236 macroautophagy
 | 
16
 | 
2.24e-02
 | 
3.30e-01
 | 
2.29e-01
 | 
| 
GO:0000407 phagophore assembly site
 | 
20
 | 
1.08e-02
 | 
3.29e-01
 | 
1.57e-01
 | 
| 
GO:0030016 myofibril
 | 
13
 | 
4.11e-02
 | 
-3.27e-01
 | 
2.94e-01
 | 
| 
GO:0045332 phospholipid
translocation
 | 
15
 | 
2.85e-02
 | 
3.27e-01
 | 
2.49e-01
 | 
| 
GO:0080025
phosphatidylinositol-3,5-bisphosphate binding
 | 
15
 | 
3.02e-02
 | 
3.23e-01
 | 
2.56e-01
 | 
| 
GO:0015030 Cajal body
 | 
26
 | 
4.44e-03
 | 
-3.22e-01
 | 
1.01e-01
 | 
| 
GO:0050918 positive chemotaxis
 | 
13
 | 
4.50e-02
 | 
3.21e-01
 | 
3.07e-01
 | 
| 
GO:0030225 macrophage
differentiation
 | 
11
 | 
6.54e-02
 | 
3.21e-01
 | 
3.44e-01
 | 
| 
GO:0005774 vacuolar membrane
 | 
10
 | 
7.98e-02
 | 
3.20e-01
 | 
3.82e-01
 | 
| 
GO:0071353 cellular response to
interleukin-4
 | 
10
 | 
7.99e-02
 | 
3.20e-01
 | 
3.82e-01
 | 
| 
GO:0035615 clathrin adaptor
activity
 | 
10
 | 
8.01e-02
 | 
3.20e-01
 | 
3.82e-01
 | 
| 
GO:0015914 phospholipid transport
 | 
25
 | 
5.69e-03
 | 
3.20e-01
 | 
1.17e-01
 | 
| 
GO:0070411 I-SMAD binding
 | 
11
 | 
6.74e-02
 | 
-3.19e-01
 | 
3.47e-01
 | 
| 
GO:0006744 ubiquinone biosynthetic
process
 | 
11
 | 
6.78e-02
 | 
3.18e-01
 | 
3.47e-01
 | 
| 
GO:0034314 Arp2/3 complex-mediated
actin nucleation
 | 
11
 | 
6.82e-02
 | 
3.18e-01
 | 
3.47e-01
 | 
| 
GO:0006936 muscle contraction
 | 
10
 | 
8.21e-02
 | 
-3.18e-01
 | 
3.86e-01
 | 
| 
GO:0070971 endoplasmic reticulum
exit site
 | 
19
 | 
1.70e-02
 | 
3.16e-01
 | 
1.92e-01
 | 
| 
GO:0007339 binding of sperm to zona
pellucida
 | 
11
 | 
6.94e-02
 | 
-3.16e-01
 | 
3.52e-01
 | 
| 
GO:0031669 cellular response to
nutrient levels
 | 
13
 | 
4.84e-02
 | 
-3.16e-01
 | 
3.11e-01
 | 
| 
GO:0006337 nucleosome disassembly
 | 
10
 | 
8.39e-02
 | 
-3.16e-01
 | 
3.88e-01
 | 
| 
GO:0034045 phagophore assembly site
membrane
 | 
12
 | 
5.96e-02
 | 
3.14e-01
 | 
3.35e-01
 | 
| 
GO:0043997 histone H4K12
acetyltransferase activity
 | 
10
 | 
8.56e-02
 | 
-3.14e-01
 | 
3.88e-01
 | 
| 
GO:1904019 epithelial cell
apoptotic process
 | 
13
 | 
5.00e-02
 | 
3.14e-01
 | 
3.16e-01
 | 
| 
GO:0016514 SWI/SNF complex
 | 
20
 | 
1.52e-02
 | 
-3.13e-01
 | 
1.87e-01
 | 
| 
GO:0048306 calcium-dependent
protein binding
 | 
20
 | 
1.53e-02
 | 
3.13e-01
 | 
1.87e-01
 | 
| 
GO:0097225 sperm midpiece
 | 
14
 | 
4.24e-02
 | 
3.13e-01
 | 
3.00e-01
 | 
| 
GO:0006913 nucleocytoplasmic
transport
 | 
18
 | 
2.18e-02
 | 
-3.12e-01
 | 
2.27e-01
 | 
| 
GO:0140658 ATP-dependent chromatin
remodeler activity
 | 
11
 | 
7.49e-02
 | 
-3.10e-01
 | 
3.69e-01
 | 
| 
GO:0060379 cardiac muscle cell
myoblast differentiation
 | 
10
 | 
8.96e-02
 | 
-3.10e-01
 | 
3.99e-01
 | 
| 
GO:0043024 ribosomal small subunit
binding
 | 
13
 | 
5.47e-02
 | 
-3.08e-01
 | 
3.26e-01
 | 
| 
GO:0002230 positive regulation of
defense response to virus by host
 | 
11
 | 
7.76e-02
 | 
-3.07e-01
 | 
3.78e-01
 | 
| 
GO:0071577 zinc ion transmembrane
transport
 | 
10
 | 
9.30e-02
 | 
-3.07e-01
 | 
4.07e-01
 | 
| 
GO:0033290 eukaryotic 48S
preinitiation complex
 | 
13
 | 
5.78e-02
 | 
3.04e-01
 | 
3.34e-01
 | 
| 
GO:0048018 receptor ligand activity
 | 
18
 | 
2.63e-02
 | 
-3.03e-01
 | 
2.38e-01
 | 
| 
GO:0030687 preribosome, large
subunit precursor
 | 
12
 | 
7.04e-02
 | 
-3.02e-01
 | 
3.55e-01
 | 
| 
GO:0005044 scavenger receptor
activity
 | 
10
 | 
9.88e-02
 | 
3.01e-01
 | 
4.19e-01
 | 
| 
GO:0045739 positive regulation of
DNA repair
 | 
20
 | 
1.97e-02
 | 
-3.01e-01
 | 
2.15e-01
 | 
| 
GO:0032968 positive regulation of
transcription elongation by RNA polymerase II
 | 
15
 | 
4.38e-02
 | 
-3.01e-01
 | 
3.05e-01
 | 
| 
GO:0005665 RNA polymerase II, core
complex
 | 
10
 | 
1.00e-01
 | 
3.00e-01
 | 
4.20e-01
 | 
| 
GO:0000422 autophagy of
mitochondrion
 | 
14
 | 
5.23e-02
 | 
3.00e-01
 | 
3.19e-01
 | 
| 
GO:0005049 nuclear export signal
receptor activity
 | 
10
 | 
1.02e-01
 | 
-2.99e-01
 | 
4.22e-01
 | 
| 
GO:0030030 cell projection
organization
 | 
13
 | 
6.28e-02
 | 
2.98e-01
 | 
3.44e-01
 | 
| 
GO:0010977 negative regulation of
neuron projection development
 | 
18
 | 
2.94e-02
 | 
-2.97e-01
 | 
2.51e-01
 | 
| 
GO:0017018 myosin phosphatase
activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0140791 histone H2AXS140
phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0180004 RNA polymerase II CTD
heptapeptide repeat Y1 phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0180005 RNA polymerase II CTD
heptapeptide repeat T4 phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0180006 RNA polymerase II CTD
heptapeptide repeat S2 phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0180007 RNA polymerase II CTD
heptapeptide repeat S5 phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0180008 RNA polymerase II CTD
heptapeptide repeat S7 phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:1990439 MAP kinase
serine/threonine phosphatase activity
 | 
13
 | 
6.49e-02
 | 
-2.96e-01
 | 
3.44e-01
 | 
| 
GO:0004888 transmembrane signaling
receptor activity
 | 
23
 | 
1.43e-02
 | 
2.95e-01
 | 
1.82e-01
 | 
| 
GO:0060047 heart contraction
 | 
10
 | 
1.06e-01
 | 
2.95e-01
 | 
4.30e-01
 | 
| 
GO:0021987 cerebral cortex
development
 | 
25
 | 
1.10e-02
 | 
2.94e-01
 | 
1.58e-01
 | 
| 
GO:0022626 cytosolic ribosome
 | 
13
 | 
6.67e-02
 | 
-2.94e-01
 | 
3.47e-01
 | 
| 
GO:0051010 microtubule plus-end
binding
 | 
11
 | 
9.23e-02
 | 
2.93e-01
 | 
4.07e-01
 | 
| 
GO:0080008 Cul4-RING E3 ubiquitin
ligase complex
 | 
13
 | 
6.73e-02
 | 
-2.93e-01
 | 
3.47e-01
 | 
| 
GO:0071560 cellular response to
transforming growth factor beta stimulus
 | 
16
 | 
4.46e-02
 | 
2.90e-01
 | 
3.06e-01
 | 
| 
GO:0001772 immunological synapse
 | 
23
 | 
1.62e-02
 | 
2.90e-01
 | 
1.92e-01
 | 
| 
GO:0045070 positive regulation of
viral genome replication
 | 
19
 | 
2.88e-02
 | 
-2.90e-01
 | 
2.50e-01
 | 
| 
GO:0048704 embryonic skeletal
system morphogenesis
 | 
18
 | 
3.35e-02
 | 
2.90e-01
 | 
2.69e-01
 | 
| 
GO:0032212 positive regulation of
telomere maintenance via telomerase
 | 
17
 | 
3.97e-02
 | 
-2.88e-01
 | 
2.87e-01
 | 
| 
GO:0001732 formation of cytoplasmic
translation initiation complex
 | 
12
 | 
8.40e-02
 | 
2.88e-01
 | 
3.88e-01
 | 
| 
GO:0031462 Cul2-RING ubiquitin
ligase complex
 | 
15
 | 
5.35e-02
 | 
-2.88e-01
 | 
3.24e-01
 | 
| 
GO:0048872 homeostasis of number of
cells
 | 
14
 | 
6.27e-02
 | 
2.87e-01
 | 
3.44e-01
 | 
| 
GO:0000792 heterochromatin
 | 
19
 | 
3.12e-02
 | 
-2.85e-01
 | 
2.63e-01
 | 
| 
GO:0043029 T cell homeostasis
 | 
13
 | 
7.49e-02
 | 
-2.85e-01
 | 
3.69e-01
 | 
| 
GO:0045216 cell-cell junction
organization
 | 
13
 | 
7.59e-02
 | 
-2.84e-01
 | 
3.72e-01
 | 
| 
GO:0035267 NuA4 histone
acetyltransferase complex
 | 
18
 | 
3.68e-02
 | 
-2.84e-01
 | 
2.76e-01
 | 
| 
GO:0020037 heme binding
 | 
51
 | 
4.55e-04
 | 
2.84e-01
 | 
2.99e-02
 | 
| 
GO:0071782 endoplasmic reticulum
tubular network
 | 
12
 | 
8.94e-02
 | 
-2.83e-01
 | 
3.99e-01
 | 
| 
GO:0032508 DNA duplex unwinding
 | 
44
 | 
1.18e-03
 | 
-2.83e-01
 | 
5.05e-02
 | 
| 
GO:0051721 protein phosphatase 2A
binding
 | 
14
 | 
6.71e-02
 | 
-2.83e-01
 | 
3.47e-01
 | 
| 
GO:0043616 keratinocyte
proliferation
 | 
11
 | 
1.05e-01
 | 
2.82e-01
 | 
4.30e-01
 | 
| 
GO:1902774 late endosome to
lysosome transport
 | 
10
 | 
1.22e-01
 | 
2.82e-01
 | 
4.58e-01
 | 
| 
GO:0048701 embryonic cranial
skeleton morphogenesis
 | 
13
 | 
7.83e-02
 | 
2.82e-01
 | 
3.78e-01
 | 
| 
GO:0030863 cortical cytoskeleton
 | 
10
 | 
1.23e-01
 | 
2.82e-01
 | 
4.58e-01
 | 
| 
GO:0030316 osteoclast
differentiation
 | 
29
 | 
8.65e-03
 | 
-2.82e-01
 | 
1.40e-01
 | 
| 
GO:0044322 endoplasmic reticulum
quality control compartment
 | 
11
 | 
1.06e-01
 | 
2.82e-01
 | 
4.30e-01
 | 
| 
GO:0030199 collagen fibril
organization
 | 
31
 | 
7.14e-03
 | 
2.79e-01
 | 
1.29e-01
 | 
| 
GO:0030515 snoRNA binding
 | 
14
 | 
7.09e-02
 | 
-2.79e-01
 | 
3.56e-01
 | 
| 
GO:0046716 muscle cell cellular
homeostasis
 | 
15
 | 
6.16e-02
 | 
-2.79e-01
 | 
3.42e-01
 | 
| 
GO:0035278 miRNA-mediated gene
silencing by inhibition of translation
 | 
12
 | 
9.60e-02
 | 
-2.78e-01
 | 
4.14e-01
 | 
| 
GO:0005901 caveola
 | 
28
 | 
1.15e-02
 | 
2.76e-01
 | 
1.63e-01
 | 
| 
GO:0050840 extracellular matrix
binding
 | 
17
 | 
4.92e-02
 | 
2.76e-01
 | 
3.15e-01
 | 
| 
GO:0005249 voltage-gated potassium
channel activity
 | 
15
 | 
6.51e-02
 | 
-2.75e-01
 | 
3.44e-01
 | 
| 
GO:1903543 positive regulation of
exosomal secretion
 | 
10
 | 
1.33e-01
 | 
2.75e-01
 | 
4.75e-01
 | 
| 
GO:0005905 clathrin-coated pit
 | 
30
 | 
9.61e-03
 | 
2.73e-01
 | 
1.47e-01
 | 
| 
GO:0035914 skeletal muscle cell
differentiation
 | 
24
 | 
2.09e-02
 | 
-2.72e-01
 | 
2.24e-01
 | 
| 
GO:0002682 regulation of immune
system process
 | 
11
 | 
1.20e-01
 | 
-2.71e-01
 | 
4.55e-01
 | 
| 
GO:0071549 cellular response to
dexamethasone stimulus
 | 
11
 | 
1.22e-01
 | 
2.69e-01
 | 
4.56e-01
 | 
| 
GO:0031624 ubiquitin conjugating
enzyme binding
 | 
17
 | 
5.49e-02
 | 
-2.69e-01
 | 
3.26e-01
 | 
| 
GO:0048813 dendrite morphogenesis
 | 
21
 | 
3.31e-02
 | 
2.69e-01
 | 
2.67e-01
 | 
| 
GO:0002224 toll-like receptor
signaling pathway
 | 
14
 | 
8.20e-02
 | 
2.69e-01
 | 
3.86e-01
 | 
| 
GO:0035770 ribonucleoprotein
granule
 | 
13
 | 
9.38e-02
 | 
-2.68e-01
 | 
4.09e-01
 | 
| 
GO:0035994 response to muscle
stretch
 | 
10
 | 
1.43e-01
 | 
-2.67e-01
 | 
4.94e-01
 | 
| 
GO:0044331 cell-cell adhesion
mediated by cadherin
 | 
11
 | 
1.26e-01
 | 
2.67e-01
 | 
4.64e-01
 | 
| 
GO:0000281 mitotic cytokinesis
 | 
34
 | 
7.21e-03
 | 
2.66e-01
 | 
1.29e-01
 | 
| 
GO:0031623 receptor internalization
 | 
21
 | 
3.49e-02
 | 
2.66e-01
 | 
2.72e-01
 | 
| 
GO:0046426 negative regulation of
receptor signaling pathway via JAK-STAT
 | 
11
 | 
1.28e-01
 | 
2.65e-01
 | 
4.67e-01
 | 
| 
GO:0000307 cyclin-dependent protein
kinase holoenzyme complex
 | 
21
 | 
3.58e-02
 | 
2.65e-01
 | 
2.74e-01
 | 
| 
GO:2001235 positive regulation of
apoptotic signaling pathway
 | 
17
 | 
5.95e-02
 | 
2.64e-01
 | 
3.35e-01
 | 
| 
GO:0008266 poly(U) RNA binding
 | 
16
 | 
6.81e-02
 | 
2.63e-01
 | 
3.47e-01
 | 
| 
GO:0000421 autophagosome membrane
 | 
23
 | 
2.88e-02
 | 
2.63e-01
 | 
2.50e-01
 | 
| 
GO:0030900 forebrain development
 | 
20
 | 
4.19e-02
 | 
-2.63e-01
 | 
2.98e-01
 | 
| 
GO:0001958 endochondral
ossification
 | 
15
 | 
7.82e-02
 | 
2.63e-01
 | 
3.78e-01
 | 
| 
GO:2000773 negative regulation of
cellular senescence
 | 
12
 | 
1.16e-01
 | 
2.62e-01
 | 
4.49e-01
 | 
| 
GO:0030866 cortical actin
cytoskeleton organization
 | 
20
 | 
4.30e-02
 | 
2.61e-01
 | 
3.02e-01
 | 
| 
GO:0035869 ciliary transition zone
 | 
22
 | 
3.44e-02
 | 
2.61e-01
 | 
2.72e-01
 | 
| 
GO:0010508 positive regulation of
autophagy
 | 
39
 | 
5.03e-03
 | 
2.60e-01
 | 
1.08e-01
 | 
| 
GO:0017015 regulation of
transforming growth factor beta receptor signaling pathway
 | 
11
 | 
1.36e-01
 | 
2.59e-01
 | 
4.82e-01
 | 
| 
GO:0097718 disordered domain
specific binding
 | 
15
 | 
8.22e-02
 | 
-2.59e-01
 | 
3.86e-01
 | 
| 
GO:0019003 GDP binding
 | 
44
 | 
2.98e-03
 | 
2.59e-01
 | 
8.36e-02
 | 
| 
GO:0006096 glycolytic process
 | 
23
 | 
3.19e-02
 | 
2.58e-01
 | 
2.63e-01
 | 
| 
GO:0071711 basement membrane
organization
 | 
11
 | 
1.39e-01
 | 
2.58e-01
 | 
4.84e-01
 | 
| 
GO:0007259 cell surface receptor
signaling pathway via JAK-STAT
 | 
21
 | 
4.13e-02
 | 
2.57e-01
 | 
2.95e-01
 | 
| 
GO:0030897 HOPS complex
 | 
10
 | 
1.59e-01
 | 
-2.57e-01
 | 
5.20e-01
 | 
| 
GO:0042771 intrinsic apoptotic
signaling pathway in response to DNA damage by p53 class mediator
 | 
17
 | 
6.68e-02
 | 
-2.57e-01
 | 
3.47e-01
 | 
| 
GO:0032391 photoreceptor connecting
cilium
 | 
18
 | 
5.97e-02
 | 
2.56e-01
 | 
3.35e-01
 | 
| 
GO:0007163 establishment or
maintenance of cell polarity
 | 
13
 | 
1.10e-01
 | 
2.56e-01
 | 
4.36e-01
 | 
| 
GO:0010839 negative regulation of
keratinocyte proliferation
 | 
14
 | 
1.01e-01
 | 
2.53e-01
 | 
4.21e-01
 | 
| 
GO:0006334 nucleosome assembly
 | 
27
 | 
2.32e-02
 | 
-2.53e-01
 | 
2.30e-01
 | 
| 
GO:0040029 epigenetic regulation of
gene expression
 | 
18
 | 
6.37e-02
 | 
-2.52e-01
 | 
3.44e-01
 | 
| 
GO:0031929 TOR signaling
 | 
13
 | 
1.16e-01
 | 
2.52e-01
 | 
4.49e-01
 | 
| 
GO:0000793 condensed chromosome
 | 
13
 | 
1.17e-01
 | 
-2.51e-01
 | 
4.50e-01
 | 
| 
GO:0043409 negative regulation of
MAPK cascade
 | 
20
 | 
5.18e-02
 | 
-2.51e-01
 | 
3.19e-01
 | 
| 
GO:0031514 motile cilium
 | 
37
 | 
8.24e-03
 | 
2.51e-01
 | 
1.40e-01
 | 
| 
GO:2000300 regulation of synaptic
vesicle exocytosis
 | 
19
 | 
5.87e-02
 | 
2.51e-01
 | 
3.35e-01
 | 
| 
GO:0043240 Fanconi anaemia nuclear
complex
 | 
11
 | 
1.51e-01
 | 
2.50e-01
 | 
5.03e-01
 | 
| 
GO:0045177 apical part of cell
 | 
35
 | 
1.07e-02
 | 
2.49e-01
 | 
1.56e-01
 | 
| 
GO:0000786 nucleosome
 | 
16
 | 
8.45e-02
 | 
-2.49e-01
 | 
3.88e-01
 | 
| 
GO:0001786 phosphatidylserine
binding
 | 
24
 | 
3.49e-02
 | 
2.49e-01
 | 
2.72e-01
 | 
| 
GO:0043531 ADP binding
 | 
21
 | 
4.84e-02
 | 
-2.49e-01
 | 
3.11e-01
 | 
| 
GO:0044344 cellular response to
fibroblast growth factor stimulus
 | 
10
 | 
1.76e-01
 | 
2.47e-01
 | 
5.40e-01
 | 
| 
GO:0099149 regulation of
postsynaptic neurotransmitter receptor internalization
 | 
12
 | 
1.38e-01
 | 
2.47e-01
 | 
4.84e-01
 | 
| 
GO:0032008 positive regulation of
TOR signaling
 | 
12
 | 
1.41e-01
 | 
2.46e-01
 | 
4.88e-01
 | 
| 
GO:0016757 glycosyltransferase
activity
 | 
15
 | 
9.95e-02
 | 
-2.46e-01
 | 
4.20e-01
 | 
| 
GO:0030136 clathrin-coated vesicle
 | 
29
 | 
2.21e-02
 | 
2.46e-01
 | 
2.28e-01
 | 
| 
GO:0001965 G-protein alpha-subunit
binding
 | 
10
 | 
1.79e-01
 | 
2.46e-01
 | 
5.47e-01
 | 
| 
GO:0002040 sprouting angiogenesis
 | 
18
 | 
7.16e-02
 | 
-2.45e-01
 | 
3.59e-01
 | 
| 
GO:0032720 negative regulation of
tumor necrosis factor production
 | 
18
 | 
7.21e-02
 | 
-2.45e-01
 | 
3.59e-01
 | 
| 
GO:0003727 single-stranded RNA
binding
 | 
21
 | 
5.24e-02
 | 
-2.45e-01
 | 
3.19e-01
 | 
| 
GO:0034704 calcium channel complex
 | 
11
 | 
1.60e-01
 | 
2.44e-01
 | 
5.20e-01
 | 
| 
GO:0061512 protein localization to
cilium
 | 
22
 | 
4.73e-02
 | 
2.44e-01
 | 
3.10e-01
 | 
| 
GO:1902042 negative regulation of
extrinsic apoptotic signaling pathway via death domain receptors
 | 
13
 | 
1.27e-01
 | 
2.44e-01
 | 
4.67e-01
 | 
| 
GO:0001750 photoreceptor outer
segment
 | 
22
 | 
4.77e-02
 | 
2.44e-01
 | 
3.10e-01
 | 
| 
GO:0015908 fatty acid transport
 | 
11
 | 
1.62e-01
 | 
2.44e-01
 | 
5.20e-01
 | 
| 
GO:0032728 positive regulation of
interferon-beta production
 | 
15
 | 
1.03e-01
 | 
-2.43e-01
 | 
4.29e-01
 | 
| 
GO:0060261 positive regulation of
transcription initiation by RNA polymerase II
 | 
30
 | 
2.15e-02
 | 
-2.43e-01
 | 
2.26e-01
 | 
| 
GO:0071363 cellular response to
growth factor stimulus
 | 
20
 | 
6.08e-02
 | 
-2.42e-01
 | 
3.38e-01
 | 
| 
GO:0000723 telomere maintenance
 | 
29
 | 
2.41e-02
 | 
-2.42e-01
 | 
2.33e-01
 | 
| 
GO:0001530 lipopolysaccharide
binding
 | 
12
 | 
1.46e-01
 | 
2.42e-01
 | 
4.99e-01
 | 
| 
GO:0005547
phosphatidylinositol-3,4,5-trisphosphate binding
 | 
21
 | 
5.52e-02
 | 
2.42e-01
 | 
3.26e-01
 | 
| 
GO:0032420 stereocilium
 | 
14
 | 
1.17e-01
 | 
2.42e-01
 | 
4.51e-01
 | 
| 
GO:0071230 cellular response to
amino acid stimulus
 | 
29
 | 
2.47e-02
 | 
2.41e-01
 | 
2.33e-01
 | 
| 
GO:0016282 eukaryotic 43S
preinitiation complex
 | 
14
 | 
1.19e-01
 | 
2.41e-01
 | 
4.53e-01
 | 
| 
GO:0048027 mRNA 5’-UTR binding
 | 
19
 | 
6.91e-02
 | 
2.41e-01
 | 
3.51e-01
 | 
| 
GO:0030018 Z disc
 | 
49
 | 
3.57e-03
 | 
-2.41e-01
 | 
9.10e-02
 | 
| 
GO:0008277 regulation of G
protein-coupled receptor signaling pathway
 | 
15
 | 
1.07e-01
 | 
2.41e-01
 | 
4.30e-01
 | 
| 
GO:0007249 canonical NF-kappaB
signal transduction
 | 
18
 | 
7.79e-02
 | 
-2.40e-01
 | 
3.78e-01
 | 
| 
GO:0140326 ATPase-coupled
intramembrane lipid transporter activity
 | 
11
 | 
1.69e-01
 | 
2.40e-01
 | 
5.31e-01
 | 
| 
GO:0031681 G-protein beta-subunit
binding
 | 
10
 | 
1.89e-01
 | 
2.40e-01
 | 
5.63e-01
 | 
| 
GO:0046034 ATP metabolic process
 | 
13
 | 
1.35e-01
 | 
-2.39e-01
 | 
4.80e-01
 | 
| 
GO:0007218 neuropeptide signaling
pathway
 | 
15
 | 
1.09e-01
 | 
2.39e-01
 | 
4.36e-01
 | 
| 
GO:0050796 regulation of insulin
secretion
 | 
12
 | 
1.53e-01
 | 
2.39e-01
 | 
5.05e-01
 | 
| 
GO:0071333 cellular response to
glucose stimulus
 | 
12
 | 
1.53e-01
 | 
-2.38e-01
 | 
5.05e-01
 | 
| 
GO:0048488 synaptic vesicle
endocytosis
 | 
21
 | 
5.93e-02
 | 
2.38e-01
 | 
3.35e-01
 | 
| 
GO:0031210 phosphatidylcholine
binding
 | 
17
 | 
9.01e-02
 | 
2.38e-01
 | 
4.00e-01
 | 
| 
GO:0008253 5’-nucleotidase activity
 | 
10
 | 
1.94e-01
 | 
-2.37e-01
 | 
5.66e-01
 | 
| 
GO:0051233 spindle midzone
 | 
17
 | 
9.04e-02
 | 
2.37e-01
 | 
4.00e-01
 | 
| 
GO:0015631 tubulin binding
 | 
27
 | 
3.31e-02
 | 
2.37e-01
 | 
2.67e-01
 | 
| 
GO:0046847 filopodium assembly
 | 
11
 | 
1.74e-01
 | 
2.37e-01
 | 
5.36e-01
 | 
| 
GO:0071346 cellular response to
type II interferon
 | 
24
 | 
4.46e-02
 | 
2.37e-01
 | 
3.06e-01
 | 
| 
GO:0030133 transport vesicle
 | 
23
 | 
5.02e-02
 | 
2.36e-01
 | 
3.16e-01
 | 
| 
GO:0060045 positive regulation of
cardiac muscle cell proliferation
 | 
13
 | 
1.41e-01
 | 
-2.36e-01
 | 
4.89e-01
 | 
| 
GO:0000077 DNA damage checkpoint
signaling
 | 
26
 | 
3.87e-02
 | 
-2.34e-01
 | 
2.84e-01
 | 
| 
GO:0034707 chloride channel complex
 | 
10
 | 
2.00e-01
 | 
2.34e-01
 | 
5.77e-01
 | 
| 
GO:0030658 transport vesicle
membrane
 | 
13
 | 
1.44e-01
 | 
2.34e-01
 | 
4.96e-01
 | 
| 
GO:0001968 fibronectin binding
 | 
10
 | 
2.01e-01
 | 
-2.34e-01
 | 
5.77e-01
 | 
| 
GO:0007076 mitotic chromosome
condensation
 | 
10
 | 
2.02e-01
 | 
2.33e-01
 | 
5.77e-01
 | 
| 
GO:0006352 DNA-templated
transcription initiation
 | 
11
 | 
1.81e-01
 | 
-2.33e-01
 | 
5.49e-01
 | 
| 
GO:0031663
lipopolysaccharide-mediated signaling pathway
 | 
10
 | 
2.02e-01
 | 
2.33e-01
 | 
5.77e-01
 | 
| 
GO:0000184 nuclear-transcribed mRNA
catabolic process, nonsense-mediated decay
 | 
21
 | 
6.51e-02
 | 
-2.33e-01
 | 
3.44e-01
 | 
| 
GO:0070979 protein K11-linked
ubiquitination
 | 
22
 | 
5.94e-02
 | 
-2.32e-01
 | 
3.35e-01
 | 
| 
GO:0001938 positive regulation of
endothelial cell proliferation
 | 
23
 | 
5.45e-02
 | 
2.32e-01
 | 
3.26e-01
 | 
| 
GO:0006094 gluconeogenesis
 | 
20
 | 
7.32e-02
 | 
2.31e-01
 | 
3.63e-01
 | 
| 
GO:0051491 positive regulation of
filopodium assembly
 | 
15
 | 
1.21e-01
 | 
-2.31e-01
 | 
4.56e-01
 | 
| 
GO:0000149 SNARE binding
 | 
31
 | 
2.61e-02
 | 
2.31e-01
 | 
2.38e-01
 | 
| 
GO:0061709 reticulophagy
 | 
15
 | 
1.22e-01
 | 
2.31e-01
 | 
4.56e-01
 | 
| 
GO:0030097 hemopoiesis
 | 
25
 | 
4.60e-02
 | 
2.31e-01
 | 
3.08e-01
 | 
| 
GO:0032981 mitochondrial
respiratory chain complex I assembly
 | 
38
 | 
1.41e-02
 | 
2.30e-01
 | 
1.82e-01
 | 
| 
GO:0032496 response to
lipopolysaccharide
 | 
37
 | 
1.57e-02
 | 
2.30e-01
 | 
1.89e-01
 | 
| 
GO:0005254 chloride channel
activity
 | 
19
 | 
8.33e-02
 | 
2.30e-01
 | 
3.88e-01
 | 
| 
GO:0034142 toll-like receptor 4
signaling pathway
 | 
14
 | 
1.38e-01
 | 
2.29e-01
 | 
4.84e-01
 | 
| 
GO:0045444 fat cell differentiation
 | 
44
 | 
8.58e-03
 | 
2.29e-01
 | 
1.40e-01
 | 
| 
GO:0003689 DNA clamp loader
activity
 | 
32
 | 
2.50e-02
 | 
-2.29e-01
 | 
2.33e-01
 | 
| 
GO:0030513 positive regulation of
BMP signaling pathway
 | 
20
 | 
7.65e-02
 | 
-2.29e-01
 | 
3.74e-01
 | 
| 
GO:0097060 synaptic membrane
 | 
11
 | 
1.92e-01
 | 
-2.27e-01
 | 
5.66e-01
 | 
| 
GO:0004197 cysteine-type
endopeptidase activity
 | 
37
 | 
1.67e-02
 | 
2.27e-01
 | 
1.92e-01
 | 
| 
GO:0009792 embryo development
ending in birth or egg hatching
 | 
10
 | 
2.14e-01
 | 
-2.27e-01
 | 
5.91e-01
 | 
| 
GO:0043408 regulation of MAPK
cascade
 | 
21
 | 
7.19e-02
 | 
-2.27e-01
 | 
3.59e-01
 | 
| 
GO:0035025 positive regulation of
Rho protein signal transduction
 | 
10
 | 
2.14e-01
 | 
-2.27e-01
 | 
5.91e-01
 | 
| 
GO:0042733 embryonic digit
morphogenesis
 | 
30
 | 
3.19e-02
 | 
2.26e-01
 | 
2.63e-01
 | 
| 
GO:0050885 neuromuscular process
controlling balance
 | 
24
 | 
5.51e-02
 | 
-2.26e-01
 | 
3.26e-01
 | 
| 
GO:0006364 rRNA processing
 | 
65
 | 
1.63e-03
 | 
-2.26e-01
 | 
5.54e-02
 | 
| 
GO:0005777 peroxisome
 | 
49
 | 
6.29e-03
 | 
2.26e-01
 | 
1.22e-01
 | 
| 
GO:0030170 pyridoxal phosphate
binding
 | 
33
 | 
2.50e-02
 | 
2.25e-01
 | 
2.33e-01
 | 
| 
GO:1990841 promoter-specific
chromatin binding
 | 
34
 | 
2.30e-02
 | 
-2.25e-01
 | 
2.30e-01
 | 
| 
GO:0009408 response to heat
 | 
19
 | 
8.91e-02
 | 
-2.25e-01
 | 
3.99e-01
 | 
| 
GO:0046875 ephrin receptor binding
 | 
17
 | 
1.08e-01
 | 
2.25e-01
 | 
4.33e-01
 | 
| 
GO:0002039 p53 binding
 | 
44
 | 
9.77e-03
 | 
-2.25e-01
 | 
1.48e-01
 | 
| 
GO:0002088 lens development in
camera-type eye
 | 
13
 | 
1.62e-01
 | 
-2.24e-01
 | 
5.20e-01
 | 
| 
GO:0005793 endoplasmic
reticulum-Golgi intermediate compartment
 | 
35
 | 
2.20e-02
 | 
2.24e-01
 | 
2.27e-01
 | 
| 
GO:0007389 pattern specification
process
 | 
14
 | 
1.47e-01
 | 
2.24e-01
 | 
4.99e-01
 | 
| 
GO:0030017 sarcomere
 | 
13
 | 
1.63e-01
 | 
2.24e-01
 | 
5.21e-01
 | 
| 
GO:0003713 transcription
coactivator activity
 | 
128
 | 
1.29e-05
 | 
-2.24e-01
 | 
2.07e-03
 | 
| 
GO:0005879 axonemal microtubule
 | 
10
 | 
2.21e-01
 | 
2.23e-01
 | 
5.95e-01
 | 
| 
GO:0009791 post-embryonic
development
 | 
36
 | 
2.10e-02
 | 
-2.22e-01
 | 
2.24e-01
 | 
| 
GO:0030041 actin filament
polymerization
 | 
16
 | 
1.24e-01
 | 
2.22e-01
 | 
4.61e-01
 | 
| 
GO:0060291 long-term synaptic
potentiation
 | 
11
 | 
2.03e-01
 | 
-2.22e-01
 | 
5.77e-01
 | 
| 
GO:0043687 post-translational
protein modification
 | 
19
 | 
9.47e-02
 | 
2.21e-01
 | 
4.11e-01
 | 
| 
GO:0097730 non-motile cilium
 | 
14
 | 
1.52e-01
 | 
2.21e-01
 | 
5.04e-01
 | 
| 
GO:0099175 regulation of
postsynapse organization
 | 
20
 | 
8.67e-02
 | 
2.21e-01
 | 
3.92e-01
 | 
| 
GO:0010569 regulation of
double-strand break repair via homologous recombination
 | 
10
 | 
2.26e-01
 | 
-2.21e-01
 | 
6.02e-01
 | 
| 
GO:0098686 hippocampal mossy fiber
to CA3 synapse
 | 
16
 | 
1.26e-01
 | 
-2.21e-01
 | 
4.64e-01
 | 
| 
GO:0010592 positive regulation of
lamellipodium assembly
 | 
10
 | 
2.28e-01
 | 
2.20e-01
 | 
6.04e-01
 | 
| 
GO:0005540 hyaluronic acid binding
 | 
13
 | 
1.69e-01
 | 
2.20e-01
 | 
5.31e-01
 | 
| 
GO:0006816 calcium ion transport
 | 
19
 | 
9.68e-02
 | 
2.20e-01
 | 
4.15e-01
 | 
| 
GO:0000151 ubiquitin ligase complex
 | 
48
 | 
8.37e-03
 | 
-2.20e-01
 | 
1.40e-01
 | 
| 
GO:0009953 dorsal/ventral pattern
formation
 | 
16
 | 
1.28e-01
 | 
-2.20e-01
 | 
4.67e-01
 | 
| 
GO:0048144 fibroblast proliferation
 | 
22
 | 
7.45e-02
 | 
2.20e-01
 | 
3.69e-01
 | 
| 
GO:0045184 establishment of protein
localization
 | 
17
 | 
1.17e-01
 | 
2.19e-01
 | 
4.51e-01
 | 
| 
GO:0008320 protein transmembrane
transporter activity
 | 
11
 | 
2.08e-01
 | 
-2.19e-01
 | 
5.83e-01
 | 
| 
GO:0034394 protein localization to
cell surface
 | 
17
 | 
1.18e-01
 | 
-2.19e-01
 | 
4.53e-01
 | 
| 
GO:0051287 NAD binding
 | 
19
 | 
9.95e-02
 | 
2.18e-01
 | 
4.20e-01
 | 
| 
GO:0003725 double-stranded RNA
binding
 | 
44
 | 
1.24e-02
 | 
-2.18e-01
 | 
1.65e-01
 | 
| 
GO:0030593 neutrophil chemotaxis
 | 
13
 | 
1.75e-01
 | 
2.17e-01
 | 
5.38e-01
 | 
| 
GO:0045931 positive regulation of
mitotic cell cycle
 | 
14
 | 
1.60e-01
 | 
2.17e-01
 | 
5.20e-01
 | 
| 
GO:0005811 lipid droplet
 | 
42
 | 
1.51e-02
 | 
2.17e-01
 | 
1.87e-01
 | 
| 
GO:0040014 regulation of
multicellular organism growth
 | 
12
 | 
1.95e-01
 | 
2.16e-01
 | 
5.67e-01
 | 
| 
GO:0001540 amyloid-beta binding
 | 
28
 | 
4.84e-02
 | 
2.16e-01
 | 
3.11e-01
 | 
| 
GO:0003925 G protein activity
 | 
18
 | 
1.14e-01
 | 
2.15e-01
 | 
4.45e-01
 | 
| 
GO:0019827 stem cell population
maintenance
 | 
21
 | 
8.78e-02
 | 
-2.15e-01
 | 
3.95e-01
 | 
| 
GO:0004402 histone
acetyltransferase activity
 | 
11
 | 
2.17e-01
 | 
-2.15e-01
 | 
5.92e-01
 | 
| 
GO:1990830 cellular response to
leukemia inhibitory factor
 | 
66
 | 
2.62e-03
 | 
-2.14e-01
 | 
7.60e-02
 | 
| 
GO:0030331 nuclear estrogen
receptor binding
 | 
19
 | 
1.06e-01
 | 
-2.14e-01
 | 
4.30e-01
 | 
| 
GO:0070050 neuron cellular
homeostasis
 | 
14
 | 
1.65e-01
 | 
-2.14e-01
 | 
5.25e-01
 | 
| 
GO:0006672 ceramide metabolic
process
 | 
10
 | 
2.41e-01
 | 
2.14e-01
 | 
6.20e-01
 | 
| 
GO:0035924 cellular response to
vascular endothelial growth factor stimulus
 | 
16
 | 
1.39e-01
 | 
2.14e-01
 | 
4.84e-01
 | 
| 
GO:0070373 negative regulation of
ERK1 and ERK2 cascade
 | 
30
 | 
4.33e-02
 | 
-2.13e-01
 | 
3.02e-01
 | 
| 
GO:1902018 negative regulation of
cilium assembly
 | 
13
 | 
1.83e-01
 | 
-2.13e-01
 | 
5.52e-01
 | 
| 
GO:0003899 DNA-directed 5’-3’ RNA
polymerase activity
 | 
10
 | 
2.43e-01
 | 
-2.13e-01
 | 
6.22e-01
 | 
| 
GO:0018279 protein N-linked
glycosylation via asparagine
 | 
11
 | 
2.21e-01
 | 
2.13e-01
 | 
5.95e-01
 | 
| 
GO:0071277 cellular response to
calcium ion
 | 
32
 | 
3.74e-02
 | 
2.13e-01
 | 
2.78e-01
 | 
| 
GO:0009615 response to virus
 | 
29
 | 
4.76e-02
 | 
2.13e-01
 | 
3.10e-01
 | 
| 
GO:0140416 transcription regulator
inhibitor activity
 | 
12
 | 
2.03e-01
 | 
-2.12e-01
 | 
5.77e-01
 | 
| 
GO:0045815 transcription
initiation-coupled chromatin remodeling
 | 
20
 | 
1.01e-01
 | 
-2.12e-01
 | 
4.21e-01
 | 
| 
GO:0043122 regulation of canonical
NF-kappaB signal transduction
 | 
18
 | 
1.20e-01
 | 
2.12e-01
 | 
4.55e-01
 | 
| 
GO:0007608 sensory perception of
smell
 | 
11
 | 
2.25e-01
 | 
2.12e-01
 | 
6.00e-01
 | 
| 
GO:0005694 chromosome
 | 
76
 | 
1.45e-03
 | 
-2.11e-01
 | 
5.34e-02
 | 
| 
GO:0070372 regulation of ERK1 and
ERK2 cascade
 | 
12
 | 
2.06e-01
 | 
-2.11e-01
 | 
5.81e-01
 | 
| 
GO:0007601 visual perception
 | 
37
 | 
2.67e-02
 | 
2.11e-01
 | 
2.41e-01
 | 
| 
GO:0071005 U2-type precatalytic
spliceosome
 | 
31
 | 
4.30e-02
 | 
-2.10e-01
 | 
3.02e-01
 | 
| 
GO:0001046 core promoter
sequence-specific DNA binding
 | 
11
 | 
2.28e-01
 | 
-2.10e-01
 | 
6.04e-01
 | 
| 
GO:0072583 clathrin-dependent
endocytosis
 | 
19
 | 
1.14e-01
 | 
2.09e-01
 | 
4.46e-01
 | 
| 
GO:0042307 positive regulation of
protein import into nucleus
 | 
25
 | 
7.04e-02
 | 
-2.09e-01
 | 
3.55e-01
 | 
| 
GO:0010824 regulation of centrosome
duplication
 | 
15
 | 
1.61e-01
 | 
-2.09e-01
 | 
5.20e-01
 | 
| 
GO:0070006 metalloaminopeptidase
activity
 | 
15
 | 
1.61e-01
 | 
2.09e-01
 | 
5.20e-01
 | 
| 
GO:0036064 ciliary basal body
 | 
103
 | 
2.56e-04
 | 
2.09e-01
 | 
2.06e-02
 | 
| 
GO:1905515 non-motile cilium
assembly
 | 
39
 | 
2.47e-02
 | 
2.08e-01
 | 
2.33e-01
 | 
| 
GO:0007162 negative regulation of
cell adhesion
 | 
17
 | 
1.38e-01
 | 
-2.08e-01
 | 
4.84e-01
 | 
| 
GO:0035102 PRC1 complex
 | 
12
 | 
2.15e-01
 | 
-2.07e-01
 | 
5.91e-01
 | 
| 
GO:0097352 autophagosome maturation
 | 
23
 | 
8.73e-02
 | 
2.06e-01
 | 
3.94e-01
 | 
| 
GO:0016973 poly(A)+ mRNA export
from nucleus
 | 
13
 | 
2.00e-01
 | 
-2.05e-01
 | 
5.77e-01
 | 
| 
GO:0030855 epithelial cell
differentiation
 | 
29
 | 
5.61e-02
 | 
2.05e-01
 | 
3.28e-01
 | 
| 
GO:0006488 dolichol-linked
oligosaccharide biosynthetic process
 | 
14
 | 
1.85e-01
 | 
2.05e-01
 | 
5.55e-01
 | 
| 
GO:0007405 neuroblast proliferation
 | 
21
 | 
1.04e-01
 | 
2.05e-01
 | 
4.30e-01
 | 
| 
GO:0043484 regulation of RNA
splicing
 | 
23
 | 
8.95e-02
 | 
-2.05e-01
 | 
3.99e-01
 | 
| 
GO:0031175 neuron projection
development
 | 
50
 | 
1.24e-02
 | 
-2.05e-01
 | 
1.65e-01
 | 
| 
GO:0051480 regulation of cytosolic
calcium ion concentration
 | 
13
 | 
2.02e-01
 | 
2.04e-01
 | 
5.77e-01
 | 
| 
GO:0008089 anterograde axonal
transport
 | 
10
 | 
2.67e-01
 | 
2.03e-01
 | 
6.50e-01
 | 
| 
GO:0007026 negative regulation of
microtubule depolymerization
 | 
17
 | 
1.49e-01
 | 
2.02e-01
 | 
5.00e-01
 | 
| 
GO:0016491 oxidoreductase activity
 | 
46
 | 
1.78e-02
 | 
2.02e-01
 | 
1.99e-01
 | 
| 
GO:0006891 intra-Golgi
vesicle-mediated transport
 | 
19
 | 
1.27e-01
 | 
2.02e-01
 | 
4.67e-01
 | 
| 
GO:0003714 transcription
corepressor activity
 | 
101
 | 
4.72e-04
 | 
-2.02e-01
 | 
2.99e-02
 | 
| 
GO:0007623 circadian rhythm
 | 
18
 | 
1.39e-01
 | 
2.01e-01
 | 
4.86e-01
 | 
| 
GO:0004438
phosphatidylinositol-3-phosphate phosphatase activity
 | 
13
 | 
2.09e-01
 | 
-2.01e-01
 | 
5.84e-01
 | 
| 
GO:0005643 nuclear pore
 | 
33
 | 
4.62e-02
 | 
-2.01e-01
 | 
3.08e-01
 | 
| 
GO:0004860 protein kinase inhibitor
activity
 | 
19
 | 
1.31e-01
 | 
2.00e-01
 | 
4.72e-01
 | 
| 
GO:0006979 response to oxidative
stress
 | 
49
 | 
1.53e-02
 | 
2.00e-01
 | 
1.87e-01
 | 
| 
GO:0006633 fatty acid biosynthetic
process
 | 
22
 | 
1.05e-01
 | 
2.00e-01
 | 
4.30e-01
 | 
| 
GO:0032956 regulation of actin
cytoskeleton organization
 | 
37
 | 
3.61e-02
 | 
1.99e-01
 | 
2.74e-01
 | 
| 
GO:0035115 embryonic forelimb
morphogenesis
 | 
16
 | 
1.69e-01
 | 
1.98e-01
 | 
5.31e-01
 | 
| 
GO:0007492 endoderm development
 | 
11
 | 
2.55e-01
 | 
-1.98e-01
 | 
6.37e-01
 | 
| 
GO:0003729 mRNA binding
 | 
145
 | 
4.00e-05
 | 
-1.98e-01
 | 
5.21e-03
 | 
| 
GO:0048812 neuron projection
morphogenesis
 | 
31
 | 
5.71e-02
 | 
-1.98e-01
 | 
3.31e-01
 | 
| 
GO:0034451 centriolar satellite
 | 
73
 | 
3.60e-03
 | 
1.97e-01
 | 
9.10e-02
 | 
| 
GO:0001501 skeletal system
development
 | 
34
 | 
4.68e-02
 | 
1.97e-01
 | 
3.09e-01
 | 
| 
GO:0010975 regulation of neuron
projection development
 | 
16
 | 
1.73e-01
 | 
1.97e-01
 | 
5.36e-01
 | 
| 
GO:0048278 vesicle docking
 | 
13
 | 
2.20e-01
 | 
1.97e-01
 | 
5.94e-01
 | 
| 
GO:0009982 pseudouridine synthase
activity
 | 
12
 | 
2.39e-01
 | 
-1.96e-01
 | 
6.20e-01
 | 
| 
GO:0048384 retinoic acid receptor
signaling pathway
 | 
11
 | 
2.60e-01
 | 
-1.96e-01
 | 
6.45e-01
 | 
| 
GO:0030946 protein tyrosine
phosphatase activity, metal-dependent
 | 
15
 | 
1.88e-01
 | 
-1.96e-01
 | 
5.61e-01
 | 
| 
GO:0140793 histone H2AXY142
phosphatase activity
 | 
15
 | 
1.88e-01
 | 
-1.96e-01
 | 
5.61e-01
 | 
| 
GO:0006654 phosphatidic acid
biosynthetic process
 | 
12
 | 
2.40e-01
 | 
1.96e-01
 | 
6.20e-01
 | 
| 
GO:0050768 negative regulation of
neurogenesis
 | 
10
 | 
2.84e-01
 | 
-1.96e-01
 | 
6.64e-01
 | 
| 
GO:0005814 centriole
 | 
92
 | 
1.20e-03
 | 
1.96e-01
 | 
5.05e-02
 | 
| 
GO:0001837 epithelial to
mesenchymal transition
 | 
16
 | 
1.77e-01
 | 
1.95e-01
 | 
5.42e-01
 | 
| 
GO:0031369 translation initiation
factor binding
 | 
12
 | 
2.42e-01
 | 
-1.95e-01
 | 
6.21e-01
 | 
| 
GO:0031573 mitotic intra-S DNA
damage checkpoint signaling
 | 
11
 | 
2.63e-01
 | 
-1.95e-01
 | 
6.49e-01
 | 
| 
GO:0007224 smoothened signaling
pathway
 | 
51
 | 
1.64e-02
 | 
1.94e-01
 | 
1.92e-01
 | 
| 
GO:0006270 DNA replication
initiation
 | 
19
 | 
1.44e-01
 | 
-1.94e-01
 | 
4.96e-01
 | 
| 
GO:0019915 lipid storage
 | 
11
 | 
2.67e-01
 | 
1.93e-01
 | 
6.50e-01
 | 
| 
GO:0007166 cell surface receptor
signaling pathway
 | 
40
 | 
3.44e-02
 | 
1.93e-01
 | 
2.72e-01
 | 
| 
GO:0030140 trans-Golgi network
transport vesicle
 | 
11
 | 
2.67e-01
 | 
-1.93e-01
 | 
6.50e-01
 | 
| 
GO:0030742 GTP-dependent protein
binding
 | 
13
 | 
2.29e-01
 | 
1.93e-01
 | 
6.04e-01
 | 
| 
GO:0005882 intermediate filament
 | 
20
 | 
1.36e-01
 | 
-1.92e-01
 | 
4.82e-01
 | 
| 
GO:0043425 bHLH transcription
factor binding
 | 
10
 | 
2.93e-01
 | 
-1.92e-01
 | 
6.75e-01
 | 
| 
GO:0008584 male gonad development
 | 
28
 | 
7.90e-02
 | 
1.92e-01
 | 
3.81e-01
 | 
| 
GO:0006325 chromatin organization
 | 
66
 | 
7.23e-03
 | 
-1.91e-01
 | 
1.29e-01
 | 
| 
GO:0010718 positive regulation of
epithelial to mesenchymal transition
 | 
26
 | 
9.19e-02
 | 
-1.91e-01
 | 
4.06e-01
 | 
| 
GO:0006338 chromatin remodeling
 | 
249
 | 
2.31e-07
 | 
-1.91e-01
 | 
5.83e-05
 | 
| 
GO:0006368 transcription elongation
by RNA polymerase II
 | 
24
 | 
1.06e-01
 | 
-1.91e-01
 | 
4.30e-01
 | 
| 
GO:0004721 phosphoprotein
phosphatase activity
 | 
21
 | 
1.31e-01
 | 
-1.90e-01
 | 
4.73e-01
 | 
| 
GO:0001974 blood vessel remodeling
 | 
16
 | 
1.88e-01
 | 
1.90e-01
 | 
5.61e-01
 | 
| 
GO:0140311 protein sequestering
activity
 | 
18
 | 
1.63e-01
 | 
1.90e-01
 | 
5.21e-01
 | 
| 
GO:0071479 cellular response to
ionizing radiation
 | 
22
 | 
1.24e-01
 | 
-1.90e-01
 | 
4.61e-01
 | 
| 
GO:1901223 negative regulation of
non-canonical NF-kappaB signal transduction
 | 
14
 | 
2.20e-01
 | 
1.89e-01
 | 
5.94e-01
 | 
| 
GO:0008094 ATP-dependent activity,
acting on DNA
 | 
11
 | 
2.80e-01
 | 
-1.88e-01
 | 
6.64e-01
 | 
| 
GO:0005815 microtubule organizing
center
 | 
36
 | 
5.13e-02
 | 
1.88e-01
 | 
3.19e-01
 | 
| 
GO:0034097 response to cytokine
 | 
12
 | 
2.61e-01
 | 
-1.87e-01
 | 
6.46e-01
 | 
| 
GO:0042102 positive regulation of T
cell proliferation
 | 
10
 | 
3.05e-01
 | 
-1.87e-01
 | 
6.85e-01
 | 
| 
GO:0000266 mitochondrial fission
 | 
10
 | 
3.06e-01
 | 
1.87e-01
 | 
6.85e-01
 | 
| 
GO:0032040 small-subunit processome
 | 
59
 | 
1.31e-02
 | 
-1.87e-01
 | 
1.70e-01
 | 
| 
GO:0043325
phosphatidylinositol-3,4-bisphosphate binding
 | 
13
 | 
2.44e-01
 | 
1.87e-01
 | 
6.22e-01
 | 
| 
GO:0000987 cis-regulatory region
sequence-specific DNA binding
 | 
21
 | 
1.40e-01
 | 
-1.86e-01
 | 
4.87e-01
 | 
| 
GO:0008168 methyltransferase
activity
 | 
13
 | 
2.47e-01
 | 
-1.86e-01
 | 
6.27e-01
 | 
| 
GO:0055037 recycling endosome
 | 
56
 | 
1.65e-02
 | 
1.85e-01
 | 
1.92e-01
 | 
| 
GO:0043153 entrainment of circadian
clock by photoperiod
 | 
13
 | 
2.48e-01
 | 
-1.85e-01
 | 
6.27e-01
 | 
| 
GO:0005721 pericentric
heterochromatin
 | 
18
 | 
1.75e-01
 | 
-1.85e-01
 | 
5.38e-01
 | 
| 
GO:0071466 cellular response to
xenobiotic stimulus
 | 
25
 | 
1.10e-01
 | 
-1.85e-01
 | 
4.36e-01
 | 
| 
GO:0001935 endothelial cell
proliferation
 | 
12
 | 
2.68e-01
 | 
1.85e-01
 | 
6.50e-01
 | 
| 
GO:0008047 enzyme activator
activity
 | 
15
 | 
2.16e-01
 | 
-1.84e-01
 | 
5.92e-01
 | 
| 
GO:0090102 cochlea development
 | 
12
 | 
2.69e-01
 | 
1.84e-01
 | 
6.50e-01
 | 
| 
GO:0001568 blood vessel development
 | 
19
 | 
1.65e-01
 | 
1.84e-01
 | 
5.25e-01
 | 
| 
GO:0001221 transcription
coregulator binding
 | 
17
 | 
1.89e-01
 | 
-1.84e-01
 | 
5.63e-01
 | 
| 
GO:0004896 cytokine receptor
activity
 | 
19
 | 
1.66e-01
 | 
1.83e-01
 | 
5.27e-01
 | 
| 
GO:0005771 multivesicular body
 | 
21
 | 
1.46e-01
 | 
1.83e-01
 | 
4.99e-01
 | 
| 
GO:0042254 ribosome biogenesis
 | 
16
 | 
2.06e-01
 | 
-1.83e-01
 | 
5.83e-01
 | 
| 
GO:0017147 Wnt-protein binding
 | 
17
 | 
1.93e-01
 | 
1.82e-01
 | 
5.66e-01
 | 
| 
GO:0015026 coreceptor activity
 | 
13
 | 
2.55e-01
 | 
1.82e-01
 | 
6.37e-01
 | 
| 
GO:0007018 microtubule-based
movement
 | 
40
 | 
4.60e-02
 | 
1.82e-01
 | 
3.08e-01
 | 
| 
GO:0051781 positive regulation of
cell division
 | 
13
 | 
2.55e-01
 | 
1.82e-01
 | 
6.37e-01
 | 
| 
GO:0008380 RNA splicing
 | 
47
 | 
3.08e-02
 | 
-1.82e-01
 | 
2.61e-01
 | 
| 
GO:0046849 bone remodeling
 | 
10
 | 
3.19e-01
 | 
-1.82e-01
 | 
6.98e-01
 | 
| 
GO:0035249 synaptic transmission,
glutamatergic
 | 
16
 | 
2.08e-01
 | 
1.82e-01
 | 
5.83e-01
 | 
| 
GO:0044782 cilium organization
 | 
13
 | 
2.57e-01
 | 
1.82e-01
 | 
6.39e-01
 | 
| 
GO:0042327 positive regulation of
phosphorylation
 | 
12
 | 
2.76e-01
 | 
1.82e-01
 | 
6.64e-01
 | 
| 
GO:0016853 isomerase activity
 | 
19
 | 
1.71e-01
 | 
-1.81e-01
 | 
5.34e-01
 | 
| 
GO:0000974 Prp19 complex
 | 
10
 | 
3.21e-01
 | 
-1.81e-01
 | 
6.99e-01
 | 
| 
GO:0038061 non-canonical NF-kappaB
signal transduction
 | 
11
 | 
2.98e-01
 | 
-1.81e-01
 | 
6.80e-01
 | 
| 
GO:0031466 Cul5-RING ubiquitin
ligase complex
 | 
11
 | 
2.98e-01
 | 
1.81e-01
 | 
6.80e-01
 | 
| 
GO:0030057 desmosome
 | 
11
 | 
2.98e-01
 | 
-1.81e-01
 | 
6.80e-01
 | 
| 
GO:0004386 helicase activity
 | 
40
 | 
4.76e-02
 | 
-1.81e-01
 | 
3.10e-01
 | 
| 
GO:0070628 proteasome binding
 | 
13
 | 
2.61e-01
 | 
-1.80e-01
 | 
6.46e-01
 | 
| 
GO:0090543 Flemming body
 | 
14
 | 
2.44e-01
 | 
1.80e-01
 | 
6.22e-01
 | 
| 
GO:0005546
phosphatidylinositol-4,5-bisphosphate binding
 | 
41
 | 
4.68e-02
 | 
1.80e-01
 | 
3.09e-01
 | 
| 
GO:0000070 mitotic sister chromatid
segregation
 | 
18
 | 
1.90e-01
 | 
1.78e-01
 | 
5.63e-01
 | 
| 
GO:0032743 positive regulation of
interleukin-2 production
 | 
16
 | 
2.17e-01
 | 
1.78e-01
 | 
5.92e-01
 | 
| 
GO:0060382 regulation of DNA strand
elongation
 | 
10
 | 
3.29e-01
 | 
-1.78e-01
 | 
7.08e-01
 | 
| 
GO:0032266
phosphatidylinositol-3-phosphate binding
 | 
32
 | 
8.16e-02
 | 
1.78e-01
 | 
3.86e-01
 | 
| 
GO:0000132 establishment of mitotic
spindle orientation
 | 
26
 | 
1.17e-01
 | 
1.78e-01
 | 
4.50e-01
 | 
| 
GO:0045454 cell redox homeostasis
 | 
20
 | 
1.69e-01
 | 
1.78e-01
 | 
5.31e-01
 | 
| 
GO:0045648 positive regulation of
erythrocyte differentiation
 | 
18
 | 
1.92e-01
 | 
-1.78e-01
 | 
5.66e-01
 | 
| 
GO:0004622 lysophospholipase
activity
 | 
10
 | 
3.31e-01
 | 
1.77e-01
 | 
7.12e-01
 | 
| 
GO:0032729 positive regulation of
type II interferon production
 | 
22
 | 
1.50e-01
 | 
1.77e-01
 | 
5.02e-01
 | 
| 
GO:0043296 apical junction complex
 | 
10
 | 
3.32e-01
 | 
-1.77e-01
 | 
7.12e-01
 | 
| 
GO:0048854 brain morphogenesis
 | 
14
 | 
2.51e-01
 | 
1.77e-01
 | 
6.33e-01
 | 
| 
GO:0097150 neuronal stem cell
population maintenance
 | 
18
 | 
1.93e-01
 | 
1.77e-01
 | 
5.66e-01
 | 
| 
GO:0044183 protein folding
chaperone
 | 
21
 | 
1.62e-01
 | 
-1.76e-01
 | 
5.20e-01
 | 
| 
GO:0007338 single fertilization
 | 
20
 | 
1.72e-01
 | 
1.76e-01
 | 
5.36e-01
 | 
| 
GO:0005762 mitochondrial large
ribosomal subunit
 | 
38
 | 
6.02e-02
 | 
1.76e-01
 | 
3.36e-01
 | 
| 
GO:0032722 positive regulation of
chemokine production
 | 
11
 | 
3.12e-01
 | 
1.76e-01
 | 
6.89e-01
 | 
| 
GO:0035613 RNA stem-loop binding
 | 
11
 | 
3.12e-01
 | 
-1.76e-01
 | 
6.89e-01
 | 
| 
GO:1904262 negative regulation of
TORC1 signaling
 | 
28
 | 
1.08e-01
 | 
1.75e-01
 | 
4.34e-01
 | 
| 
GO:0006622 protein targeting to
lysosome
 | 
15
 | 
2.41e-01
 | 
1.75e-01
 | 
6.20e-01
 | 
| 
GO:0006376 mRNA splice site
recognition
 | 
12
 | 
2.94e-01
 | 
-1.75e-01
 | 
6.76e-01
 | 
| 
GO:0046854 phosphatidylinositol
phosphate biosynthetic process
 | 
18
 | 
2.00e-01
 | 
-1.75e-01
 | 
5.77e-01
 | 
| 
GO:0006487 protein N-linked
glycosylation
 | 
30
 | 
9.80e-02
 | 
1.75e-01
 | 
4.18e-01
 | 
| 
GO:0000146 microfilament motor
activity
 | 
19
 | 
1.88e-01
 | 
-1.74e-01
 | 
5.61e-01
 | 
| 
GO:2000378 negative regulation of
reactive oxygen species metabolic process
 | 
10
 | 
3.40e-01
 | 
1.74e-01
 | 
7.18e-01
 | 
| 
GO:0007064 mitotic sister chromatid
cohesion
 | 
10
 | 
3.40e-01
 | 
1.74e-01
 | 
7.18e-01
 | 
| 
GO:0035064 methylated histone
binding
 | 
42
 | 
5.23e-02
 | 
-1.73e-01
 | 
3.19e-01
 | 
| 
GO:0030163 protein catabolic
process
 | 
31
 | 
9.54e-02
 | 
1.73e-01
 | 
4.12e-01
 | 
| 
GO:0035198 miRNA binding
 | 
20
 | 
1.80e-01
 | 
-1.73e-01
 | 
5.49e-01
 | 
| 
GO:0051592 response to calcium ion
 | 
20
 | 
1.80e-01
 | 
1.73e-01
 | 
5.49e-01
 | 
| 
GO:0031072 heat shock protein
binding
 | 
27
 | 
1.21e-01
 | 
-1.73e-01
 | 
4.55e-01
 | 
| 
GO:2001243 negative regulation of
intrinsic apoptotic signaling pathway
 | 
13
 | 
2.85e-01
 | 
-1.71e-01
 | 
6.64e-01
 | 
| 
GO:0061351 neural precursor cell
proliferation
 | 
14
 | 
2.67e-01
 | 
-1.71e-01
 | 
6.50e-01
 | 
| 
GO:0007097 nuclear migration
 | 
15
 | 
2.53e-01
 | 
1.71e-01
 | 
6.35e-01
 | 
| 
GO:0032757 positive regulation of
interleukin-8 production
 | 
17
 | 
2.24e-01
 | 
1.70e-01
 | 
5.99e-01
 | 
| 
GO:0005637 nuclear inner membrane
 | 
24
 | 
1.49e-01
 | 
1.70e-01
 | 
5.00e-01
 | 
| 
GO:0046329 negative regulation of
JNK cascade
 | 
12
 | 
3.09e-01
 | 
1.70e-01
 | 
6.86e-01
 | 
| 
GO:2000042 negative regulation of
double-strand break repair via homologous recombination
 | 
16
 | 
2.41e-01
 | 
-1.69e-01
 | 
6.20e-01
 | 
| 
GO:0033017 sarcoplasmic reticulum
membrane
 | 
10
 | 
3.54e-01
 | 
-1.69e-01
 | 
7.30e-01
 | 
| 
GO:0061024 membrane organization
 | 
13
 | 
2.91e-01
 | 
1.69e-01
 | 
6.73e-01
 | 
| 
GO:0050681 nuclear androgen
receptor binding
 | 
16
 | 
2.41e-01
 | 
-1.69e-01
 | 
6.20e-01
 | 
| 
GO:0001650 fibrillar center
 | 
101
 | 
3.33e-03
 | 
-1.69e-01
 | 
9.06e-02
 | 
| 
GO:0004521 RNA endonuclease
activity
 | 
20
 | 
1.90e-01
 | 
1.69e-01
 | 
5.64e-01
 | 
| 
GO:0032760 positive regulation of
tumor necrosis factor production
 | 
33
 | 
9.28e-02
 | 
1.69e-01
 | 
4.07e-01
 | 
| 
GO:0006275 regulation of DNA
replication
 | 
24
 | 
1.53e-01
 | 
-1.69e-01
 | 
5.05e-01
 | 
| 
GO:0043536 positive regulation of
blood vessel endothelial cell migration
 | 
18
 | 
2.16e-01
 | 
1.68e-01
 | 
5.92e-01
 | 
| 
GO:0032467 positive regulation of
cytokinesis
 | 
14
 | 
2.75e-01
 | 
1.68e-01
 | 
6.63e-01
 | 
| 
GO:0001894 tissue homeostasis
 | 
13
 | 
2.94e-01
 | 
-1.68e-01
 | 
6.76e-01
 | 
| 
GO:0007098 centrosome cycle
 | 
17
 | 
2.31e-01
 | 
1.68e-01
 | 
6.06e-01
 | 
| 
GO:0030488 tRNA methylation
 | 
20
 | 
1.95e-01
 | 
-1.68e-01
 | 
5.67e-01
 | 
| 
GO:0030837 negative regulation of
actin filament polymerization
 | 
14
 | 
2.78e-01
 | 
1.67e-01
 | 
6.64e-01
 | 
| 
GO:0045202 synapse
 | 
163
 | 
2.34e-04
 | 
1.67e-01
 | 
2.06e-02
 | 
| 
GO:0071013 catalytic step 2
spliceosome
 | 
52
 | 
3.71e-02
 | 
-1.67e-01
 | 
2.77e-01
 | 
| 
GO:0031468 nuclear membrane
reassembly
 | 
11
 | 
3.38e-01
 | 
1.67e-01
 | 
7.17e-01
 | 
| 
GO:1905168 positive regulation of
double-strand break repair via homologous recombination
 | 
25
 | 
1.49e-01
 | 
-1.67e-01
 | 
5.00e-01
 | 
| 
GO:0071300 cellular response to
retinoic acid
 | 
17
 | 
2.35e-01
 | 
-1.66e-01
 | 
6.13e-01
 | 
| 
GO:0045766 positive regulation of
angiogenesis
 | 
53
 | 
3.64e-02
 | 
1.66e-01
 | 
2.75e-01
 | 
| 
GO:0036464 cytoplasmic
ribonucleoprotein granule
 | 
36
 | 
8.45e-02
 | 
1.66e-01
 | 
3.88e-01
 | 
| 
GO:0015459 potassium channel
regulator activity
 | 
14
 | 
2.83e-01
 | 
-1.66e-01
 | 
6.64e-01
 | 
| 
GO:0032715 negative regulation of
interleukin-6 production
 | 
14
 | 
2.83e-01
 | 
-1.66e-01
 | 
6.64e-01
 | 
| 
GO:0007095 mitotic G2 DNA damage
checkpoint signaling
 | 
30
 | 
1.17e-01
 | 
-1.66e-01
 | 
4.50e-01
 | 
| 
GO:0001508 action potential
 | 
11
 | 
3.42e-01
 | 
-1.66e-01
 | 
7.19e-01
 | 
| 
GO:0090050 positive regulation of
cell migration involved in sprouting angiogenesis
 | 
14
 | 
2.85e-01
 | 
1.65e-01
 | 
6.64e-01
 | 
| 
GO:0014704 intercalated disc
 | 
13
 | 
3.03e-01
 | 
1.65e-01
 | 
6.84e-01
 | 
| 
GO:0046856 phosphatidylinositol
dephosphorylation
 | 
26
 | 
1.46e-01
 | 
-1.65e-01
 | 
4.99e-01
 | 
| 
GO:0033627 cell adhesion mediated
by integrin
 | 
23
 | 
1.72e-01
 | 
1.65e-01
 | 
5.36e-01
 | 
| 
GO:0048010 vascular endothelial
growth factor receptor signaling pathway
 | 
13
 | 
3.04e-01
 | 
-1.65e-01
 | 
6.84e-01
 | 
| 
GO:0005581 collagen trimer
 | 
20
 | 
2.04e-01
 | 
1.64e-01
 | 
5.77e-01
 | 
| 
GO:0070498 interleukin-1-mediated
signaling pathway
 | 
11
 | 
3.46e-01
 | 
1.64e-01
 | 
7.24e-01
 | 
| 
GO:0098685 Schaffer collateral -
CA1 synapse
 | 
44
 | 
6.00e-02
 | 
1.64e-01
 | 
3.36e-01
 | 
| 
GO:0017124 SH3 domain binding
 | 
43
 | 
6.31e-02
 | 
1.64e-01
 | 
3.44e-01
 | 
| 
GO:0003333 amino acid transmembrane
transport
 | 
10
 | 
3.70e-01
 | 
-1.64e-01
 | 
7.41e-01
 | 
| 
GO:0030509 BMP signaling pathway
 | 
38
 | 
8.10e-02
 | 
-1.64e-01
 | 
3.84e-01
 | 
| 
GO:0097431 mitotic spindle pole
 | 
27
 | 
1.42e-01
 | 
-1.63e-01
 | 
4.90e-01
 | 
| 
GO:0033192 calmodulin-dependent
protein phosphatase activity
 | 
16
 | 
2.59e-01
 | 
-1.63e-01
 | 
6.44e-01
 | 
| 
GO:0045732 positive regulation of
protein catabolic process
 | 
47
 | 
5.35e-02
 | 
1.63e-01
 | 
3.24e-01
 | 
| 
GO:0098793 presynapse
 | 
63
 | 
2.59e-02
 | 
1.62e-01
 | 
2.38e-01
 | 
| 
GO:0031334 positive regulation of
protein-containing complex assembly
 | 
17
 | 
2.47e-01
 | 
1.62e-01
 | 
6.27e-01
 | 
| 
GO:0043679 axon terminus
 | 
17
 | 
2.47e-01
 | 
-1.62e-01
 | 
6.27e-01
 | 
| 
GO:0030036 actin cytoskeleton
organization
 | 
107
 | 
3.99e-03
 | 
-1.61e-01
 | 
9.40e-02
 | 
| 
GO:0000045 autophagosome assembly
 | 
52
 | 
4.44e-02
 | 
1.61e-01
 | 
3.06e-01
 | 
| 
GO:0001707 mesoderm formation
 | 
15
 | 
2.81e-01
 | 
-1.61e-01
 | 
6.64e-01
 | 
| 
GO:0006281 DNA repair
 | 
95
 | 
6.82e-03
 | 
-1.61e-01
 | 
1.29e-01
 | 
| 
GO:0042277 peptide binding
 | 
10
 | 
3.79e-01
 | 
-1.61e-01
 | 
7.45e-01
 | 
| 
GO:0010608 post-transcriptional
regulation of gene expression
 | 
11
 | 
3.57e-01
 | 
-1.61e-01
 | 
7.31e-01
 | 
| 
GO:0005828 kinetochore microtubule
 | 
10
 | 
3.80e-01
 | 
1.60e-01
 | 
7.45e-01
 | 
| 
GO:0072593 reactive oxygen species
metabolic process
 | 
15
 | 
2.82e-01
 | 
1.60e-01
 | 
6.64e-01
 | 
| 
GO:0097194 execution phase of
apoptosis
 | 
10
 | 
3.82e-01
 | 
1.60e-01
 | 
7.47e-01
 | 
| 
GO:0003151 outflow tract
morphogenesis
 | 
19
 | 
2.28e-01
 | 
1.60e-01
 | 
6.04e-01
 | 
| 
GO:0090443 FAR/SIN/STRIPAK complex
 | 
12
 | 
3.38e-01
 | 
1.60e-01
 | 
7.17e-01
 | 
| 
GO:0042273 ribosomal large subunit
biogenesis
 | 
22
 | 
1.97e-01
 | 
-1.59e-01
 | 
5.73e-01
 | 
| 
GO:0007052 mitotic spindle
organization
 | 
34
 | 
1.10e-01
 | 
1.59e-01
 | 
4.36e-01
 | 
| 
GO:0030286 dynein complex
 | 
10
 | 
3.85e-01
 | 
1.59e-01
 | 
7.50e-01
 | 
| 
GO:0006397 mRNA processing
 | 
72
 | 
2.05e-02
 | 
-1.58e-01
 | 
2.21e-01
 | 
| 
GO:0016485 protein processing
 | 
40
 | 
8.38e-02
 | 
1.58e-01
 | 
3.88e-01
 | 
| 
GO:0010976 positive regulation of
neuron projection development
 | 
30
 | 
1.34e-01
 | 
1.58e-01
 | 
4.79e-01
 | 
| 
GO:0005769 early endosome
 | 
141
 | 
1.24e-03
 | 
1.58e-01
 | 
5.05e-02
 | 
| 
GO:0034446 substrate
adhesion-dependent cell spreading
 | 
34
 | 
1.12e-01
 | 
-1.57e-01
 | 
4.40e-01
 | 
| 
GO:0072089 stem cell proliferation
 | 
21
 | 
2.13e-01
 | 
1.57e-01
 | 
5.88e-01
 | 
| 
GO:0007214 gamma-aminobutyric acid
signaling pathway
 | 
11
 | 
3.67e-01
 | 
1.57e-01
 | 
7.41e-01
 | 
| 
GO:0016226 iron-sulfur cluster
assembly
 | 
17
 | 
2.62e-01
 | 
1.57e-01
 | 
6.48e-01
 | 
| 
GO:0006805 xenobiotic metabolic
process
 | 
17
 | 
2.64e-01
 | 
1.57e-01
 | 
6.49e-01
 | 
| 
GO:0030833 regulation of actin
filament polymerization
 | 
21
 | 
2.15e-01
 | 
1.56e-01
 | 
5.91e-01
 | 
| 
GO:0048706 embryonic skeletal
system development
 | 
16
 | 
2.79e-01
 | 
1.56e-01
 | 
6.64e-01
 | 
| 
GO:0042593 glucose homeostasis
 | 
42
 | 
8.04e-02
 | 
1.56e-01
 | 
3.82e-01
 | 
| 
GO:0000775 chromosome, centromeric
region
 | 
31
 | 
1.33e-01
 | 
1.56e-01
 | 
4.75e-01
 | 
| 
GO:0045335 phagocytic vesicle
 | 
36
 | 
1.06e-01
 | 
1.56e-01
 | 
4.30e-01
 | 
| 
GO:0007131 reciprocal meiotic
recombination
 | 
12
 | 
3.52e-01
 | 
1.55e-01
 | 
7.29e-01
 | 
| 
GO:0008053 mitochondrial fusion
 | 
17
 | 
2.68e-01
 | 
-1.55e-01
 | 
6.50e-01
 | 
| 
GO:0051056 regulation of small
GTPase mediated signal transduction
 | 
16
 | 
2.83e-01
 | 
1.55e-01
 | 
6.64e-01
 | 
| 
GO:0007200 phospholipase
C-activating G protein-coupled receptor signaling pathway
 | 
26
 | 
1.73e-01
 | 
1.54e-01
 | 
5.36e-01
 | 
| 
GO:0034332 adherens junction
organization
 | 
11
 | 
3.76e-01
 | 
1.54e-01
 | 
7.45e-01
 | 
| 
GO:0046718 symbiont entry into host
cell
 | 
22
 | 
2.11e-01
 | 
-1.54e-01
 | 
5.87e-01
 | 
| 
GO:0048009 insulin-like growth
factor receptor signaling pathway
 | 
31
 | 
1.38e-01
 | 
-1.54e-01
 | 
4.84e-01
 | 
| 
GO:0005245 voltage-gated calcium
channel activity
 | 
11
 | 
3.78e-01
 | 
1.53e-01
 | 
7.45e-01
 | 
| 
GO:0070830 bicellular tight
junction assembly
 | 
19
 | 
2.47e-01
 | 
1.53e-01
 | 
6.27e-01
 | 
| 
GO:0045669 positive regulation of
osteoblast differentiation
 | 
37
 | 
1.07e-01
 | 
-1.53e-01
 | 
4.32e-01
 | 
| 
GO:0032012 regulation of ARF
protein signal transduction
 | 
14
 | 
3.22e-01
 | 
1.53e-01
 | 
6.99e-01
 | 
| 
GO:0033962 P-body assembly
 | 
14
 | 
3.23e-01
 | 
-1.52e-01
 | 
6.99e-01
 | 
| 
GO:0005764 lysosome
 | 
133
 | 
2.46e-03
 | 
1.52e-01
 | 
7.37e-02
 | 
| 
GO:0045595 regulation of cell
differentiation
 | 
13
 | 
3.42e-01
 | 
1.52e-01
 | 
7.19e-01
 | 
| 
GO:0071944 cell periphery
 | 
12
 | 
3.63e-01
 | 
1.52e-01
 | 
7.37e-01
 | 
| 
GO:0009966 regulation of signal
transduction
 | 
38
 | 
1.06e-01
 | 
-1.52e-01
 | 
4.30e-01
 | 
| 
GO:0046488 phosphatidylinositol
metabolic process
 | 
13
 | 
3.45e-01
 | 
-1.51e-01
 | 
7.22e-01
 | 
| 
GO:0050808 synapse organization
 | 
17
 | 
2.80e-01
 | 
-1.51e-01
 | 
6.64e-01
 | 
| 
GO:0008305 integrin complex
 | 
18
 | 
2.66e-01
 | 
1.51e-01
 | 
6.50e-01
 | 
| 
GO:0009653 anatomical structure
morphogenesis
 | 
22
 | 
2.20e-01
 | 
-1.51e-01
 | 
5.94e-01
 | 
| 
GO:0019221 cytokine-mediated
signaling pathway
 | 
44
 | 
8.32e-02
 | 
1.51e-01
 | 
3.88e-01
 | 
| 
GO:0005975 carbohydrate metabolic
process
 | 
49
 | 
6.77e-02
 | 
1.51e-01
 | 
3.47e-01
 | 
| 
GO:0006457 protein folding
 | 
81
 | 
1.94e-02
 | 
-1.50e-01
 | 
2.13e-01
 | 
| 
GO:0044233 mitochondria-associated
endoplasmic reticulum membrane contact site
 | 
16
 | 
2.99e-01
 | 
1.50e-01
 | 
6.80e-01
 | 
| 
GO:0048026 positive regulation of
mRNA splicing, via spliceosome
 | 
12
 | 
3.69e-01
 | 
-1.50e-01
 | 
7.41e-01
 | 
| 
GO:0060271 cilium assembly
 | 
125
 | 
3.90e-03
 | 
1.50e-01
 | 
9.40e-02
 | 
| 
GO:0006935 chemotaxis
 | 
14
 | 
3.33e-01
 | 
1.50e-01
 | 
7.12e-01
 | 
| 
GO:0021915 neural tube development
 | 
16
 | 
3.00e-01
 | 
1.50e-01
 | 
6.82e-01
 | 
| 
GO:0045197 establishment or
maintenance of epithelial cell apical/basal polarity
 | 
14
 | 
3.33e-01
 | 
-1.50e-01
 | 
7.12e-01
 | 
| 
GO:0030968 endoplasmic reticulum
unfolded protein response
 | 
30
 | 
1.57e-01
 | 
1.49e-01
 | 
5.14e-01
 | 
| 
GO:0031333 negative regulation of
protein-containing complex assembly
 | 
16
 | 
3.02e-01
 | 
1.49e-01
 | 
6.83e-01
 | 
| 
GO:0150052 regulation of
postsynapse assembly
 | 
13
 | 
3.52e-01
 | 
-1.49e-01
 | 
7.29e-01
 | 
| 
GO:0034220 monoatomic ion
transmembrane transport
 | 
19
 | 
2.62e-01
 | 
1.49e-01
 | 
6.48e-01
 | 
| 
GO:0000228 nuclear chromosome
 | 
13
 | 
3.55e-01
 | 
-1.48e-01
 | 
7.30e-01
 | 
| 
GO:0004435 phosphatidylinositol
phospholipase C activity
 | 
12
 | 
3.74e-01
 | 
1.48e-01
 | 
7.45e-01
 | 
| 
GO:0016740 transferase activity
 | 
23
 | 
2.20e-01
 | 
-1.48e-01
 | 
5.95e-01
 | 
| 
GO:0097192 extrinsic apoptotic
signaling pathway in absence of ligand
 | 
12
 | 
3.76e-01
 | 
-1.48e-01
 | 
7.45e-01
 | 
| 
GO:0071480 cellular response to
gamma radiation
 | 
14
 | 
3.39e-01
 | 
-1.48e-01
 | 
7.18e-01
 | 
| 
GO:0005385 zinc ion transmembrane
transporter activity
 | 
15
 | 
3.23e-01
 | 
-1.47e-01
 | 
6.99e-01
 | 
| 
GO:0070371 ERK1 and ERK2 cascade
 | 
20
 | 
2.54e-01
 | 
1.47e-01
 | 
6.36e-01
 | 
| 
GO:0048008 platelet-derived growth
factor receptor signaling pathway
 | 
17
 | 
2.93e-01
 | 
-1.47e-01
 | 
6.75e-01
 | 
| 
GO:0007129 homologous chromosome
pairing at meiosis
 | 
13
 | 
3.58e-01
 | 
-1.47e-01
 | 
7.32e-01
 | 
| 
GO:0000794 condensed nuclear
chromosome
 | 
20
 | 
2.54e-01
 | 
1.47e-01
 | 
6.36e-01
 | 
| 
GO:0001558 regulation of cell
growth
 | 
24
 | 
2.12e-01
 | 
-1.47e-01
 | 
5.87e-01
 | 
| 
GO:0008237 metallopeptidase
activity
 | 
12
 | 
3.77e-01
 | 
1.47e-01
 | 
7.45e-01
 | 
| 
GO:0005871 kinesin complex
 | 
22
 | 
2.33e-01
 | 
1.47e-01
 | 
6.10e-01
 | 
| 
GO:0040018 positive regulation of
multicellular organism growth
 | 
16
 | 
3.09e-01
 | 
-1.47e-01
 | 
6.86e-01
 | 
| 
GO:0003676 nucleic acid binding
 | 
106
 | 
9.22e-03
 | 
-1.47e-01
 | 
1.47e-01
 | 
| 
GO:0009267 cellular response to
starvation
 | 
48
 | 
7.95e-02
 | 
1.46e-01
 | 
3.82e-01
 | 
| 
GO:0031490 chromatin DNA binding
 | 
41
 | 
1.05e-01
 | 
-1.46e-01
 | 
4.30e-01
 | 
| 
GO:0043495 protein-membrane adaptor
activity
 | 
17
 | 
2.97e-01
 | 
1.46e-01
 | 
6.79e-01
 | 
| 
GO:0006261 DNA-templated DNA
replication
 | 
18
 | 
2.83e-01
 | 
-1.46e-01
 | 
6.64e-01
 | 
| 
GO:0086091 regulation of heart rate
by cardiac conduction
 | 
18
 | 
2.83e-01
 | 
-1.46e-01
 | 
6.64e-01
 | 
| 
GO:0001782 B cell homeostasis
 | 
12
 | 
3.83e-01
 | 
-1.45e-01
 | 
7.49e-01
 | 
| 
GO:0015813 L-glutamate
transmembrane transport
 | 
11
 | 
4.04e-01
 | 
-1.45e-01
 | 
7.62e-01
 | 
| 
GO:0019904 protein domain specific
binding
 | 
104
 | 
1.06e-02
 | 
1.45e-01
 | 
1.56e-01
 | 
| 
GO:0000086 G2/M transition of
mitotic cell cycle
 | 
25
 | 
2.09e-01
 | 
1.45e-01
 | 
5.84e-01
 | 
| 
GO:0009410 response to xenobiotic
stimulus
 | 
47
 | 
8.57e-02
 | 
-1.45e-01
 | 
3.88e-01
 | 
| 
GO:0015485 cholesterol binding
 | 
28
 | 
1.85e-01
 | 
1.45e-01
 | 
5.55e-01
 | 
| 
GO:0051497 negative regulation of
stress fiber assembly
 | 
18
 | 
2.88e-01
 | 
1.45e-01
 | 
6.68e-01
 | 
| 
GO:0034244 negative regulation of
transcription elongation by RNA polymerase II
 | 
13
 | 
3.68e-01
 | 
1.44e-01
 | 
7.41e-01
 | 
| 
GO:0098609 cell-cell adhesion
 | 
82
 | 
2.44e-02
 | 
-1.44e-01
 | 
2.33e-01
 | 
| 
GO:0010494 cytoplasmic stress
granule
 | 
58
 | 
5.82e-02
 | 
-1.44e-01
 | 
3.35e-01
 | 
| 
GO:2000811 negative regulation of
anoikis
 | 
10
 | 
4.31e-01
 | 
1.44e-01
 | 
7.78e-01
 | 
| 
GO:0071320 cellular response to
cAMP
 | 
18
 | 
2.91e-01
 | 
1.44e-01
 | 
6.73e-01
 | 
| 
GO:0032570 response to progesterone
 | 
13
 | 
3.69e-01
 | 
-1.44e-01
 | 
7.41e-01
 | 
| 
GO:0034599 cellular response to
oxidative stress
 | 
44
 | 
9.97e-02
 | 
1.44e-01
 | 
4.20e-01
 | 
| 
GO:0006612 protein targeting to
membrane
 | 
24
 | 
2.24e-01
 | 
-1.43e-01
 | 
5.99e-01
 | 
| 
GO:0071816 tail-anchored membrane
protein insertion into ER membrane
 | 
10
 | 
4.33e-01
 | 
1.43e-01
 | 
7.78e-01
 | 
| 
GO:0035176 social behavior
 | 
16
 | 
3.21e-01
 | 
1.43e-01
 | 
6.99e-01
 | 
| 
GO:0000781 chromosome, telomeric
region
 | 
75
 | 
3.22e-02
 | 
-1.43e-01
 | 
2.63e-01
 | 
| 
GO:0005198 structural molecule
activity
 | 
37
 | 
1.32e-01
 | 
1.43e-01
 | 
4.74e-01
 | 
| 
GO:0042098 T cell proliferation
 | 
16
 | 
3.23e-01
 | 
-1.43e-01
 | 
6.99e-01
 | 
| 
GO:0048147 negative regulation of
fibroblast proliferation
 | 
14
 | 
3.55e-01
 | 
-1.43e-01
 | 
7.30e-01
 | 
| 
GO:0061631 ubiquitin conjugating
enzyme activity
 | 
24
 | 
2.27e-01
 | 
1.43e-01
 | 
6.04e-01
 | 
| 
GO:0032456 endocytic recycling
 | 
42
 | 
1.11e-01
 | 
1.42e-01
 | 
4.37e-01
 | 
| 
GO:0004857 enzyme inhibitor
activity
 | 
12
 | 
3.94e-01
 | 
-1.42e-01
 | 
7.54e-01
 | 
| 
GO:0032755 positive regulation of
interleukin-6 production
 | 
32
 | 
1.65e-01
 | 
1.42e-01
 | 
5.24e-01
 | 
| 
GO:0005681 spliceosomal complex
 | 
43
 | 
1.08e-01
 | 
-1.42e-01
 | 
4.34e-01
 | 
| 
GO:0090314 positive regulation of
protein targeting to membrane
 | 
12
 | 
3.96e-01
 | 
1.42e-01
 | 
7.54e-01
 | 
| 
GO:0000145 exocyst
 | 
11
 | 
4.17e-01
 | 
-1.41e-01
 | 
7.72e-01
 | 
| 
GO:0042100 B cell proliferation
 | 
14
 | 
3.61e-01
 | 
1.41e-01
 | 
7.34e-01
 | 
| 
GO:0098982 GABA-ergic synapse
 | 
30
 | 
1.81e-01
 | 
1.41e-01
 | 
5.49e-01
 | 
| 
GO:0016605 PML body
 | 
61
 | 
5.69e-02
 | 
-1.41e-01
 | 
3.31e-01
 | 
| 
GO:0048513 animal organ development
 | 
11
 | 
4.19e-01
 | 
1.41e-01
 | 
7.72e-01
 | 
| 
GO:0006898 receptor-mediated
endocytosis
 | 
23
 | 
2.44e-01
 | 
1.41e-01
 | 
6.22e-01
 | 
| 
GO:0005005 transmembrane-ephrin
receptor activity
 | 
14
 | 
3.63e-01
 | 
-1.40e-01
 | 
7.37e-01
 | 
| 
GO:0007004 telomere maintenance via
telomerase
 | 
11
 | 
4.21e-01
 | 
-1.40e-01
 | 
7.73e-01
 | 
| 
GO:0060038 cardiac muscle cell
proliferation
 | 
12
 | 
4.03e-01
 | 
1.39e-01
 | 
7.62e-01
 | 
| 
GO:0046966 nuclear thyroid hormone
receptor binding
 | 
15
 | 
3.51e-01
 | 
-1.39e-01
 | 
7.29e-01
 | 
| 
GO:0005930 axoneme
 | 
48
 | 
9.67e-02
 | 
1.39e-01
 | 
4.15e-01
 | 
| 
GO:0005788 endoplasmic reticulum
lumen
 | 
40
 | 
1.30e-01
 | 
-1.38e-01
 | 
4.70e-01
 | 
| 
GO:0035725 sodium ion transmembrane
transport
 | 
48
 | 
9.72e-02
 | 
1.38e-01
 | 
4.15e-01
 | 
| 
GO:0030054 cell junction
 | 
52
 | 
8.57e-02
 | 
-1.38e-01
 | 
3.88e-01
 | 
| 
GO:0101031 protein folding
chaperone complex
 | 
18
 | 
3.11e-01
 | 
-1.38e-01
 | 
6.88e-01
 | 
| 
GO:0006511 ubiquitin-dependent
protein catabolic process
 | 
117
 | 
1.02e-02
 | 
-1.38e-01
 | 
1.51e-01
 | 
| 
GO:0030317 flagellated sperm
motility
 | 
28
 | 
2.09e-01
 | 
1.37e-01
 | 
5.83e-01
 | 
| 
GO:0006302 double-strand break
repair
 | 
45
 | 
1.11e-01
 | 
-1.37e-01
 | 
4.37e-01
 | 
| 
GO:0043565 sequence-specific DNA
binding
 | 
56
 | 
7.60e-02
 | 
-1.37e-01
 | 
3.72e-01
 | 
| 
GO:0030496 midbody
 | 
100
 | 
1.80e-02
 | 
1.37e-01
 | 
2.00e-01
 | 
| 
GO:1904115 axon cytoplasm
 | 
25
 | 
2.36e-01
 | 
1.37e-01
 | 
6.15e-01
 | 
| 
GO:0003774 cytoskeletal motor
activity
 | 
13
 | 
3.93e-01
 | 
1.37e-01
 | 
7.54e-01
 | 
| 
GO:0070403 NAD+ binding
 | 
11
 | 
4.33e-01
 | 
1.36e-01
 | 
7.78e-01
 | 
| 
GO:0050729 positive regulation of
inflammatory response
 | 
22
 | 
2.68e-01
 | 
1.36e-01
 | 
6.50e-01
 | 
| 
GO:0019901 protein kinase binding
 | 
236
 | 
3.23e-04
 | 
1.36e-01
 | 
2.38e-02
 | 
| 
GO:0042572 retinol metabolic
process
 | 
12
 | 
4.14e-01
 | 
1.36e-01
 | 
7.72e-01
 | 
| 
GO:0045787 positive regulation of
cell cycle
 | 
13
 | 
3.96e-01
 | 
1.36e-01
 | 
7.54e-01
 | 
| 
GO:0042632 cholesterol homeostasis
 | 
38
 | 
1.49e-01
 | 
1.35e-01
 | 
5.00e-01
 | 
| 
GO:0034198 cellular response to
amino acid starvation
 | 
31
 | 
1.93e-01
 | 
1.35e-01
 | 
5.66e-01
 | 
| 
GO:0045821 positive regulation of
glycolytic process
 | 
10
 | 
4.60e-01
 | 
1.35e-01
 | 
7.89e-01
 | 
| 
GO:0042393 histone binding
 | 
94
 | 
2.44e-02
 | 
-1.35e-01
 | 
2.33e-01
 | 
| 
GO:0010761 fibroblast migration
 | 
10
 | 
4.62e-01
 | 
1.34e-01
 | 
7.91e-01
 | 
| 
GO:0004693 cyclin-dependent protein
serine/threonine kinase activity
 | 
10
 | 
4.62e-01
 | 
1.34e-01
 | 
7.91e-01
 | 
| 
GO:0004715 non-membrane spanning
protein tyrosine kinase activity
 | 
20
 | 
2.99e-01
 | 
1.34e-01
 | 
6.80e-01
 | 
| 
GO:0036092
phosphatidylinositol-3-phosphate biosynthetic process
 | 
14
 | 
3.86e-01
 | 
1.34e-01
 | 
7.50e-01
 | 
| 
GO:0006914 autophagy
 | 
44
 | 
1.25e-01
 | 
1.34e-01
 | 
4.62e-01
 | 
| 
GO:0006268 DNA unwinding involved
in DNA replication
 | 
14
 | 
3.86e-01
 | 
-1.34e-01
 | 
7.50e-01
 | 
| 
GO:0006468 protein phosphorylation
 | 
12
 | 
4.23e-01
 | 
-1.34e-01
 | 
7.73e-01
 | 
| 
GO:0005730 nucleolus
 | 
443
 | 
1.66e-06
 | 
-1.33e-01
 | 
3.68e-04
 | 
| 
GO:0005669 transcription factor
TFIID complex
 | 
22
 | 
2.80e-01
 | 
-1.33e-01
 | 
6.64e-01
 | 
| 
GO:0043197 dendritic spine
 | 
46
 | 
1.20e-01
 | 
1.33e-01
 | 
4.55e-01
 | 
| 
GO:0046907 intracellular transport
 | 
14
 | 
3.92e-01
 | 
1.32e-01
 | 
7.54e-01
 | 
| 
GO:0042274 ribosomal small subunit
biogenesis
 | 
44
 | 
1.29e-01
 | 
-1.32e-01
 | 
4.70e-01
 | 
| 
GO:0016887 ATP hydrolysis activity
 | 
216
 | 
8.45e-04
 | 
-1.32e-01
 | 
3.73e-02
 | 
| 
GO:0046627 negative regulation of
insulin receptor signaling pathway
 | 
16
 | 
3.61e-01
 | 
1.32e-01
 | 
7.34e-01
 | 
| 
GO:0016581 NuRD complex
 | 
10
 | 
4.70e-01
 | 
-1.32e-01
 | 
7.92e-01
 | 
| 
GO:0007156 homophilic cell adhesion
via plasma membrane adhesion molecules
 | 
39
 | 
1.54e-01
 | 
-1.32e-01
 | 
5.08e-01
 | 
| 
GO:0006367 transcription initiation
at RNA polymerase II promoter
 | 
20
 | 
3.08e-01
 | 
-1.32e-01
 | 
6.86e-01
 | 
| 
GO:0005009 insulin receptor
activity
 | 
14
 | 
3.96e-01
 | 
-1.31e-01
 | 
7.54e-01
 | 
| 
GO:0071364 cellular response to
epidermal growth factor stimulus
 | 
19
 | 
3.23e-01
 | 
1.31e-01
 | 
6.99e-01
 | 
| 
GO:0005164 tumor necrosis factor
receptor binding
 | 
13
 | 
4.14e-01
 | 
1.31e-01
 | 
7.72e-01
 | 
| 
GO:0071889 14-3-3 protein binding
 | 
15
 | 
3.81e-01
 | 
-1.31e-01
 | 
7.47e-01
 | 
| 
GO:0090307 mitotic spindle assembly
 | 
30
 | 
2.16e-01
 | 
-1.31e-01
 | 
5.92e-01
 | 
| 
GO:0007157 heterophilic cell-cell
adhesion via plasma membrane cell adhesion molecules
 | 
13
 | 
4.15e-01
 | 
1.31e-01
 | 
7.72e-01
 | 
| 
GO:0030155 regulation of cell
adhesion
 | 
18
 | 
3.38e-01
 | 
-1.30e-01
 | 
7.17e-01
 | 
| 
GO:0042789 mRNA transcription by
RNA polymerase II
 | 
26
 | 
2.50e-01
 | 
-1.30e-01
 | 
6.31e-01
 | 
| 
GO:0009749 response to glucose
 | 
14
 | 
3.99e-01
 | 
-1.30e-01
 | 
7.57e-01
 | 
| 
GO:0070536 protein K63-linked
deubiquitination
 | 
16
 | 
3.69e-01
 | 
-1.30e-01
 | 
7.41e-01
 | 
| 
GO:0033209 tumor necrosis
factor-mediated signaling pathway
 | 
15
 | 
3.85e-01
 | 
-1.30e-01
 | 
7.50e-01
 | 
| 
GO:0000922 spindle pole
 | 
69
 | 
6.34e-02
 | 
1.29e-01
 | 
3.44e-01
 | 
| 
GO:0006695 cholesterol biosynthetic
process
 | 
16
 | 
3.71e-01
 | 
1.29e-01
 | 
7.41e-01
 | 
| 
GO:0070161 anchoring junction
 | 
17
 | 
3.57e-01
 | 
-1.29e-01
 | 
7.31e-01
 | 
| 
GO:0050661 NADP binding
 | 
15
 | 
3.87e-01
 | 
1.29e-01
 | 
7.51e-01
 | 
| 
GO:0005515 protein binding
 | 
90
 | 
3.48e-02
 | 
-1.29e-01
 | 
2.72e-01
 | 
| 
GO:0019888 protein phosphatase
regulator activity
 | 
16
 | 
3.73e-01
 | 
-1.29e-01
 | 
7.45e-01
 | 
| 
GO:0007411 axon guidance
 | 
77
 | 
5.11e-02
 | 
-1.29e-01
 | 
3.19e-01
 | 
| 
GO:0045742 positive regulation of
epidermal growth factor receptor signaling pathway
 | 
13
 | 
4.23e-01
 | 
-1.29e-01
 | 
7.73e-01
 | 
| 
GO:0008143 poly(A) binding
 | 
13
 | 
4.24e-01
 | 
1.28e-01
 | 
7.73e-01
 | 
| 
GO:1902894 negative regulation of
miRNA transcription
 | 
12
 | 
4.43e-01
 | 
-1.28e-01
 | 
7.82e-01
 | 
| 
GO:0055038 recycling endosome
membrane
 | 
43
 | 
1.49e-01
 | 
1.27e-01
 | 
5.00e-01
 | 
| 
GO:0045600 positive regulation of
fat cell differentiation
 | 
21
 | 
3.13e-01
 | 
1.27e-01
 | 
6.89e-01
 | 
| 
GO:0090303 positive regulation of
wound healing
 | 
11
 | 
4.65e-01
 | 
1.27e-01
 | 
7.92e-01
 | 
| 
GO:0008180 COP9 signalosome
 | 
21
 | 
3.14e-01
 | 
1.27e-01
 | 
6.90e-01
 | 
| 
GO:0034450 ubiquitin-ubiquitin
ligase activity
 | 
12
 | 
4.47e-01
 | 
1.27e-01
 | 
7.83e-01
 | 
| 
GO:0007266 Rho protein signal
transduction
 | 
33
 | 
2.08e-01
 | 
1.27e-01
 | 
5.83e-01
 | 
| 
GO:0043138 3’-5’ DNA helicase
activity
 | 
10
 | 
4.89e-01
 | 
-1.26e-01
 | 
8.02e-01
 | 
| 
GO:0012507 ER to Golgi transport
vesicle membrane
 | 
11
 | 
4.69e-01
 | 
1.26e-01
 | 
7.92e-01
 | 
| 
GO:0051402 neuron apoptotic process
 | 
42
 | 
1.58e-01
 | 
1.26e-01
 | 
5.16e-01
 | 
| 
GO:0046677 response to antibiotic
 | 
13
 | 
4.31e-01
 | 
1.26e-01
 | 
7.78e-01
 | 
| 
GO:0016607 nuclear speck
 | 
241
 | 
7.95e-04
 | 
-1.26e-01
 | 
3.60e-02
 | 
| 
GO:0035329 hippo signaling
 | 
18
 | 
3.56e-01
 | 
1.26e-01
 | 
7.31e-01
 | 
| 
GO:0061157 mRNA destabilization
 | 
12
 | 
4.51e-01
 | 
-1.26e-01
 | 
7.85e-01
 | 
| 
GO:0008360 regulation of cell shape
 | 
60
 | 
9.43e-02
 | 
-1.25e-01
 | 
4.10e-01
 | 
| 
GO:0004879 nuclear receptor
activity
 | 
38
 | 
1.83e-01
 | 
1.25e-01
 | 
5.52e-01
 | 
| 
GO:0032993 protein-DNA complex
 | 
21
 | 
3.23e-01
 | 
1.25e-01
 | 
6.99e-01
 | 
| 
GO:0008023 transcription elongation
factor complex
 | 
14
 | 
4.20e-01
 | 
-1.24e-01
 | 
7.73e-01
 | 
| 
GO:0042626 ATPase-coupled
transmembrane transporter activity
 | 
17
 | 
3.75e-01
 | 
1.24e-01
 | 
7.45e-01
 | 
| 
GO:0005782 peroxisomal matrix
 | 
10
 | 
4.96e-01
 | 
1.24e-01
 | 
8.02e-01
 | 
| 
GO:0032465 regulation of
cytokinesis
 | 
23
 | 
3.02e-01
 | 
1.24e-01
 | 
6.84e-01
 | 
| 
GO:0070131 positive regulation of
mitochondrial translation
 | 
10
 | 
4.96e-01
 | 
-1.24e-01
 | 
8.02e-01
 | 
| 
GO:0070301 cellular response to
hydrogen peroxide
 | 
23
 | 
3.03e-01
 | 
-1.24e-01
 | 
6.84e-01
 | 
| 
GO:0046513 ceramide biosynthetic
process
 | 
19
 | 
3.49e-01
 | 
-1.24e-01
 | 
7.28e-01
 | 
| 
GO:0099171 presynaptic modulation
of chemical synaptic transmission
 | 
11
 | 
4.77e-01
 | 
1.24e-01
 | 
7.99e-01
 | 
| 
GO:0006886 intracellular protein
transport
 | 
160
 | 
7.06e-03
 | 
1.24e-01
 | 
1.29e-01
 | 
| 
GO:0008201 heparin binding
 | 
56
 | 
1.10e-01
 | 
1.24e-01
 | 
4.36e-01
 | 
| 
GO:0030234 enzyme regulator
activity
 | 
14
 | 
4.24e-01
 | 
1.23e-01
 | 
7.73e-01
 | 
| 
GO:0050769 positive regulation of
neurogenesis
 | 
12
 | 
4.60e-01
 | 
-1.23e-01
 | 
7.89e-01
 | 
| 
GO:0030198 extracellular matrix
organization
 | 
77
 | 
6.20e-02
 | 
1.23e-01
 | 
3.42e-01
 | 
| 
GO:0045724 positive regulation of
cilium assembly
 | 
13
 | 
4.43e-01
 | 
1.23e-01
 | 
7.82e-01
 | 
| 
GO:0007611 learning or memory
 | 
15
 | 
4.11e-01
 | 
1.23e-01
 | 
7.69e-01
 | 
| 
GO:0051085 chaperone
cofactor-dependent protein refolding
 | 
23
 | 
3.09e-01
 | 
-1.23e-01
 | 
6.86e-01
 | 
| 
GO:0007030 Golgi organization
 | 
63
 | 
9.42e-02
 | 
1.22e-01
 | 
4.10e-01
 | 
| 
GO:0007628 adult walking behavior
 | 
13
 | 
4.47e-01
 | 
-1.22e-01
 | 
7.83e-01
 | 
| 
GO:0005743 mitochondrial inner
membrane
 | 
180
 | 
4.91e-03
 | 
1.22e-01
 | 
1.07e-01
 | 
| 
GO:0000398 mRNA splicing, via
spliceosome
 | 
87
 | 
5.01e-02
 | 
-1.22e-01
 | 
3.16e-01
 | 
| 
GO:0019894 kinesin binding
 | 
22
 | 
3.24e-01
 | 
1.22e-01
 | 
6.99e-01
 | 
| 
GO:0005010 insulin-like growth
factor receptor activity
 | 
13
 | 
4.48e-01
 | 
-1.21e-01
 | 
7.84e-01
 | 
| 
GO:0048568 embryonic organ
development
 | 
15
 | 
4.16e-01
 | 
1.21e-01
 | 
7.72e-01
 | 
| 
GO:0015629 actin cytoskeleton
 | 
115
 | 
2.49e-02
 | 
-1.21e-01
 | 
2.33e-01
 | 
| 
GO:0045665 negative regulation of
neuron differentiation
 | 
25
 | 
2.94e-01
 | 
-1.21e-01
 | 
6.76e-01
 | 
| 
GO:0005008 hepatocyte growth factor
receptor activity
 | 
13
 | 
4.50e-01
 | 
-1.21e-01
 | 
7.84e-01
 | 
| 
GO:0043596 nuclear replication fork
 | 
10
 | 
5.08e-01
 | 
1.21e-01
 | 
8.08e-01
 | 
| 
GO:0042645 mitochondrial nucleoid
 | 
37
 | 
2.03e-01
 | 
-1.21e-01
 | 
5.77e-01
 | 
| 
GO:0005759 mitochondrial matrix
 | 
119
 | 
2.30e-02
 | 
1.21e-01
 | 
2.30e-01
 | 
| 
GO:0060218 hematopoietic stem cell
differentiation
 | 
11
 | 
4.88e-01
 | 
1.21e-01
 | 
8.02e-01
 | 
| 
GO:0000785 chromatin
 | 
241
 | 
1.31e-03
 | 
-1.21e-01
 | 
5.15e-02
 | 
| 
GO:0016192 vesicle-mediated
transport
 | 
101
 | 
3.67e-02
 | 
1.20e-01
 | 
2.76e-01
 | 
| 
GO:0005801 cis-Golgi network
 | 
28
 | 
2.70e-01
 | 
1.20e-01
 | 
6.53e-01
 | 
| 
GO:0050750 low-density lipoprotein
particle receptor binding
 | 
12
 | 
4.70e-01
 | 
-1.20e-01
 | 
7.92e-01
 | 
| 
GO:0002102 podosome
 | 
19
 | 
3.64e-01
 | 
1.20e-01
 | 
7.37e-01
 | 
| 
GO:0071011 precatalytic spliceosome
 | 
12
 | 
4.71e-01
 | 
1.20e-01
 | 
7.92e-01
 | 
| 
GO:0003723 RNA binding
 | 
372
 | 
7.50e-05
 | 
-1.20e-01
 | 
8.28e-03
 | 
| 
GO:0003682 chromatin binding
 | 
238
 | 
1.50e-03
 | 
-1.20e-01
 | 
5.42e-02
 | 
| 
GO:1990904 ribonucleoprotein
complex
 | 
104
 | 
3.52e-02
 | 
1.20e-01
 | 
2.72e-01
 | 
| 
GO:0001937 negative regulation of
endothelial cell proliferation
 | 
12
 | 
4.73e-01
 | 
-1.20e-01
 | 
7.94e-01
 | 
| 
GO:0010506 regulation of autophagy
 | 
26
 | 
2.91e-01
 | 
1.20e-01
 | 
6.73e-01
 | 
| 
GO:0050679 positive regulation of
epithelial cell proliferation
 | 
20
 | 
3.55e-01
 | 
-1.19e-01
 | 
7.30e-01
 | 
| 
GO:1902476 chloride transmembrane
transport
 | 
39
 | 
1.97e-01
 | 
1.19e-01
 | 
5.73e-01
 | 
| 
GO:0043022 ribosome binding
 | 
46
 | 
1.62e-01
 | 
-1.19e-01
 | 
5.20e-01
 | 
| 
GO:0045879 negative regulation of
smoothened signaling pathway
 | 
16
 | 
4.10e-01
 | 
1.19e-01
 | 
7.69e-01
 | 
| 
GO:0008289 lipid binding
 | 
44
 | 
1.72e-01
 | 
1.19e-01
 | 
5.36e-01
 | 
| 
GO:0033344 cholesterol efflux
 | 
11
 | 
4.96e-01
 | 
-1.19e-01
 | 
8.02e-01
 | 
| 
GO:0006986 response to unfolded
protein
 | 
12
 | 
4.78e-01
 | 
-1.18e-01
 | 
7.99e-01
 | 
| 
GO:0045171 intercellular bridge
 | 
55
 | 
1.30e-01
 | 
1.18e-01
 | 
4.70e-01
 | 
| 
GO:0006897 endocytosis
 | 
92
 | 
5.04e-02
 | 
1.18e-01
 | 
3.16e-01
 | 
| 
GO:0008283 cell population
proliferation
 | 
65
 | 
1.00e-01
 | 
-1.18e-01
 | 
4.20e-01
 | 
| 
GO:0030150 protein import into
mitochondrial matrix
 | 
12
 | 
4.80e-01
 | 
1.18e-01
 | 
8.00e-01
 | 
| 
GO:0006413 translational initiation
 | 
30
 | 
2.65e-01
 | 
-1.18e-01
 | 
6.50e-01
 | 
| 
GO:0016787 hydrolase activity
 | 
108
 | 
3.54e-02
 | 
-1.17e-01
 | 
2.72e-01
 | 
| 
GO:0008198 ferrous iron binding
 | 
12
 | 
4.82e-01
 | 
-1.17e-01
 | 
8.01e-01
 | 
| 
GO:0042169 SH2 domain binding
 | 
20
 | 
3.64e-01
 | 
1.17e-01
 | 
7.37e-01
 | 
| 
GO:0070412 R-SMAD binding
 | 
13
 | 
4.65e-01
 | 
-1.17e-01
 | 
7.92e-01
 | 
| 
GO:0032007 negative regulation of
TOR signaling
 | 
18
 | 
3.91e-01
 | 
1.17e-01
 | 
7.54e-01
 | 
| 
GO:0006509 membrane protein
ectodomain proteolysis
 | 
15
 | 
4.34e-01
 | 
-1.17e-01
 | 
7.78e-01
 | 
| 
GO:0017116 single-stranded DNA
helicase activity
 | 
16
 | 
4.19e-01
 | 
-1.17e-01
 | 
7.72e-01
 | 
| 
GO:0016567 protein ubiquitination
 | 
155
 | 
1.24e-02
 | 
-1.17e-01
 | 
1.65e-01
 | 
| 
GO:0060828 regulation of canonical
Wnt signaling pathway
 | 
18
 | 
3.92e-01
 | 
-1.16e-01
 | 
7.54e-01
 | 
| 
GO:0005109 frizzled binding
 | 
18
 | 
3.94e-01
 | 
1.16e-01
 | 
7.54e-01
 | 
| 
GO:0006629 lipid metabolic process
 | 
52
 | 
1.48e-01
 | 
1.16e-01
 | 
5.00e-01
 | 
| 
GO:0071539 protein localization to
centrosome
 | 
20
 | 
3.69e-01
 | 
1.16e-01
 | 
7.41e-01
 | 
| 
GO:0015297 antiporter activity
 | 
18
 | 
3.94e-01
 | 
1.16e-01
 | 
7.54e-01
 | 
| 
GO:0010719 negative regulation of
epithelial to mesenchymal transition
 | 
16
 | 
4.23e-01
 | 
-1.16e-01
 | 
7.73e-01
 | 
| 
GO:0032039 integrator complex
 | 
15
 | 
4.38e-01
 | 
-1.16e-01
 | 
7.80e-01
 | 
| 
GO:0019933 cAMP-mediated signaling
 | 
13
 | 
4.71e-01
 | 
1.16e-01
 | 
7.92e-01
 | 
| 
GO:0051321 meiotic cell cycle
 | 
21
 | 
3.60e-01
 | 
-1.15e-01
 | 
7.34e-01
 | 
| 
GO:0019706 protein-cysteine
S-palmitoyltransferase activity
 | 
17
 | 
4.11e-01
 | 
-1.15e-01
 | 
7.69e-01
 | 
| 
GO:0030426 growth cone
 | 
41
 | 
2.03e-01
 | 
-1.15e-01
 | 
5.77e-01
 | 
| 
GO:0051131 chaperone-mediated
protein complex assembly
 | 
14
 | 
4.56e-01
 | 
-1.15e-01
 | 
7.86e-01
 | 
| 
GO:0008327 methyl-CpG binding
 | 
16
 | 
4.26e-01
 | 
-1.15e-01
 | 
7.74e-01
 | 
| 
GO:0030010 establishment of cell
polarity
 | 
18
 | 
3.99e-01
 | 
1.15e-01
 | 
7.57e-01
 | 
| 
GO:0032259 methylation
 | 
76
 | 
8.46e-02
 | 
-1.15e-01
 | 
3.88e-01
 | 
| 
GO:0070063 RNA polymerase binding
 | 
12
 | 
4.92e-01
 | 
1.14e-01
 | 
8.02e-01
 | 
| 
GO:0001618 virus receptor activity
 | 
10
 | 
5.32e-01
 | 
-1.14e-01
 | 
8.27e-01
 | 
| 
GO:0140693 molecular condensate
scaffold activity
 | 
24
 | 
3.33e-01
 | 
-1.14e-01
 | 
7.12e-01
 | 
| 
GO:0005615 extracellular space
 | 
397
 | 
1.05e-04
 | 
1.14e-01
 | 
1.10e-02
 | 
| 
GO:0010212 response to ionizing
radiation
 | 
24
 | 
3.34e-01
 | 
-1.14e-01
 | 
7.13e-01
 | 
| 
GO:2001237 negative regulation of
extrinsic apoptotic signaling pathway
 | 
19
 | 
3.91e-01
 | 
-1.14e-01
 | 
7.54e-01
 | 
| 
GO:0008017 microtubule binding
 | 
153
 | 
1.55e-02
 | 
1.14e-01
 | 
1.88e-01
 | 
| 
GO:0030670 phagocytic vesicle
membrane
 | 
19
 | 
3.92e-01
 | 
1.13e-01
 | 
7.54e-01
 | 
| 
GO:0120009 intermembrane lipid
transfer
 | 
16
 | 
4.33e-01
 | 
1.13e-01
 | 
7.78e-01
 | 
| 
GO:0031410 cytoplasmic vesicle
 | 
106
 | 
4.47e-02
 | 
1.13e-01
 | 
3.06e-01
 | 
| 
GO:0071260 cellular response to
mechanical stimulus
 | 
23
 | 
3.48e-01
 | 
1.13e-01
 | 
7.27e-01
 | 
| 
GO:0001917 photoreceptor inner
segment
 | 
23
 | 
3.49e-01
 | 
1.13e-01
 | 
7.28e-01
 | 
| 
GO:0001708 cell fate specification
 | 
12
 | 
4.99e-01
 | 
-1.13e-01
 | 
8.03e-01
 | 
| 
GO:0051290 protein
heterotetramerization
 | 
10
 | 
5.38e-01
 | 
-1.13e-01
 | 
8.29e-01
 | 
| 
GO:0050770 regulation of
axonogenesis
 | 
13
 | 
4.82e-01
 | 
-1.13e-01
 | 
8.01e-01
 | 
| 
GO:0140374 antiviral innate immune
response
 | 
20
 | 
3.84e-01
 | 
-1.12e-01
 | 
7.50e-01
 | 
| 
GO:0072659 protein localization to
plasma membrane
 | 
75
 | 
9.27e-02
 | 
1.12e-01
 | 
4.07e-01
 | 
| 
GO:0007612 learning
 | 
14
 | 
4.67e-01
 | 
-1.12e-01
 | 
7.92e-01
 | 
| 
GO:0050852 T cell receptor
signaling pathway
 | 
50
 | 
1.70e-01
 | 
1.12e-01
 | 
5.31e-01
 | 
| 
GO:0006893 Golgi to plasma membrane
transport
 | 
19
 | 
3.98e-01
 | 
-1.12e-01
 | 
7.56e-01
 | 
| 
GO:0051536 iron-sulfur cluster
binding
 | 
12
 | 
5.02e-01
 | 
1.12e-01
 | 
8.06e-01
 | 
| 
GO:0050839 cell adhesion molecule
binding
 | 
21
 | 
3.75e-01
 | 
-1.12e-01
 | 
7.45e-01
 | 
| 
GO:0007265 Ras protein signal
transduction
 | 
37
 | 
2.40e-01
 | 
-1.12e-01
 | 
6.20e-01
 | 
| 
GO:1904707 positive regulation of
vascular associated smooth muscle cell proliferation
 | 
14
 | 
4.70e-01
 | 
-1.12e-01
 | 
7.92e-01
 | 
| 
GO:0030178 negative regulation of
Wnt signaling pathway
 | 
17
 | 
4.26e-01
 | 
-1.12e-01
 | 
7.74e-01
 | 
| 
GO:0043015 gamma-tubulin binding
 | 
21
 | 
3.77e-01
 | 
1.11e-01
 | 
7.45e-01
 | 
| 
GO:0060326 cell chemotaxis
 | 
27
 | 
3.17e-01
 | 
-1.11e-01
 | 
6.95e-01
 | 
| 
GO:0005938 cell cortex
 | 
74
 | 
9.85e-02
 | 
1.11e-01
 | 
4.19e-01
 | 
| 
GO:0006888 endoplasmic reticulum to
Golgi vesicle-mediated transport
 | 
67
 | 
1.16e-01
 | 
1.11e-01
 | 
4.50e-01
 | 
| 
GO:0004930 G protein-coupled
receptor activity
 | 
58
 | 
1.45e-01
 | 
-1.11e-01
 | 
4.96e-01
 | 
| 
GO:0005686 U2 snRNP
 | 
16
 | 
4.43e-01
 | 
-1.11e-01
 | 
7.82e-01
 | 
| 
GO:0060079 excitatory postsynaptic
potential
 | 
16
 | 
4.44e-01
 | 
1.10e-01
 | 
7.82e-01
 | 
| 
GO:0051260 protein
homooligomerization
 | 
47
 | 
1.92e-01
 | 
-1.10e-01
 | 
5.66e-01
 | 
| 
GO:0051219 phosphoprotein binding
 | 
20
 | 
3.94e-01
 | 
1.10e-01
 | 
7.54e-01
 | 
| 
GO:0008361 regulation of cell size
 | 
13
 | 
4.93e-01
 | 
1.10e-01
 | 
8.02e-01
 | 
| 
GO:0017053 transcription repressor
complex
 | 
34
 | 
2.68e-01
 | 
-1.10e-01
 | 
6.50e-01
 | 
| 
GO:0035035 histone
acetyltransferase binding
 | 
12
 | 
5.11e-01
 | 
-1.10e-01
 | 
8.13e-01
 | 
| 
GO:0035591 signaling adaptor
activity
 | 
40
 | 
2.32e-01
 | 
1.09e-01
 | 
6.09e-01
 | 
| 
GO:0004252 serine-type
endopeptidase activity
 | 
50
 | 
1.83e-01
 | 
1.09e-01
 | 
5.52e-01
 | 
| 
GO:0007059 chromosome segregation
 | 
41
 | 
2.27e-01
 | 
1.09e-01
 | 
6.04e-01
 | 
| 
GO:0043923 positive regulation by
host of viral transcription
 | 
12
 | 
5.14e-01
 | 
1.09e-01
 | 
8.15e-01
 | 
| 
GO:0032481 positive regulation of
type I interferon production
 | 
18
 | 
4.24e-01
 | 
1.09e-01
 | 
7.73e-01
 | 
| 
GO:0007605 sensory perception of
sound
 | 
54
 | 
1.67e-01
 | 
1.09e-01
 | 
5.27e-01
 | 
| 
GO:0061630 ubiquitin protein ligase
activity
 | 
176
 | 
1.30e-02
 | 
-1.09e-01
 | 
1.70e-01
 | 
| 
GO:0005776 autophagosome
 | 
41
 | 
2.29e-01
 | 
1.09e-01
 | 
6.04e-01
 | 
| 
GO:0032880 regulation of protein
localization
 | 
42
 | 
2.23e-01
 | 
1.09e-01
 | 
5.99e-01
 | 
| 
GO:1900181 negative regulation of
protein localization to nucleus
 | 
11
 | 
5.33e-01
 | 
-1.09e-01
 | 
8.27e-01
 | 
| 
GO:0005509 calcium ion binding
 | 
261
 | 
2.62e-03
 | 
1.09e-01
 | 
7.60e-02
 | 
| 
GO:0022008 neurogenesis
 | 
31
 | 
2.97e-01
 | 
-1.08e-01
 | 
6.79e-01
 | 
| 
GO:0000159 protein phosphatase type
2A complex
 | 
12
 | 
5.16e-01
 | 
-1.08e-01
 | 
8.16e-01
 | 
| 
GO:0001649 osteoblast
differentiation
 | 
39
 | 
2.43e-01
 | 
-1.08e-01
 | 
6.22e-01
 | 
| 
GO:0006099 tricarboxylic acid cycle
 | 
19
 | 
4.15e-01
 | 
1.08e-01
 | 
7.72e-01
 | 
| 
GO:0045824 negative regulation of
innate immune response
 | 
16
 | 
4.55e-01
 | 
-1.08e-01
 | 
7.86e-01
 | 
| 
GO:0004694 eukaryotic translation
initiation factor 2alpha kinase activity
 | 
34
 | 
2.77e-01
 | 
1.08e-01
 | 
6.64e-01
 | 
| 
GO:0034644 cellular response to UV
 | 
33
 | 
2.84e-01
 | 
-1.08e-01
 | 
6.64e-01
 | 
| 
GO:0005158 insulin receptor binding
 | 
13
 | 
5.01e-01
 | 
-1.08e-01
 | 
8.06e-01
 | 
| 
GO:0030220 platelet formation
 | 
11
 | 
5.37e-01
 | 
-1.07e-01
 | 
8.29e-01
 | 
| 
GO:0072542 protein phosphatase
activator activity
 | 
10
 | 
5.57e-01
 | 
-1.07e-01
 | 
8.40e-01
 | 
| 
GO:0051560 mitochondrial calcium
ion homeostasis
 | 
13
 | 
5.03e-01
 | 
-1.07e-01
 | 
8.06e-01
 | 
| 
GO:0016460 myosin II complex
 | 
12
 | 
5.21e-01
 | 
-1.07e-01
 | 
8.22e-01
 | 
| 
GO:0098839 postsynaptic density
membrane
 | 
34
 | 
2.80e-01
 | 
1.07e-01
 | 
6.64e-01
 | 
| 
GO:0042391 regulation of membrane
potential
 | 
13
 | 
5.06e-01
 | 
-1.07e-01
 | 
8.08e-01
 | 
| 
GO:0004843 cysteine-type
deubiquitinase activity
 | 
58
 | 
1.61e-01
 | 
-1.06e-01
 | 
5.20e-01
 | 
| 
GO:0005795 Golgi stack
 | 
18
 | 
4.35e-01
 | 
1.06e-01
 | 
7.79e-01
 | 
| 
GO:0030218 erythrocyte
differentiation
 | 
27
 | 
3.39e-01
 | 
1.06e-01
 | 
7.18e-01
 | 
| 
GO:0008408 3’-5’ exonuclease
activity
 | 
10
 | 
5.61e-01
 | 
-1.06e-01
 | 
8.42e-01
 | 
| 
GO:0007032 endosome organization
 | 
28
 | 
3.32e-01
 | 
-1.06e-01
 | 
7.12e-01
 | 
| 
GO:0045740 positive regulation of
DNA replication
 | 
11
 | 
5.43e-01
 | 
-1.06e-01
 | 
8.34e-01
 | 
| 
GO:0016922 nuclear receptor binding
 | 
21
 | 
4.01e-01
 | 
1.06e-01
 | 
7.60e-01
 | 
| 
GO:0000939 inner kinetochore
 | 
10
 | 
5.64e-01
 | 
1.06e-01
 | 
8.42e-01
 | 
| 
GO:0002376 immune system process
 | 
12
 | 
5.27e-01
 | 
1.05e-01
 | 
8.25e-01
 | 
| 
GO:0051382 kinetochore assembly
 | 
11
 | 
5.46e-01
 | 
1.05e-01
 | 
8.35e-01
 | 
| 
GO:0007517 muscle organ development
 | 
11
 | 
5.46e-01
 | 
1.05e-01
 | 
8.35e-01
 | 
| 
GO:0030864 cortical actin
cytoskeleton
 | 
32
 | 
3.04e-01
 | 
1.05e-01
 | 
6.84e-01
 | 
| 
GO:0005765 lysosomal membrane
 | 
137
 | 
3.44e-02
 | 
1.05e-01
 | 
2.72e-01
 | 
| 
GO:0030838 positive regulation of
actin filament polymerization
 | 
26
 | 
3.55e-01
 | 
1.05e-01
 | 
7.30e-01
 | 
| 
GO:0005929 cilium
 | 
78
 | 
1.11e-01
 | 
1.05e-01
 | 
4.37e-01
 | 
| 
GO:0042127 regulation of cell
population proliferation
 | 
44
 | 
2.30e-01
 | 
1.05e-01
 | 
6.06e-01
 | 
| 
GO:0016239 positive regulation of
macroautophagy
 | 
17
 | 
4.56e-01
 | 
1.04e-01
 | 
7.86e-01
 | 
| 
GO:0051898 negative regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
 | 
35
 | 
2.86e-01
 | 
-1.04e-01
 | 
6.65e-01
 | 
| 
GO:0030295 protein kinase activator
activity
 | 
21
 | 
4.08e-01
 | 
-1.04e-01
 | 
7.68e-01
 | 
| 
GO:0006605 protein targeting
 | 
18
 | 
4.44e-01
 | 
1.04e-01
 | 
7.82e-01
 | 
| 
GO:0050830 defense response to
Gram-positive bacterium
 | 
15
 | 
4.85e-01
 | 
1.04e-01
 | 
8.02e-01
 | 
| 
GO:0005096 GTPase activator
activity
 | 
151
 | 
2.76e-02
 | 
1.04e-01
 | 
2.45e-01
 | 
| 
GO:0005507 copper ion binding
 | 
24
 | 
3.78e-01
 | 
-1.04e-01
 | 
7.45e-01
 | 
| 
GO:0005125 cytokine activity
 | 
28
 | 
3.42e-01
 | 
1.04e-01
 | 
7.19e-01
 | 
| 
GO:0050890 cognition
 | 
18
 | 
4.49e-01
 | 
1.03e-01
 | 
7.84e-01
 | 
| 
GO:0045190 isotype switching
 | 
13
 | 
5.22e-01
 | 
-1.03e-01
 | 
8.22e-01
 | 
| 
GO:0032206 positive regulation of
telomere maintenance
 | 
14
 | 
5.07e-01
 | 
-1.02e-01
 | 
8.08e-01
 | 
| 
GO:0007417 central nervous system
development
 | 
42
 | 
2.51e-01
 | 
1.02e-01
 | 
6.33e-01
 | 
| 
GO:0000209 protein
polyubiquitination
 | 
77
 | 
1.21e-01
 | 
-1.02e-01
 | 
4.55e-01
 | 
| 
GO:0042826 histone deacetylase
binding
 | 
66
 | 
1.51e-01
 | 
-1.02e-01
 | 
5.03e-01
 | 
| 
GO:0034237 protein kinase A
regulatory subunit binding
 | 
15
 | 
4.93e-01
 | 
-1.02e-01
 | 
8.02e-01
 | 
| 
GO:0001569 branching involved in
blood vessel morphogenesis
 | 
15
 | 
4.93e-01
 | 
-1.02e-01
 | 
8.02e-01
 | 
| 
GO:0030424 axon
 | 
120
 | 
5.41e-02
 | 
-1.02e-01
 | 
3.26e-01
 | 
| 
GO:0043005 neuron projection
 | 
97
 | 
8.31e-02
 | 
1.02e-01
 | 
3.88e-01
 | 
| 
GO:0031398 positive regulation of
protein ubiquitination
 | 
40
 | 
2.65e-01
 | 
1.02e-01
 | 
6.50e-01
 | 
| 
GO:0006260 DNA replication
 | 
34
 | 
3.04e-01
 | 
-1.02e-01
 | 
6.84e-01
 | 
| 
GO:0034504 protein localization to
nucleus
 | 
20
 | 
4.31e-01
 | 
-1.02e-01
 | 
7.78e-01
 | 
| 
GO:0003677 DNA binding
 | 
337
 | 
1.44e-03
 | 
-1.01e-01
 | 
5.34e-02
 | 
| 
GO:0070847 core mediator complex
 | 
19
 | 
4.45e-01
 | 
1.01e-01
 | 
7.82e-01
 | 
| 
GO:0042060 wound healing
 | 
28
 | 
3.54e-01
 | 
1.01e-01
 | 
7.30e-01
 | 
| 
GO:0008092 cytoskeletal protein
binding
 | 
15
 | 
4.98e-01
 | 
-1.01e-01
 | 
8.03e-01
 | 
| 
GO:0000166 nucleotide binding
 | 
37
 | 
2.88e-01
 | 
-1.01e-01
 | 
6.68e-01
 | 
| 
GO:0034497 protein localization to
phagophore assembly site
 | 
11
 | 
5.63e-01
 | 
1.01e-01
 | 
8.42e-01
 | 
| 
GO:0004864 protein phosphatase
inhibitor activity
 | 
13
 | 
5.29e-01
 | 
-1.01e-01
 | 
8.26e-01
 | 
| 
GO:0001947 heart looping
 | 
23
 | 
4.05e-01
 | 
1.00e-01
 | 
7.63e-01
 | 
| 
GO:0090316 positive regulation of
intracellular protein transport
 | 
14
 | 
5.17e-01
 | 
1.00e-01
 | 
8.16e-01
 | 
| 
GO:0006865 amino acid transport
 | 
11
 | 
5.67e-01
 | 
9.98e-02
 | 
8.43e-01
 | 
| 
GO:0004842 ubiquitin-protein
transferase activity
 | 
65
 | 
1.65e-01
 | 
-9.98e-02
 | 
5.24e-01
 | 
| 
GO:0000381 regulation of
alternative mRNA splicing, via spliceosome
 | 
31
 | 
3.38e-01
 | 
-9.95e-02
 | 
7.17e-01
 | 
| 
GO:0030141 secretory granule
 | 
18
 | 
4.66e-01
 | 
9.94e-02
 | 
7.92e-01
 | 
| 
GO:0050905 neuromuscular process
 | 
10
 | 
5.87e-01
 | 
9.93e-02
 | 
8.57e-01
 | 
| 
GO:0061136 regulation of
proteasomal protein catabolic process
 | 
11
 | 
5.70e-01
 | 
9.89e-02
 | 
8.45e-01
 | 
| 
GO:0042162 telomeric DNA binding
 | 
20
 | 
4.44e-01
 | 
-9.88e-02
 | 
7.82e-01
 | 
| 
GO:0030534 adult behavior
 | 
10
 | 
5.89e-01
 | 
9.87e-02
 | 
8.58e-01
 | 
| 
GO:0031491 nucleosome binding
 | 
25
 | 
3.94e-01
 | 
-9.86e-02
 | 
7.54e-01
 | 
| 
GO:0030183 B cell differentiation
 | 
27
 | 
3.77e-01
 | 
9.83e-02
 | 
7.45e-01
 | 
| 
GO:0008076 voltage-gated potassium
channel complex
 | 
21
 | 
4.36e-01
 | 
-9.83e-02
 | 
7.80e-01
 | 
| 
GO:0071526 semaphorin-plexin
signaling pathway
 | 
23
 | 
4.19e-01
 | 
-9.74e-02
 | 
7.72e-01
 | 
| 
GO:0045746 negative regulation of
Notch signaling pathway
 | 
15
 | 
5.14e-01
 | 
9.72e-02
 | 
8.15e-01
 | 
| 
GO:0061608 nuclear import signal
receptor activity
 | 
14
 | 
5.29e-01
 | 
-9.72e-02
 | 
8.26e-01
 | 
| 
GO:0042981 regulation of apoptotic
process
 | 
54
 | 
2.18e-01
 | 
-9.69e-02
 | 
5.93e-01
 | 
| 
GO:0031901 early endosome membrane
 | 
75
 | 
1.47e-01
 | 
9.69e-02
 | 
4.99e-01
 | 
| 
GO:0045666 positive regulation of
neuron differentiation
 | 
26
 | 
3.93e-01
 | 
9.68e-02
 | 
7.54e-01
 | 
| 
GO:0045165 cell fate commitment
 | 
20
 | 
4.54e-01
 | 
9.68e-02
 | 
7.86e-01
 | 
| 
GO:0031124 mRNA 3’-end processing
 | 
13
 | 
5.46e-01
 | 
9.67e-02
 | 
8.35e-01
 | 
| 
GO:0001666 response to hypoxia
 | 
51
 | 
2.33e-01
 | 
-9.65e-02
 | 
6.10e-01
 | 
| 
GO:0007094 mitotic spindle assembly
checkpoint signaling
 | 
19
 | 
4.67e-01
 | 
9.65e-02
 | 
7.92e-01
 | 
| 
GO:0006346 DNA
methylation-dependent constitutive heterochromatin formation
 | 
10
 | 
5.98e-01
 | 
-9.64e-02
 | 
8.59e-01
 | 
| 
GO:0043113 receptor clustering
 | 
12
 | 
5.64e-01
 | 
-9.62e-02
 | 
8.42e-01
 | 
| 
GO:1902895 positive regulation of
miRNA transcription
 | 
24
 | 
4.16e-01
 | 
-9.59e-02
 | 
7.72e-01
 | 
| 
GO:0070374 positive regulation of
ERK1 and ERK2 cascade
 | 
59
 | 
2.03e-01
 | 
9.59e-02
 | 
5.77e-01
 | 
| 
GO:0140627 ubiquitin-dependent
protein catabolic process via the C-end degron rule pathway
 | 
10
 | 
6.00e-01
 | 
-9.59e-02
 | 
8.59e-01
 | 
| 
GO:0060976 coronary vasculature
development
 | 
18
 | 
4.82e-01
 | 
-9.58e-02
 | 
8.01e-01
 | 
| 
GO:0008654 phospholipid
biosynthetic process
 | 
12
 | 
5.67e-01
 | 
-9.54e-02
 | 
8.43e-01
 | 
| 
GO:0051315 attachment of mitotic
spindle microtubules to kinetochore
 | 
10
 | 
6.02e-01
 | 
9.52e-02
 | 
8.59e-01
 | 
| 
GO:0051018 protein kinase A binding
 | 
12
 | 
5.71e-01
 | 
-9.44e-02
 | 
8.46e-01
 | 
| 
GO:0140297 DNA-binding
transcription factor binding
 | 
72
 | 
1.67e-01
 | 
-9.44e-02
 | 
5.27e-01
 | 
| 
GO:0017025 TBP-class protein
binding
 | 
18
 | 
4.88e-01
 | 
-9.44e-02
 | 
8.02e-01
 | 
| 
GO:0045995 regulation of embryonic
development
 | 
27
 | 
3.97e-01
 | 
-9.41e-02
 | 
7.56e-01
 | 
| 
GO:0006644 phospholipid metabolic
process
 | 
11
 | 
5.89e-01
 | 
9.40e-02
 | 
8.58e-01
 | 
| 
GO:0000400 four-way junction DNA
binding
 | 
14
 | 
5.43e-01
 | 
9.38e-02
 | 
8.34e-01
 | 
| 
GO:1903078 positive regulation of
protein localization to plasma membrane
 | 
21
 | 
4.57e-01
 | 
9.38e-02
 | 
7.86e-01
 | 
| 
GO:0009887 animal organ
morphogenesis
 | 
34
 | 
3.44e-01
 | 
-9.37e-02
 | 
7.22e-01
 | 
| 
GO:0032435 negative regulation of
proteasomal ubiquitin-dependent protein catabolic process
 | 
19
 | 
4.82e-01
 | 
9.31e-02
 | 
8.01e-01
 | 
| 
GO:0045022 early endosome to late
endosome transport
 | 
19
 | 
4.83e-01
 | 
9.29e-02
 | 
8.01e-01
 | 
| 
GO:0030276 clathrin binding
 | 
17
 | 
5.08e-01
 | 
9.28e-02
 | 
8.08e-01
 | 
| 
GO:0051965 positive regulation of
synapse assembly
 | 
22
 | 
4.51e-01
 | 
9.28e-02
 | 
7.85e-01
 | 
| 
GO:0061436 establishment of skin
barrier
 | 
13
 | 
5.63e-01
 | 
-9.27e-02
 | 
8.42e-01
 | 
| 
GO:0035987 endodermal cell
differentiation
 | 
22
 | 
4.56e-01
 | 
9.19e-02
 | 
7.86e-01
 | 
| 
GO:0030168 platelet activation
 | 
11
 | 
5.98e-01
 | 
-9.18e-02
 | 
8.59e-01
 | 
| 
GO:0003777 microtubule motor
activity
 | 
23
 | 
4.47e-01
 | 
9.16e-02
 | 
7.83e-01
 | 
| 
GO:0048870 cell motility
 | 
12
 | 
5.84e-01
 | 
9.14e-02
 | 
8.55e-01
 | 
| 
GO:0035567 non-canonical Wnt
signaling pathway
 | 
13
 | 
5.69e-01
 | 
9.13e-02
 | 
8.44e-01
 | 
| 
GO:0007169 cell surface receptor
protein tyrosine kinase signaling pathway
 | 
42
 | 
3.07e-01
 | 
9.11e-02
 | 
6.86e-01
 | 
| 
GO:0036211 protein modification
process
 | 
16
 | 
5.28e-01
 | 
9.10e-02
 | 
8.26e-01
 | 
| 
GO:0003712 transcription
coregulator activity
 | 
76
 | 
1.73e-01
 | 
-9.04e-02
 | 
5.36e-01
 | 
| 
GO:0001227 DNA-binding
transcription repressor activity, RNA polymerase II-specific
 | 
113
 | 
9.73e-02
 | 
-9.04e-02
 | 
4.15e-01
 | 
| 
GO:0090734 site of DNA damage
 | 
22
 | 
4.63e-01
 | 
-9.03e-02
 | 
7.92e-01
 | 
| 
GO:0050728 negative regulation of
inflammatory response
 | 
48
 | 
2.81e-01
 | 
8.99e-02
 | 
6.64e-01
 | 
| 
GO:0016791 phosphatase activity
 | 
15
 | 
5.47e-01
 | 
-8.99e-02
 | 
8.35e-01
 | 
| 
GO:0009898 cytoplasmic side of
plasma membrane
 | 
49
 | 
2.78e-01
 | 
8.95e-02
 | 
6.64e-01
 | 
| 
GO:0071222 cellular response to
lipopolysaccharide
 | 
45
 | 
2.99e-01
 | 
8.95e-02
 | 
6.80e-01
 | 
| 
GO:2001238 positive regulation of
extrinsic apoptotic signaling pathway
 | 
12
 | 
5.92e-01
 | 
8.94e-02
 | 
8.58e-01
 | 
| 
GO:0006355 regulation of
DNA-templated transcription
 | 
160
 | 
5.14e-02
 | 
-8.94e-02
 | 
3.19e-01
 | 
| 
GO:0072686 mitotic spindle
 | 
69
 | 
2.00e-01
 | 
8.94e-02
 | 
5.77e-01
 | 
| 
GO:0005813 centrosome
 | 
344
 | 
4.57e-03
 | 
8.94e-02
 | 
1.02e-01
 | 
| 
GO:0106222 lncRNA binding
 | 
17
 | 
5.24e-01
 | 
-8.93e-02
 | 
8.23e-01
 | 
| 
GO:0030500 regulation of bone
mineralization
 | 
12
 | 
5.93e-01
 | 
8.92e-02
 | 
8.59e-01
 | 
| 
GO:0050870 positive regulation of T
cell activation
 | 
14
 | 
5.64e-01
 | 
8.91e-02
 | 
8.42e-01
 | 
| 
GO:0003148 outflow tract septum
morphogenesis
 | 
12
 | 
5.95e-01
 | 
-8.86e-02
 | 
8.59e-01
 | 
| 
GO:0005604 basement membrane
 | 
44
 | 
3.10e-01
 | 
-8.86e-02
 | 
6.86e-01
 | 
| 
GO:0060612 adipose tissue
development
 | 
23
 | 
4.64e-01
 | 
8.83e-02
 | 
7.92e-01
 | 
| 
GO:0008033 tRNA processing
 | 
15
 | 
5.54e-01
 | 
-8.83e-02
 | 
8.40e-01
 | 
| 
GO:0032868 response to insulin
 | 
22
 | 
4.74e-01
 | 
-8.82e-02
 | 
7.95e-01
 | 
| 
GO:0001516 prostaglandin
biosynthetic process
 | 
10
 | 
6.29e-01
 | 
8.81e-02
 | 
8.79e-01
 | 
| 
GO:0005802 trans-Golgi network
 | 
100
 | 
1.29e-01
 | 
8.81e-02
 | 
4.69e-01
 | 
| 
GO:0071347 cellular response to
interleukin-1
 | 
17
 | 
5.31e-01
 | 
8.79e-02
 | 
8.26e-01
 | 
| 
GO:0030878 thyroid gland
development
 | 
14
 | 
5.69e-01
 | 
8.79e-02
 | 
8.44e-01
 | 
| 
GO:0061484 hematopoietic stem cell
homeostasis
 | 
12
 | 
5.99e-01
 | 
-8.78e-02
 | 
8.59e-01
 | 
| 
GO:0005903 brush border
 | 
20
 | 
4.97e-01
 | 
-8.78e-02
 | 
8.02e-01
 | 
| 
GO:0019902 phosphatase binding
 | 
23
 | 
4.67e-01
 | 
8.77e-02
 | 
7.92e-01
 | 
| 
GO:0050804 modulation of chemical
synaptic transmission
 | 
34
 | 
3.77e-01
 | 
8.76e-02
 | 
7.45e-01
 | 
| 
GO:0070840 dynein complex binding
 | 
11
 | 
6.16e-01
 | 
8.75e-02
 | 
8.68e-01
 | 
| 
GO:0009925 basal plasma membrane
 | 
12
 | 
6.00e-01
 | 
8.75e-02
 | 
8.59e-01
 | 
| 
GO:0043010 camera-type eye
development
 | 
22
 | 
4.78e-01
 | 
8.74e-02
 | 
7.99e-01
 | 
| 
GO:0070382 exocytic vesicle
 | 
10
 | 
6.33e-01
 | 
8.73e-02
 | 
8.81e-01
 | 
| 
GO:0097546 ciliary base
 | 
17
 | 
5.34e-01
 | 
8.71e-02
 | 
8.27e-01
 | 
| 
GO:0001817 regulation of cytokine
production
 | 
26
 | 
4.43e-01
 | 
-8.70e-02
 | 
7.82e-01
 | 
| 
GO:0061025 membrane fusion
 | 
21
 | 
4.91e-01
 | 
-8.69e-02
 | 
8.02e-01
 | 
| 
GO:0031201 SNARE complex
 | 
33
 | 
3.88e-01
 | 
-8.69e-02
 | 
7.52e-01
 | 
| 
GO:1990782 protein tyrosine kinase
binding
 | 
14
 | 
5.74e-01
 | 
8.68e-02
 | 
8.46e-01
 | 
| 
GO:0070530 K63-linked polyubiquitin
modification-dependent protein binding
 | 
18
 | 
5.24e-01
 | 
-8.68e-02
 | 
8.23e-01
 | 
| 
GO:0006303 double-strand break
repair via nonhomologous end joining
 | 
20
 | 
5.02e-01
 | 
-8.67e-02
 | 
8.06e-01
 | 
| 
GO:0005021 vascular endothelial
growth factor receptor activity
 | 
15
 | 
5.61e-01
 | 
-8.67e-02
 | 
8.42e-01
 | 
| 
GO:0060348 bone development
 | 
26
 | 
4.45e-01
 | 
8.66e-02
 | 
7.82e-01
 | 
| 
GO:0009968 negative regulation of
signal transduction
 | 
14
 | 
5.75e-01
 | 
8.66e-02
 | 
8.46e-01
 | 
| 
GO:0005778 peroxisomal membrane
 | 
28
 | 
4.28e-01
 | 
-8.65e-02
 | 
7.75e-01
 | 
| 
GO:0051539 4 iron, 4 sulfur cluster
binding
 | 
33
 | 
3.90e-01
 | 
-8.65e-02
 | 
7.54e-01
 | 
| 
GO:0005666 RNA polymerase III
complex
 | 
12
 | 
6.04e-01
 | 
8.65e-02
 | 
8.59e-01
 | 
| 
GO:0043627 response to estrogen
 | 
10
 | 
6.36e-01
 | 
-8.64e-02
 | 
8.84e-01
 | 
| 
GO:0016604 nuclear body
 | 
174
 | 
5.00e-02
 | 
-8.63e-02
 | 
3.16e-01
 | 
| 
GO:0045722 positive regulation of
gluconeogenesis
 | 
11
 | 
6.21e-01
 | 
8.62e-02
 | 
8.74e-01
 | 
| 
GO:0009986 cell surface
 | 
183
 | 
4.59e-02
 | 
8.57e-02
 | 
3.08e-01
 | 
| 
GO:0051726 regulation of cell cycle
 | 
104
 | 
1.32e-01
 | 
-8.56e-02
 | 
4.74e-01
 | 
| 
GO:0032587 ruffle membrane
 | 
41
 | 
3.47e-01
 | 
8.50e-02
 | 
7.25e-01
 | 
| 
GO:0016459 myosin complex
 | 
24
 | 
4.71e-01
 | 
-8.50e-02
 | 
7.92e-01
 | 
| 
GO:0016592 mediator complex
 | 
28
 | 
4.37e-01
 | 
-8.49e-02
 | 
7.80e-01
 | 
| 
GO:0035082 axoneme assembly
 | 
10
 | 
6.43e-01
 | 
8.46e-02
 | 
8.88e-01
 | 
| 
GO:0014069 postsynaptic density
 | 
96
 | 
1.53e-01
 | 
8.45e-02
 | 
5.05e-01
 | 
| 
GO:0006006 glucose metabolic
process
 | 
26
 | 
4.56e-01
 | 
-8.44e-02
 | 
7.86e-01
 | 
| 
GO:0048511 rhythmic process
 | 
25
 | 
4.65e-01
 | 
-8.44e-02
 | 
7.92e-01
 | 
| 
GO:2000114 regulation of
establishment of cell polarity
 | 
10
 | 
6.46e-01
 | 
8.39e-02
 | 
8.90e-01
 | 
| 
GO:0003180 aortic valve
morphogenesis
 | 
11
 | 
6.31e-01
 | 
-8.38e-02
 | 
8.79e-01
 | 
| 
GO:0003755 peptidyl-prolyl
cis-trans isomerase activity
 | 
30
 | 
4.27e-01
 | 
-8.37e-02
 | 
7.75e-01
 | 
| 
GO:0042813 Wnt receptor activity
 | 
12
 | 
6.16e-01
 | 
8.37e-02
 | 
8.68e-01
 | 
| 
GO:0031507 heterochromatin
formation
 | 
27
 | 
4.52e-01
 | 
-8.36e-02
 | 
7.85e-01
 | 
| 
GO:0030215 semaphorin receptor
binding
 | 
11
 | 
6.31e-01
 | 
-8.35e-02
 | 
8.80e-01
 | 
| 
GO:0006366 transcription by RNA
polymerase II
 | 
73
 | 
2.18e-01
 | 
-8.34e-02
 | 
5.93e-01
 | 
| 
GO:0008104 protein localization
 | 
67
 | 
2.40e-01
 | 
8.31e-02
 | 
6.20e-01
 | 
| 
GO:0005977 glycogen metabolic
process
 | 
13
 | 
6.05e-01
 | 
8.30e-02
 | 
8.59e-01
 | 
| 
GO:0022857 transmembrane
transporter activity
 | 
41
 | 
3.59e-01
 | 
-8.29e-02
 | 
7.32e-01
 | 
| 
GO:0050772 positive regulation of
axonogenesis
 | 
13
 | 
6.05e-01
 | 
-8.29e-02
 | 
8.59e-01
 | 
| 
GO:0071407 cellular response to
organic cyclic compound
 | 
11
 | 
6.35e-01
 | 
-8.27e-02
 | 
8.83e-01
 | 
| 
GO:0004177 aminopeptidase activity
 | 
13
 | 
6.06e-01
 | 
-8.26e-02
 | 
8.59e-01
 | 
| 
GO:0045494 photoreceptor cell
maintenance
 | 
24
 | 
4.84e-01
 | 
8.25e-02
 | 
8.02e-01
 | 
| 
GO:0001784 phosphotyrosine residue
binding
 | 
27
 | 
4.60e-01
 | 
-8.22e-02
 | 
7.89e-01
 | 
| 
GO:0005739 mitochondrion
 | 
607
 | 
6.04e-04
 | 
8.21e-02
 | 
3.28e-02
 | 
| 
GO:0000082 G1/S transition of
mitotic cell cycle
 | 
40
 | 
3.70e-01
 | 
8.20e-02
 | 
7.41e-01
 | 
| 
GO:0005689 U12-type spliceosomal
complex
 | 
20
 | 
5.26e-01
 | 
-8.20e-02
 | 
8.24e-01
 | 
| 
GO:0001657 ureteric bud development
 | 
14
 | 
5.97e-01
 | 
-8.16e-02
 | 
8.59e-01
 | 
| 
GO:0006974 DNA damage response
 | 
120
 | 
1.24e-01
 | 
-8.14e-02
 | 
4.61e-01
 | 
| 
GO:0061077 chaperone-mediated
protein folding
 | 
16
 | 
5.75e-01
 | 
-8.11e-02
 | 
8.46e-01
 | 
| 
GO:0051019 mitogen-activated
protein kinase binding
 | 
11
 | 
6.43e-01
 | 
8.08e-02
 | 
8.88e-01
 | 
| 
GO:0071339 MLL1 complex
 | 
18
 | 
5.54e-01
 | 
-8.06e-02
 | 
8.40e-01
 | 
| 
GO:0045727 positive regulation of
translation
 | 
36
 | 
4.04e-01
 | 
8.04e-02
 | 
7.62e-01
 | 
| 
GO:0005794 Golgi apparatus
 | 
468
 | 
3.14e-03
 | 
8.01e-02
 | 
8.66e-02
 | 
| 
GO:0006906 vesicle fusion
 | 
15
 | 
5.91e-01
 | 
8.01e-02
 | 
8.58e-01
 | 
| 
GO:0030134 COPII-coated ER to Golgi
transport vesicle
 | 
21
 | 
5.26e-01
 | 
7.99e-02
 | 
8.24e-01
 | 
| 
GO:0005154 epidermal growth factor
receptor binding
 | 
19
 | 
5.47e-01
 | 
-7.98e-02
 | 
8.35e-01
 | 
| 
GO:0015035 protein-disulfide
reductase activity
 | 
14
 | 
6.05e-01
 | 
7.98e-02
 | 
8.59e-01
 | 
| 
GO:0008333 endosome to lysosome
transport
 | 
32
 | 
4.36e-01
 | 
7.95e-02
 | 
7.80e-01
 | 
| 
GO:0071805 potassium ion
transmembrane transport
 | 
41
 | 
3.79e-01
 | 
7.94e-02
 | 
7.45e-01
 | 
| 
GO:0016363 nuclear matrix
 | 
46
 | 
3.52e-01
 | 
-7.93e-02
 | 
7.29e-01
 | 
| 
GO:0000977 RNA polymerase II
transcription regulatory region sequence-specific DNA binding
 | 
84
 | 
2.10e-01
 | 
7.91e-02
 | 
5.85e-01
 | 
| 
GO:0036297 interstrand cross-link
repair
 | 
24
 | 
5.04e-01
 | 
7.89e-02
 | 
8.06e-01
 | 
| 
GO:0048015
phosphatidylinositol-mediated signaling
 | 
18
 | 
5.63e-01
 | 
7.88e-02
 | 
8.42e-01
 | 
| 
GO:0017134 fibroblast growth factor
binding
 | 
12
 | 
6.36e-01
 | 
7.88e-02
 | 
8.84e-01
 | 
| 
GO:0140672 ATAC complex
 | 
11
 | 
6.51e-01
 | 
-7.88e-02
 | 
8.94e-01
 | 
| 
GO:0030511 positive regulation of
transforming growth factor beta receptor signaling pathway
 | 
19
 | 
5.55e-01
 | 
7.83e-02
 | 
8.40e-01
 | 
| 
GO:0140801 histone H2AXY142 kinase
activity
 | 
22
 | 
5.25e-01
 | 
-7.83e-02
 | 
8.24e-01
 | 
| 
GO:1990166 protein localization to
site of double-strand break
 | 
10
 | 
6.68e-01
 | 
7.83e-02
 | 
9.00e-01
 | 
| 
GO:0007399 nervous system
development
 | 
89
 | 
2.03e-01
 | 
-7.81e-02
 | 
5.77e-01
 | 
| 
GO:0044291 cell-cell contact zone
 | 
13
 | 
6.27e-01
 | 
-7.79e-02
 | 
8.77e-01
 | 
| 
GO:0005768 endosome
 | 
113
 | 
1.53e-01
 | 
7.78e-02
 | 
5.05e-01
 | 
| 
GO:0002250 adaptive immune response
 | 
21
 | 
5.38e-01
 | 
7.76e-02
 | 
8.29e-01
 | 
| 
GO:0001525 angiogenesis
 | 
85
 | 
2.17e-01
 | 
7.76e-02
 | 
5.92e-01
 | 
| 
GO:0006493 protein O-linked
glycosylation
 | 
31
 | 
4.56e-01
 | 
-7.73e-02
 | 
7.86e-01
 | 
| 
GO:0051879 Hsp90 protein binding
 | 
26
 | 
4.95e-01
 | 
7.73e-02
 | 
8.02e-01
 | 
| 
GO:0032731 positive regulation of
interleukin-1 beta production
 | 
12
 | 
6.43e-01
 | 
7.73e-02
 | 
8.88e-01
 | 
| 
GO:0035791 platelet-derived growth
factor receptor-beta signaling pathway
 | 
15
 | 
6.05e-01
 | 
-7.72e-02
 | 
8.59e-01
 | 
| 
GO:0001764 neuron migration
 | 
40
 | 
4.01e-01
 | 
-7.68e-02
 | 
7.59e-01
 | 
| 
GO:0001222 transcription
corepressor binding
 | 
27
 | 
4.90e-01
 | 
-7.67e-02
 | 
8.02e-01
 | 
| 
GO:0045668 negative regulation of
osteoblast differentiation
 | 
27
 | 
4.91e-01
 | 
7.66e-02
 | 
8.02e-01
 | 
| 
GO:0030027 lamellipodium
 | 
92
 | 
2.08e-01
 | 
-7.61e-02
 | 
5.83e-01
 | 
| 
GO:0007229 integrin-mediated
signaling pathway
 | 
45
 | 
3.78e-01
 | 
-7.60e-02
 | 
7.45e-01
 | 
| 
GO:0045814 negative regulation of
gene expression, epigenetic
 | 
16
 | 
5.99e-01
 | 
-7.60e-02
 | 
8.59e-01
 | 
| 
GO:0048167 regulation of synaptic
plasticity
 | 
16
 | 
5.99e-01
 | 
-7.59e-02
 | 
8.59e-01
 | 
| 
GO:1990837 sequence-specific
double-stranded DNA binding
 | 
47
 | 
3.70e-01
 | 
7.56e-02
 | 
7.41e-01
 | 
| 
GO:1900182 positive regulation of
protein localization to nucleus
 | 
25
 | 
5.13e-01
 | 
-7.56e-02
 | 
8.15e-01
 | 
| 
GO:0060041 retina development in
camera-type eye
 | 
21
 | 
5.49e-01
 | 
-7.55e-02
 | 
8.37e-01
 | 
| 
GO:0008542 visual learning
 | 
20
 | 
5.59e-01
 | 
7.54e-02
 | 
8.42e-01
 | 
| 
GO:0097191 extrinsic apoptotic
signaling pathway
 | 
20
 | 
5.60e-01
 | 
7.53e-02
 | 
8.42e-01
 | 
| 
GO:0001570 vasculogenesis
 | 
26
 | 
5.07e-01
 | 
-7.51e-02
 | 
8.08e-01
 | 
| 
GO:0035861 site of double-strand
break
 | 
58
 | 
3.24e-01
 | 
-7.50e-02
 | 
6.99e-01
 | 
| 
GO:0050919 negative chemotaxis
 | 
20
 | 
5.63e-01
 | 
7.48e-02
 | 
8.42e-01
 | 
| 
GO:0070300 phosphatidic acid
binding
 | 
13
 | 
6.41e-01
 | 
7.47e-02
 | 
8.88e-01
 | 
| 
GO:0004726 non-membrane spanning
protein tyrosine phosphatase activity
 | 
19
 | 
5.73e-01
 | 
-7.46e-02
 | 
8.46e-01
 | 
| 
GO:0045893 positive regulation of
DNA-templated transcription
 | 
222
 | 
5.62e-02
 | 
-7.46e-02
 | 
3.28e-01
 | 
| 
GO:0032922 circadian regulation of
gene expression
 | 
34
 | 
4.52e-01
 | 
-7.45e-02
 | 
7.85e-01
 | 
| 
GO:0033116 endoplasmic
reticulum-Golgi intermediate compartment membrane
 | 
18
 | 
5.86e-01
 | 
7.42e-02
 | 
8.56e-01
 | 
| 
GO:0030159 signaling receptor
complex adaptor activity
 | 
13
 | 
6.44e-01
 | 
7.41e-02
 | 
8.88e-01
 | 
| 
GO:0016180 snRNA processing
 | 
10
 | 
6.85e-01
 | 
-7.41e-02
 | 
9.03e-01
 | 
| 
GO:0071949 FAD binding
 | 
27
 | 
5.06e-01
 | 
7.40e-02
 | 
8.08e-01
 | 
| 
GO:0019838 growth factor binding
 | 
11
 | 
6.71e-01
 | 
-7.40e-02
 | 
9.00e-01
 | 
| 
GO:0001756 somitogenesis
 | 
25
 | 
5.24e-01
 | 
-7.36e-02
 | 
8.23e-01
 | 
| 
GO:0006909 phagocytosis
 | 
22
 | 
5.50e-01
 | 
7.36e-02
 | 
8.37e-01
 | 
| 
GO:0035401 histone H3Y41 kinase
activity
 | 
21
 | 
5.61e-01
 | 
-7.33e-02
 | 
8.42e-01
 | 
| 
GO:0006915 apoptotic process
 | 
135
 | 
1.43e-01
 | 
7.31e-02
 | 
4.94e-01
 | 
| 
GO:0060412 ventricular septum
morphogenesis
 | 
18
 | 
5.93e-01
 | 
7.27e-02
 | 
8.59e-01
 | 
| 
GO:0010629 negative regulation of
gene expression
 | 
101
 | 
2.08e-01
 | 
7.26e-02
 | 
5.83e-01
 | 
| 
GO:0098794 postsynapse
 | 
66
 | 
3.08e-01
 | 
7.26e-02
 | 
6.86e-01
 | 
| 
GO:0015701 bicarbonate transport
 | 
11
 | 
6.77e-01
 | 
-7.25e-02
 | 
9.00e-01
 | 
| 
GO:0002020 protease binding
 | 
44
 | 
4.07e-01
 | 
7.24e-02
 | 
7.65e-01
 | 
| 
GO:0000976 transcription
cis-regulatory region binding
 | 
54
 | 
3.58e-01
 | 
-7.23e-02
 | 
7.32e-01
 | 
| 
GO:0030425 dendrite
 | 
133
 | 
1.51e-01
 | 
-7.22e-02
 | 
5.03e-01
 | 
| 
GO:0072657 protein localization to
membrane
 | 
19
 | 
5.86e-01
 | 
-7.22e-02
 | 
8.56e-01
 | 
| 
GO:0035264 multicellular organism
growth
 | 
67
 | 
3.08e-01
 | 
-7.20e-02
 | 
6.86e-01
 | 
| 
GO:0002931 response to ischemia
 | 
10
 | 
6.95e-01
 | 
-7.16e-02
 | 
9.11e-01
 | 
| 
GO:0008154 actin polymerization or
depolymerization
 | 
12
 | 
6.68e-01
 | 
-7.16e-02
 | 
9.00e-01
 | 
| 
GO:0007368 determination of
left/right symmetry
 | 
28
 | 
5.13e-01
 | 
7.14e-02
 | 
8.15e-01
 | 
| 
GO:0034063 stress granule assembly
 | 
21
 | 
5.72e-01
 | 
-7.13e-02
 | 
8.46e-01
 | 
| 
GO:0072344 rescue of stalled
ribosome
 | 
26
 | 
5.30e-01
 | 
-7.12e-02
 | 
8.26e-01
 | 
| 
GO:0051123 RNA polymerase II
preinitiation complex assembly
 | 
16
 | 
6.22e-01
 | 
-7.12e-02
 | 
8.74e-01
 | 
| 
GO:0030374 nuclear receptor
coactivator activity
 | 
30
 | 
5.00e-01
 | 
-7.11e-02
 | 
8.05e-01
 | 
| 
GO:0045747 positive regulation of
Notch signaling pathway
 | 
23
 | 
5.56e-01
 | 
7.10e-02
 | 
8.40e-01
 | 
| 
GO:0005576 extracellular region
 | 
239
 | 
5.96e-02
 | 
7.09e-02
 | 
3.35e-01
 | 
| 
GO:0005783 endoplasmic reticulum
 | 
433
 | 
1.19e-02
 | 
7.08e-02
 | 
1.63e-01
 | 
| 
GO:0034605 cellular response to
heat
 | 
16
 | 
6.24e-01
 | 
-7.07e-02
 | 
8.76e-01
 | 
| 
GO:2000045 regulation of G1/S
transition of mitotic cell cycle
 | 
19
 | 
5.94e-01
 | 
7.07e-02
 | 
8.59e-01
 | 
| 
GO:0030672 synaptic vesicle
membrane
 | 
44
 | 
4.18e-01
 | 
7.06e-02
 | 
7.72e-01
 | 
| 
GO:0004653 polypeptide
N-acetylgalactosaminyltransferase activity
 | 
10
 | 
7.00e-01
 | 
7.04e-02
 | 
9.11e-01
 | 
| 
GO:0035019 somatic stem cell
population maintenance
 | 
31
 | 
4.98e-01
 | 
7.03e-02
 | 
8.03e-01
 | 
| 
GO:0007268 chemical synaptic
transmission
 | 
33
 | 
4.87e-01
 | 
6.99e-02
 | 
8.02e-01
 | 
| 
GO:0007409 axonogenesis
 | 
41
 | 
4.41e-01
 | 
-6.96e-02
 | 
7.82e-01
 | 
| 
GO:0004711 ribosomal protein S6
kinase activity
 | 
32
 | 
4.96e-01
 | 
6.95e-02
 | 
8.02e-01
 | 
| 
GO:0006869 lipid transport
 | 
27
 | 
5.32e-01
 | 
6.95e-02
 | 
8.27e-01
 | 
| 
GO:0035331 negative regulation of
hippo signaling
 | 
18
 | 
6.10e-01
 | 
-6.94e-02
 | 
8.64e-01
 | 
| 
GO:0006874 intracellular calcium
ion homeostasis
 | 
37
 | 
4.69e-01
 | 
-6.88e-02
 | 
7.92e-01
 | 
| 
GO:0050660 flavin adenine
dinucleotide binding
 | 
33
 | 
4.96e-01
 | 
6.85e-02
 | 
8.02e-01
 | 
| 
GO:0051028 mRNA transport
 | 
27
 | 
5.38e-01
 | 
-6.84e-02
 | 
8.29e-01
 | 
| 
GO:0060236 regulation of mitotic
spindle organization
 | 
12
 | 
6.82e-01
 | 
-6.84e-02
 | 
9.02e-01
 | 
| 
GO:0048786 presynaptic active zone
 | 
10
 | 
7.09e-01
 | 
6.81e-02
 | 
9.14e-01
 | 
| 
GO:0017022 myosin binding
 | 
11
 | 
6.96e-01
 | 
-6.81e-02
 | 
9.11e-01
 | 
| 
GO:0042383 sarcolemma
 | 
37
 | 
4.75e-01
 | 
6.79e-02
 | 
7.96e-01
 | 
| 
GO:0005925 focal adhesion
 | 
115
 | 
2.10e-01
 | 
-6.78e-02
 | 
5.84e-01
 | 
| 
GO:0048487 beta-tubulin binding
 | 
22
 | 
5.83e-01
 | 
6.76e-02
 | 
8.55e-01
 | 
| 
GO:0007626 locomotory behavior
 | 
28
 | 
5.36e-01
 | 
6.75e-02
 | 
8.29e-01
 | 
| 
GO:0030282 bone mineralization
 | 
24
 | 
5.67e-01
 | 
6.75e-02
 | 
8.43e-01
 | 
| 
GO:0060090 molecular adaptor
activity
 | 
75
 | 
3.14e-01
 | 
6.74e-02
 | 
6.90e-01
 | 
| 
GO:0098655 monoatomic cation
transmembrane transport
 | 
14
 | 
6.65e-01
 | 
6.70e-02
 | 
8.99e-01
 | 
| 
GO:0032211 negative regulation of
telomere maintenance via telomerase
 | 
10
 | 
7.14e-01
 | 
-6.69e-02
 | 
9.16e-01
 | 
| 
GO:0030073 insulin secretion
 | 
13
 | 
6.77e-01
 | 
-6.68e-02
 | 
9.00e-01
 | 
| 
GO:0043130 ubiquitin binding
 | 
62
 | 
3.64e-01
 | 
-6.67e-02
 | 
7.37e-01
 | 
| 
GO:0001726 ruffle
 | 
43
 | 
4.51e-01
 | 
6.64e-02
 | 
7.85e-01
 | 
| 
GO:0051894 positive regulation of
focal adhesion assembly
 | 
15
 | 
6.56e-01
 | 
6.64e-02
 | 
8.96e-01
 | 
| 
GO:1990023 mitotic spindle midzone
 | 
10
 | 
7.16e-01
 | 
6.63e-02
 | 
9.17e-01
 | 
| 
GO:0098586 cellular response to
virus
 | 
22
 | 
5.90e-01
 | 
-6.63e-02
 | 
8.58e-01
 | 
| 
GO:0005516 calmodulin binding
 | 
68
 | 
3.45e-01
 | 
6.63e-02
 | 
7.22e-01
 | 
| 
GO:0035091 phosphatidylinositol
binding
 | 
74
 | 
3.25e-01
 | 
6.63e-02
 | 
7.00e-01
 | 
| 
GO:0000139 Golgi membrane
 | 
262
 | 
6.65e-02
 | 
6.60e-02
 | 
3.47e-01
 | 
| 
GO:0019903 protein phosphatase
binding
 | 
49
 | 
4.24e-01
 | 
6.60e-02
 | 
7.73e-01
 | 
| 
GO:0048705 skeletal system
morphogenesis
 | 
14
 | 
6.69e-01
 | 
6.59e-02
 | 
9.00e-01
 | 
| 
GO:0045892 negative regulation of
DNA-templated transcription
 | 
174
 | 
1.35e-01
 | 
-6.58e-02
 | 
4.80e-01
 | 
| 
GO:0009617 response to bacterium
 | 
36
 | 
4.96e-01
 | 
-6.55e-02
 | 
8.02e-01
 | 
| 
GO:0071168 protein localization to
chromatin
 | 
17
 | 
6.40e-01
 | 
6.55e-02
 | 
8.88e-01
 | 
| 
GO:0007029 endoplasmic reticulum
organization
 | 
16
 | 
6.50e-01
 | 
6.54e-02
 | 
8.94e-01
 | 
| 
GO:0031012 extracellular matrix
 | 
90
 | 
2.84e-01
 | 
-6.54e-02
 | 
6.64e-01
 | 
| 
GO:0016235 aggresome
 | 
17
 | 
6.41e-01
 | 
6.54e-02
 | 
8.88e-01
 | 
| 
GO:0070064 proline-rich region
binding
 | 
10
 | 
7.20e-01
 | 
6.54e-02
 | 
9.18e-01
 | 
| 
GO:0007080 mitotic metaphase
chromosome alignment
 | 
23
 | 
5.87e-01
 | 
6.54e-02
 | 
8.57e-01
 | 
| 
GO:0005667 transcription regulator
complex
 | 
90
 | 
2.85e-01
 | 
-6.53e-02
 | 
6.64e-01
 | 
| 
GO:0006396 RNA processing
 | 
21
 | 
6.05e-01
 | 
-6.52e-02
 | 
8.59e-01
 | 
| 
GO:0048873 homeostasis of number of
cells within a tissue
 | 
14
 | 
6.73e-01
 | 
6.52e-02
 | 
9.00e-01
 | 
| 
GO:0051865 protein
autoubiquitination
 | 
38
 | 
4.88e-01
 | 
-6.51e-02
 | 
8.02e-01
 | 
| 
GO:0071356 cellular response to
tumor necrosis factor
 | 
37
 | 
4.95e-01
 | 
-6.49e-02
 | 
8.02e-01
 | 
| 
GO:0032735 positive regulation of
interleukin-12 production
 | 
12
 | 
6.98e-01
 | 
6.48e-02
 | 
9.11e-01
 | 
| 
GO:0051403 stress-activated MAPK
cascade
 | 
12
 | 
6.98e-01
 | 
6.47e-02
 | 
9.11e-01
 | 
| 
GO:0043021 ribonucleoprotein
complex binding
 | 
23
 | 
5.92e-01
 | 
6.46e-02
 | 
8.58e-01
 | 
| 
GO:0000176 nuclear exosome (RNase
complex)
 | 
12
 | 
6.99e-01
 | 
-6.45e-02
 | 
9.11e-01
 | 
| 
GO:0055088 lipid homeostasis
 | 
19
 | 
6.27e-01
 | 
-6.44e-02
 | 
8.77e-01
 | 
| 
GO:1901673 regulation of mitotic
spindle assembly
 | 
16
 | 
6.56e-01
 | 
-6.43e-02
 | 
8.96e-01
 | 
| 
GO:0031966 mitochondrial membrane
 | 
38
 | 
4.94e-01
 | 
6.42e-02
 | 
8.02e-01
 | 
| 
GO:0051649 establishment of
localization in cell
 | 
40
 | 
4.83e-01
 | 
6.42e-02
 | 
8.01e-01
 | 
| 
GO:0005886 plasma membrane
 | 
1527
 | 
4.12e-05
 | 
6.41e-02
 | 
5.21e-03
 | 
| 
GO:0007193 adenylate
cyclase-inhibiting G protein-coupled receptor signaling pathway
 | 
11
 | 
7.14e-01
 | 
6.38e-02
 | 
9.16e-01
 | 
| 
GO:0000287 magnesium ion binding
 | 
150
 | 
1.80e-01
 | 
6.35e-02
 | 
5.49e-01
 | 
| 
GO:0042742 defense response to
bacterium
 | 
28
 | 
5.62e-01
 | 
6.34e-02
 | 
8.42e-01
 | 
| 
GO:0010008 endosome membrane
 | 
86
 | 
3.11e-01
 | 
6.33e-02
 | 
6.87e-01
 | 
| 
GO:0019886 antigen processing and
presentation of exogenous peptide antigen via MHC class II
 | 
12
 | 
7.05e-01
 | 
-6.31e-02
 | 
9.14e-01
 | 
| 
GO:0001654 eye development
 | 
17
 | 
6.53e-01
 | 
6.30e-02
 | 
8.95e-01
 | 
| 
GO:0031547 brain-derived
neurotrophic factor receptor signaling pathway
 | 
14
 | 
6.83e-01
 | 
-6.30e-02
 | 
9.03e-01
 | 
| 
GO:0043014 alpha-tubulin binding
 | 
23
 | 
6.02e-01
 | 
6.28e-02
 | 
8.59e-01
 | 
| 
GO:0050673 epithelial cell
proliferation
 | 
20
 | 
6.27e-01
 | 
-6.27e-02
 | 
8.77e-01
 | 
| 
GO:0034614 cellular response to
reactive oxygen species
 | 
16
 | 
6.64e-01
 | 
-6.27e-02
 | 
8.99e-01
 | 
| 
GO:0051259 protein complex
oligomerization
 | 
14
 | 
6.86e-01
 | 
-6.25e-02
 | 
9.03e-01
 | 
| 
GO:0031032 actomyosin structure
organization
 | 
17
 | 
6.56e-01
 | 
-6.25e-02
 | 
8.96e-01
 | 
| 
GO:0003281 ventricular septum
development
 | 
15
 | 
6.76e-01
 | 
-6.24e-02
 | 
9.00e-01
 | 
| 
GO:0099560 synaptic membrane
adhesion
 | 
15
 | 
6.77e-01
 | 
-6.21e-02
 | 
9.00e-01
 | 
| 
GO:0006400 tRNA modification
 | 
11
 | 
7.23e-01
 | 
6.18e-02
 | 
9.18e-01
 | 
| 
GO:0005518 collagen binding
 | 
34
 | 
5.34e-01
 | 
-6.16e-02
 | 
8.27e-01
 | 
| 
GO:0051302 regulation of cell
division
 | 
11
 | 
7.24e-01
 | 
-6.16e-02
 | 
9.18e-01
 | 
| 
GO:0070098 chemokine-mediated
signaling pathway
 | 
10
 | 
7.36e-01
 | 
-6.15e-02
 | 
9.20e-01
 | 
| 
GO:0003924 GTPase activity
 | 
176
 | 
1.60e-01
 | 
6.15e-02
 | 
5.20e-01
 | 
| 
GO:0006506 GPI anchor biosynthetic
process
 | 
25
 | 
5.96e-01
 | 
6.12e-02
 | 
8.59e-01
 | 
| 
GO:0030175 filopodium
 | 
31
 | 
5.56e-01
 | 
6.11e-02
 | 
8.40e-01
 | 
| 
GO:0010842 retina layer formation
 | 
12
 | 
7.14e-01
 | 
-6.10e-02
 | 
9.16e-01
 | 
| 
GO:0070402 NADPH binding
 | 
10
 | 
7.38e-01
 | 
6.10e-02
 | 
9.20e-01
 | 
| 
GO:1902600 proton transmembrane
transport
 | 
59
 | 
4.19e-01
 | 
6.09e-02
 | 
7.72e-01
 | 
| 
GO:0004198 calcium-dependent
cysteine-type endopeptidase activity
 | 
10
 | 
7.39e-01
 | 
6.08e-02
 | 
9.20e-01
 | 
| 
GO:0007155 cell adhesion
 | 
107
 | 
2.79e-01
 | 
-6.07e-02
 | 
6.64e-01
 | 
| 
GO:0051087 protein-folding
chaperone binding
 | 
55
 | 
4.38e-01
 | 
-6.05e-02
 | 
7.80e-01
 | 
| 
GO:0031397 negative regulation of
protein ubiquitination
 | 
33
 | 
5.48e-01
 | 
6.05e-02
 | 
8.35e-01
 | 
| 
GO:0004713 protein tyrosine kinase
activity
 | 
34
 | 
5.42e-01
 | 
-6.05e-02
 | 
8.34e-01
 | 
| 
GO:0043410 positive regulation of
MAPK cascade
 | 
61
 | 
4.14e-01
 | 
6.05e-02
 | 
7.72e-01
 | 
| 
GO:0001664 G protein-coupled
receptor binding
 | 
22
 | 
6.24e-01
 | 
6.04e-02
 | 
8.76e-01
 | 
| 
GO:0003684 damaged DNA binding
 | 
34
 | 
5.43e-01
 | 
-6.03e-02
 | 
8.34e-01
 | 
| 
GO:0051016 barbed-end actin
filament capping
 | 
16
 | 
6.77e-01
 | 
-6.02e-02
 | 
9.00e-01
 | 
| 
GO:0099523 presynaptic cytosol
 | 
11
 | 
7.30e-01
 | 
6.02e-02
 | 
9.20e-01
 | 
| 
GO:0019882 antigen processing and
presentation
 | 
11
 | 
7.32e-01
 | 
5.96e-02
 | 
9.20e-01
 | 
| 
GO:0036503 ERAD pathway
 | 
59
 | 
4.30e-01
 | 
-5.95e-02
 | 
7.77e-01
 | 
| 
GO:0034067 protein localization to
Golgi apparatus
 | 
13
 | 
7.11e-01
 | 
-5.93e-02
 | 
9.16e-01
 | 
| 
GO:0005741 mitochondrial outer
membrane
 | 
95
 | 
3.20e-01
 | 
-5.91e-02
 | 
6.99e-01
 | 
| 
GO:0007274 neuromuscular synaptic
transmission
 | 
12
 | 
7.23e-01
 | 
-5.90e-02
 | 
9.18e-01
 | 
| 
GO:0007281 germ cell development
 | 
14
 | 
7.02e-01
 | 
-5.90e-02
 | 
9.12e-01
 | 
| 
GO:0061744 motor behavior
 | 
16
 | 
6.84e-01
 | 
5.88e-02
 | 
9.03e-01
 | 
| 
GO:0006508 proteolysis
 | 
174
 | 
1.83e-01
 | 
5.87e-02
 | 
5.52e-01
 | 
| 
GO:0046872 metal ion binding
 | 
877
 | 
3.56e-03
 | 
-5.86e-02
 | 
9.10e-02
 | 
| 
GO:0030971 receptor tyrosine kinase
binding
 | 
32
 | 
5.66e-01
 | 
5.86e-02
 | 
8.43e-01
 | 
| 
GO:0045505 dynein intermediate
chain binding
 | 
17
 | 
6.77e-01
 | 
-5.84e-02
 | 
9.00e-01
 | 
| 
GO:0005789 endoplasmic reticulum
membrane
 | 
402
 | 
4.61e-02
 | 
5.82e-02
 | 
3.08e-01
 | 
| 
GO:0004676
3-phosphoinositide-dependent protein kinase activity
 | 
31
 | 
5.75e-01
 | 
5.82e-02
 | 
8.46e-01
 | 
| 
GO:0007165 signal transduction
 | 
263
 | 
1.05e-01
 | 
5.82e-02
 | 
4.30e-01
 | 
| 
GO:0007596 blood coagulation
 | 
25
 | 
6.15e-01
 | 
5.81e-02
 | 
8.68e-01
 | 
| 
GO:0000049 tRNA binding
 | 
52
 | 
4.70e-01
 | 
-5.79e-02
 | 
7.92e-01
 | 
| 
GO:0007040 lysosome organization
 | 
33
 | 
5.65e-01
 | 
-5.78e-02
 | 
8.43e-01
 | 
| 
GO:0017148 negative regulation of
translation
 | 
43
 | 
5.14e-01
 | 
-5.75e-02
 | 
8.15e-01
 | 
| 
GO:0007005 mitochondrion
organization
 | 
61
 | 
4.38e-01
 | 
5.74e-02
 | 
7.80e-01
 | 
| 
GO:0030216 keratinocyte
differentiation
 | 
27
 | 
6.06e-01
 | 
5.74e-02
 | 
8.59e-01
 | 
| 
GO:0035403 histone H3T6 kinase
activity
 | 
32
 | 
5.74e-01
 | 
5.74e-02
 | 
8.46e-01
 | 
| 
GO:0006730 one-carbon metabolic
process
 | 
13
 | 
7.20e-01
 | 
-5.74e-02
 | 
9.18e-01
 | 
| 
GO:0000226 microtubule cytoskeleton
organization
 | 
69
 | 
4.11e-01
 | 
5.73e-02
 | 
7.69e-01
 | 
| 
GO:0000502 proteasome complex
 | 
13
 | 
7.21e-01
 | 
-5.72e-02
 | 
9.18e-01
 | 
| 
GO:1901981 phosphatidylinositol
phosphate binding
 | 
15
 | 
7.02e-01
 | 
5.71e-02
 | 
9.12e-01
 | 
| 
GO:0051959 dynein light
intermediate chain binding
 | 
16
 | 
6.93e-01
 | 
-5.70e-02
 | 
9.10e-01
 | 
| 
GO:0000932 P-body
 | 
60
 | 
4.47e-01
 | 
-5.68e-02
 | 
7.83e-01
 | 
| 
GO:0070888 E-box binding
 | 
21
 | 
6.53e-01
 | 
5.68e-02
 | 
8.95e-01
 | 
| 
GO:0010595 positive regulation of
endothelial cell migration
 | 
26
 | 
6.17e-01
 | 
5.66e-02
 | 
8.70e-01
 | 
| 
GO:0005178 integrin binding
 | 
66
 | 
4.28e-01
 | 
-5.65e-02
 | 
7.75e-01
 | 
| 
GO:0007267 cell-cell signaling
 | 
13
 | 
7.24e-01
 | 
-5.65e-02
 | 
9.18e-01
 | 
| 
GO:0031941 filamentous actin
 | 
19
 | 
6.70e-01
 | 
-5.64e-02
 | 
9.00e-01
 | 
| 
GO:0016324 apical plasma membrane
 | 
122
 | 
2.82e-01
 | 
5.64e-02
 | 
6.64e-01
 | 
| 
GO:0000122 negative regulation of
transcription by RNA polymerase II
 | 
395
 | 
5.57e-02
 | 
-5.64e-02
 | 
3.28e-01
 | 
| 
GO:0051020 GTPase binding
 | 
15
 | 
7.06e-01
 | 
-5.63e-02
 | 
9.14e-01
 | 
| 
GO:0009306 protein secretion
 | 
20
 | 
6.63e-01
 | 
5.62e-02
 | 
8.99e-01
 | 
| 
GO:0005874 microtubule
 | 
131
 | 
2.68e-01
 | 
5.62e-02
 | 
6.50e-01
 | 
| 
GO:0003341 cilium movement
 | 
10
 | 
7.59e-01
 | 
5.61e-02
 | 
9.20e-01
 | 
| 
GO:0046330 positive regulation of
JNK cascade
 | 
38
 | 
5.50e-01
 | 
-5.60e-02
 | 
8.37e-01
 | 
| 
GO:0048839 inner ear development
 | 
12
 | 
7.37e-01
 | 
5.60e-02
 | 
9.20e-01
 | 
| 
GO:0004867 serine-type
endopeptidase inhibitor activity
 | 
21
 | 
6.57e-01
 | 
5.60e-02
 | 
8.97e-01
 | 
| 
GO:0042147 retrograde transport,
endosome to Golgi
 | 
50
 | 
4.95e-01
 | 
5.59e-02
 | 
8.02e-01
 | 
| 
GO:0038066 p38MAPK cascade
 | 
12
 | 
7.38e-01
 | 
5.58e-02
 | 
9.20e-01
 | 
| 
GO:0031902 late endosome membrane
 | 
67
 | 
4.33e-01
 | 
5.55e-02
 | 
7.78e-01
 | 
| 
GO:0043539 protein serine/threonine
kinase activator activity
 | 
34
 | 
5.76e-01
 | 
5.54e-02
 | 
8.47e-01
 | 
| 
GO:0004497 monooxygenase activity
 | 
11
 | 
7.50e-01
 | 
5.54e-02
 | 
9.20e-01
 | 
| 
GO:0008285 negative regulation of
cell population proliferation
 | 
117
 | 
3.03e-01
 | 
5.52e-02
 | 
6.84e-01
 | 
| 
GO:0006289 nucleotide-excision
repair
 | 
22
 | 
6.55e-01
 | 
-5.51e-02
 | 
8.96e-01
 | 
| 
GO:0035904 aorta development
 | 
15
 | 
7.13e-01
 | 
5.50e-02
 | 
9.16e-01
 | 
| 
GO:0090201 negative regulation of
release of cytochrome c from mitochondria
 | 
11
 | 
7.52e-01
 | 
-5.49e-02
 | 
9.20e-01
 | 
| 
GO:0010314
phosphatidylinositol-5-phosphate binding
 | 
11
 | 
7.53e-01
 | 
-5.48e-02
 | 
9.20e-01
 | 
| 
GO:0008217 regulation of blood
pressure
 | 
20
 | 
6.74e-01
 | 
5.44e-02
 | 
9.00e-01
 | 
| 
GO:0004714 transmembrane receptor
protein tyrosine kinase activity
 | 
14
 | 
7.25e-01
 | 
5.44e-02
 | 
9.18e-01
 | 
| 
GO:0019955 cytokine binding
 | 
11
 | 
7.56e-01
 | 
-5.40e-02
 | 
9.20e-01
 | 
| 
GO:0050714 positive regulation of
protein secretion
 | 
19
 | 
6.84e-01
 | 
5.40e-02
 | 
9.03e-01
 | 
| 
GO:1900026 positive regulation of
substrate adhesion-dependent cell spreading
 | 
24
 | 
6.47e-01
 | 
-5.40e-02
 | 
8.90e-01
 | 
| 
GO:0030334 regulation of cell
migration
 | 
35
 | 
5.81e-01
 | 
5.39e-02
 | 
8.53e-01
 | 
| 
GO:0006882 intracellular zinc ion
homeostasis
 | 
13
 | 
7.40e-01
 | 
5.32e-02
 | 
9.20e-01
 | 
| 
GO:0007369 gastrulation
 | 
10
 | 
7.72e-01
 | 
-5.29e-02
 | 
9.25e-01
 | 
| 
GO:0001736 establishment of planar
polarity
 | 
12
 | 
7.52e-01
 | 
5.27e-02
 | 
9.20e-01
 | 
| 
GO:0000993 RNA polymerase II
complex binding
 | 
23
 | 
6.63e-01
 | 
-5.26e-02
 | 
8.99e-01
 | 
| 
GO:0051117 ATPase binding
 | 
44
 | 
5.47e-01
 | 
5.26e-02
 | 
8.35e-01
 | 
| 
GO:0015031 protein transport
 | 
173
 | 
2.35e-01
 | 
5.25e-02
 | 
6.13e-01
 | 
| 
GO:0030177 positive regulation of
Wnt signaling pathway
 | 
17
 | 
7.08e-01
 | 
5.25e-02
 | 
9.14e-01
 | 
| 
GO:0002062 chondrocyte
differentiation
 | 
22
 | 
6.70e-01
 | 
5.25e-02
 | 
9.00e-01
 | 
| 
GO:0000791 euchromatin
 | 
29
 | 
6.25e-01
 | 
-5.24e-02
 | 
8.76e-01
 | 
| 
GO:0045111 intermediate filament
cytoskeleton
 | 
23
 | 
6.64e-01
 | 
5.23e-02
 | 
8.99e-01
 | 
| 
GO:2000786 positive regulation of
autophagosome assembly
 | 
14
 | 
7.35e-01
 | 
5.23e-02
 | 
9.20e-01
 | 
| 
GO:0005856 cytoskeleton
 | 
174
 | 
2.37e-01
 | 
5.21e-02
 | 
6.15e-01
 | 
| 
GO:0007507 heart development
 | 
80
 | 
4.23e-01
 | 
-5.18e-02
 | 
7.73e-01
 | 
| 
GO:0042472 inner ear morphogenesis
 | 
27
 | 
6.41e-01
 | 
5.18e-02
 | 
8.88e-01
 | 
| 
GO:0000242 pericentriolar material
 | 
14
 | 
7.37e-01
 | 
-5.18e-02
 | 
9.20e-01
 | 
| 
GO:0048471 perinuclear region of
cytoplasm
 | 
289
 | 
1.32e-01
 | 
5.17e-02
 | 
4.74e-01
 | 
| 
GO:0042177 negative regulation of
protein catabolic process
 | 
24
 | 
6.61e-01
 | 
5.17e-02
 | 
8.99e-01
 | 
| 
GO:0060173 limb development
 | 
24
 | 
6.62e-01
 | 
-5.16e-02
 | 
8.99e-01
 | 
| 
GO:0035024 negative regulation of
Rho protein signal transduction
 | 
14
 | 
7.39e-01
 | 
5.15e-02
 | 
9.20e-01
 | 
| 
GO:0007179 transforming growth
factor beta receptor signaling pathway
 | 
49
 | 
5.33e-01
 | 
-5.15e-02
 | 
8.27e-01
 | 
| 
GO:0006955 immune response
 | 
42
 | 
5.64e-01
 | 
-5.14e-02
 | 
8.42e-01
 | 
| 
GO:1990247
N6-methyladenosine-containing RNA reader activity
 | 
10
 | 
7.79e-01
 | 
-5.13e-02
 | 
9.25e-01
 | 
| 
GO:0005004 GPI-linked ephrin
receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0005011 macrophage
colony-stimulating factor receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0005018 platelet-derived growth
factor alpha-receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0005020 stem cell factor
receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0008288 boss receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0035790 platelet-derived growth
factor receptor-alpha signaling pathway
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0036323 vascular endothelial
growth factor receptor-1 signaling pathway
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0036332 placental growth factor
receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0038145 macrophage
colony-stimulating factor signaling pathway
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0060175 brain-derived
neurotrophic factor receptor activity
 | 
12
 | 
7.59e-01
 | 
-5.11e-02
 | 
9.20e-01
 | 
| 
GO:0016342 catenin complex
 | 
13
 | 
7.50e-01
 | 
5.11e-02
 | 
9.20e-01
 | 
| 
GO:0003700 DNA-binding
transcription factor activity
 | 
78
 | 
4.38e-01
 | 
-5.09e-02
 | 
7.80e-01
 | 
| 
GO:0030512 negative regulation of
transforming growth factor beta receptor signaling pathway
 | 
41
 | 
5.74e-01
 | 
5.08e-02
 | 
8.46e-01
 | 
| 
GO:0006954 inflammatory response
 | 
82
 | 
4.28e-01
 | 
5.07e-02
 | 
7.75e-01
 | 
| 
GO:0070273
phosphatidylinositol-4-phosphate binding
 | 
17
 | 
7.18e-01
 | 
-5.06e-02
 | 
9.17e-01
 | 
| 
GO:0045087 innate immune response
 | 
80
 | 
4.41e-01
 | 
4.99e-02
 | 
7.82e-01
 | 
| 
GO:0043123 positive regulation of
canonical NF-kappaB signal transduction
 | 
76
 | 
4.54e-01
 | 
4.97e-02
 | 
7.86e-01
 | 
| 
GO:0046982 protein
heterodimerization activity
 | 
130
 | 
3.28e-01
 | 
4.97e-02
 | 
7.07e-01
 | 
| 
GO:0000776 kinetochore
 | 
90
 | 
4.18e-01
 | 
4.95e-02
 | 
7.72e-01
 | 
| 
GO:0045453 bone resorption
 | 
11
 | 
7.77e-01
 | 
-4.94e-02
 | 
9.25e-01
 | 
| 
GO:0003950 NAD+-protein
poly-ADP-ribosyltransferase activity
 | 
16
 | 
7.33e-01
 | 
-4.92e-02
 | 
9.20e-01
 | 
| 
GO:0003779 actin binding
 | 
140
 | 
3.16e-01
 | 
-4.91e-02
 | 
6.94e-01
 | 
| 
GO:0044325 transmembrane
transporter binding
 | 
57
 | 
5.21e-01
 | 
4.91e-02
 | 
8.22e-01
 | 
| 
GO:0052689 carboxylic ester
hydrolase activity
 | 
12
 | 
7.69e-01
 | 
4.90e-02
 | 
9.24e-01
 | 
| 
GO:0008306 associative learning
 | 
11
 | 
7.79e-01
 | 
4.89e-02
 | 
9.25e-01
 | 
| 
GO:0016020 membrane
 | 
953
 | 
1.18e-02
 | 
4.87e-02
 | 
1.63e-01
 | 
| 
GO:0038023 signaling receptor
activity
 | 
39
 | 
5.99e-01
 | 
4.86e-02
 | 
8.59e-01
 | 
| 
GO:0030206 chondroitin sulfate
biosynthetic process
 | 
11
 | 
7.81e-01
 | 
4.85e-02
 | 
9.26e-01
 | 
| 
GO:0016779 nucleotidyltransferase
activity
 | 
11
 | 
7.81e-01
 | 
4.84e-02
 | 
9.26e-01
 | 
| 
GO:0016358 dendrite development
 | 
19
 | 
7.16e-01
 | 
4.82e-02
 | 
9.17e-01
 | 
| 
GO:0030336 negative regulation of
cell migration
 | 
50
 | 
5.56e-01
 | 
-4.81e-02
 | 
8.40e-01
 | 
| 
GO:0051897 positive regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
 | 
76
 | 
4.70e-01
 | 
4.80e-02
 | 
7.92e-01
 | 
| 
GO:0010634 positive regulation of
epithelial cell migration
 | 
19
 | 
7.18e-01
 | 
4.79e-02
 | 
9.17e-01
 | 
| 
GO:0046983 protein dimerization
activity
 | 
70
 | 
4.89e-01
 | 
-4.79e-02
 | 
8.02e-01
 | 
| 
GO:0035098 ESC/E(Z) complex
 | 
12
 | 
7.74e-01
 | 
4.78e-02
 | 
9.25e-01
 | 
| 
GO:0050680 negative regulation of
epithelial cell proliferation
 | 
25
 | 
6.80e-01
 | 
-4.77e-02
 | 
9.02e-01
 | 
| 
GO:0030901 midbrain development
 | 
11
 | 
7.85e-01
 | 
4.76e-02
 | 
9.27e-01
 | 
| 
GO:0031647 regulation of protein
stability
 | 
57
 | 
5.35e-01
 | 
4.75e-02
 | 
8.28e-01
 | 
| 
GO:0030514 negative regulation of
BMP signaling pathway
 | 
27
 | 
6.70e-01
 | 
4.74e-02
 | 
9.00e-01
 | 
| 
GO:0042803 protein homodimerization
activity
 | 
372
 | 
1.19e-01
 | 
4.72e-02
 | 
4.55e-01
 | 
| 
GO:0001676 long-chain fatty acid
metabolic process
 | 
11
 | 
7.86e-01
 | 
-4.72e-02
 | 
9.28e-01
 | 
| 
GO:0030330 DNA damage response,
signal transduction by p53 class mediator
 | 
12
 | 
7.78e-01
 | 
4.71e-02
 | 
9.25e-01
 | 
| 
GO:0097602 cullin family protein
binding
 | 
16
 | 
7.45e-01
 | 
-4.70e-02
 | 
9.20e-01
 | 
| 
GO:0009060 aerobic respiration
 | 
10
 | 
7.97e-01
 | 
-4.70e-02
 | 
9.34e-01
 | 
| 
GO:0036126 sperm flagellum
 | 
32
 | 
6.46e-01
 | 
4.69e-02
 | 
8.90e-01
 | 
| 
GO:0007275 multicellular organism
development
 | 
26
 | 
6.80e-01
 | 
4.67e-02
 | 
9.02e-01
 | 
| 
GO:0050766 positive regulation of
phagocytosis
 | 
14
 | 
7.63e-01
 | 
-4.66e-02
 | 
9.20e-01
 | 
| 
GO:0032580 Golgi cisterna membrane
 | 
27
 | 
6.76e-01
 | 
4.65e-02
 | 
9.00e-01
 | 
| 
GO:0033617 mitochondrial cytochrome
c oxidase assembly
 | 
13
 | 
7.72e-01
 | 
-4.65e-02
 | 
9.25e-01
 | 
| 
GO:0010628 positive regulation of
gene expression
 | 
146
 | 
3.35e-01
 | 
4.63e-02
 | 
7.13e-01
 | 
| 
GO:0045214 sarcomere organization
 | 
12
 | 
7.82e-01
 | 
4.61e-02
 | 
9.26e-01
 | 
| 
GO:0005102 signaling receptor
binding
 | 
80
 | 
4.78e-01
 | 
4.59e-02
 | 
7.99e-01
 | 
| 
GO:0006486 protein glycosylation
 | 
45
 | 
5.95e-01
 | 
-4.58e-02
 | 
8.59e-01
 | 
| 
GO:0009611 response to wounding
 | 
20
 | 
7.23e-01
 | 
4.57e-02
 | 
9.18e-01
 | 
| 
GO:0007204 positive regulation of
cytosolic calcium ion concentration
 | 
19
 | 
7.31e-01
 | 
-4.56e-02
 | 
9.20e-01
 | 
| 
GO:0097009 energy homeostasis
 | 
22
 | 
7.12e-01
 | 
-4.55e-02
 | 
9.16e-01
 | 
| 
GO:0030182 neuron differentiation
 | 
57
 | 
5.53e-01
 | 
-4.55e-02
 | 
8.40e-01
 | 
| 
GO:0048536 spleen development
 | 
23
 | 
7.06e-01
 | 
-4.54e-02
 | 
9.14e-01
 | 
| 
GO:0006402 mRNA catabolic process
 | 
14
 | 
7.69e-01
 | 
4.53e-02
 | 
9.24e-01
 | 
| 
GO:0003887 DNA-directed DNA
polymerase activity
 | 
16
 | 
7.54e-01
 | 
-4.52e-02
 | 
9.20e-01
 | 
| 
GO:0001671 ATPase activator
activity
 | 
18
 | 
7.40e-01
 | 
-4.52e-02
 | 
9.20e-01
 | 
| 
GO:0048255 mRNA stabilization
 | 
16
 | 
7.55e-01
 | 
-4.51e-02
 | 
9.20e-01
 | 
| 
GO:0033077 T cell differentiation
in thymus
 | 
18
 | 
7.40e-01
 | 
4.51e-02
 | 
9.20e-01
 | 
| 
GO:0097190 apoptotic signaling
pathway
 | 
20
 | 
7.27e-01
 | 
4.51e-02
 | 
9.19e-01
 | 
| 
GO:0031625 ubiquitin protein ligase
binding
 | 
172
 | 
3.09e-01
 | 
-4.51e-02
 | 
6.86e-01
 | 
| 
GO:0005978 glycogen biosynthetic
process
 | 
11
 | 
7.97e-01
 | 
4.49e-02
 | 
9.34e-01
 | 
| 
GO:2001222 regulation of neuron
migration
 | 
10
 | 
8.06e-01
 | 
4.49e-02
 | 
9.37e-01
 | 
| 
GO:0061629 RNA polymerase
II-specific DNA-binding transcription factor binding
 | 
83
 | 
4.80e-01
 | 
-4.49e-02
 | 
8.00e-01
 | 
| 
GO:0005635 nuclear envelope
 | 
77
 | 
4.97e-01
 | 
-4.49e-02
 | 
8.02e-01
 | 
| 
GO:1990756 ubiquitin-like
ligase-substrate adaptor activity
 | 
71
 | 
5.16e-01
 | 
-4.46e-02
 | 
8.16e-01
 | 
| 
GO:0016601 Rac protein signal
transduction
 | 
17
 | 
7.50e-01
 | 
4.46e-02
 | 
9.20e-01
 | 
| 
GO:0048146 positive regulation of
fibroblast proliferation
 | 
19
 | 
7.37e-01
 | 
4.45e-02
 | 
9.20e-01
 | 
| 
GO:0031648 protein destabilization
 | 
32
 | 
6.66e-01
 | 
4.42e-02
 | 
9.00e-01
 | 
| 
GO:0048477 oogenesis
 | 
14
 | 
7.75e-01
 | 
-4.42e-02
 | 
9.25e-01
 | 
| 
GO:0032024 positive regulation of
insulin secretion
 | 
21
 | 
7.27e-01
 | 
4.41e-02
 | 
9.19e-01
 | 
| 
GO:0004725 protein tyrosine
phosphatase activity
 | 
44
 | 
6.14e-01
 | 
-4.40e-02
 | 
8.68e-01
 | 
| 
GO:0043231 intracellular
membrane-bounded organelle
 | 
116
 | 
4.16e-01
 | 
4.38e-02
 | 
7.72e-01
 | 
| 
GO:0120020 cholesterol transfer
activity
 | 
11
 | 
8.02e-01
 | 
-4.37e-02
 | 
9.35e-01
 | 
| 
GO:0001669 acrosomal vesicle
 | 
26
 | 
7.00e-01
 | 
4.37e-02
 | 
9.11e-01
 | 
| 
GO:0007264 small GTPase-mediated
signal transduction
 | 
47
 | 
6.07e-01
 | 
-4.34e-02
 | 
8.60e-01
 | 
| 
GO:0072518 Rho-dependent protein
serine/threonine kinase activity
 | 
32
 | 
6.72e-01
 | 
4.33e-02
 | 
9.00e-01
 | 
| 
GO:0006357 regulation of
transcription by RNA polymerase II
 | 
549
 | 
8.53e-02
 | 
-4.32e-02
 | 
3.88e-01
 | 
| 
GO:0050699 WW domain binding
 | 
11
 | 
8.04e-01
 | 
-4.31e-02
 | 
9.36e-01
 | 
| 
GO:0005654 nucleoplasm
 | 
1532
 | 
5.83e-03
 | 
-4.30e-02
 | 
1.18e-01
 | 
| 
GO:0061462 protein localization to
lysosome
 | 
10
 | 
8.14e-01
 | 
4.30e-02
 | 
9.38e-01
 | 
| 
GO:0006513 protein
monoubiquitination
 | 
27
 | 
7.00e-01
 | 
-4.28e-02
 | 
9.11e-01
 | 
| 
GO:0048666 neuron development
 | 
26
 | 
7.06e-01
 | 
-4.28e-02
 | 
9.14e-01
 | 
| 
GO:0031965 nuclear membrane
 | 
121
 | 
4.17e-01
 | 
-4.28e-02
 | 
7.72e-01
 | 
| 
GO:0060325 face morphogenesis
 | 
21
 | 
7.34e-01
 | 
4.28e-02
 | 
9.20e-01
 | 
| 
GO:0007613 memory
 | 
28
 | 
6.95e-01
 | 
-4.28e-02
 | 
9.11e-01
 | 
| 
GO:0030544 Hsp70 protein binding
 | 
29
 | 
6.91e-01
 | 
-4.27e-02
 | 
9.08e-01
 | 
| 
GO:0005758 mitochondrial
intermembrane space
 | 
47
 | 
6.13e-01
 | 
4.26e-02
 | 
8.67e-01
 | 
| 
GO:0050853 B cell receptor
signaling pathway
 | 
19
 | 
7.48e-01
 | 
-4.25e-02
 | 
9.20e-01
 | 
| 
GO:0007420 brain development
 | 
77
 | 
5.22e-01
 | 
-4.22e-02
 | 
8.23e-01
 | 
| 
GO:0051896 regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
 | 
12
 | 
8.00e-01
 | 
-4.22e-02
 | 
9.35e-01
 | 
| 
GO:0016525 negative regulation of
angiogenesis
 | 
35
 | 
6.67e-01
 | 
-4.21e-02
 | 
9.00e-01
 | 
| 
GO:0001658 branching involved in
ureteric bud morphogenesis
 | 
18
 | 
7.59e-01
 | 
-4.17e-02
 | 
9.20e-01
 | 
| 
GO:0006631 fatty acid metabolic
process
 | 
34
 | 
6.75e-01
 | 
4.16e-02
 | 
9.00e-01
 | 
| 
GO:0140359 ABC-type transporter
activity
 | 
11
 | 
8.13e-01
 | 
-4.13e-02
 | 
9.38e-01
 | 
| 
GO:0042605 peptide antigen binding
 | 
10
 | 
8.22e-01
 | 
-4.10e-02
 | 
9.42e-01
 | 
| 
GO:0008284 positive regulation of
cell population proliferation
 | 
157
 | 
3.77e-01
 | 
4.09e-02
 | 
7.45e-01
 | 
| 
GO:0030674 protein-macromolecule
adaptor activity
 | 
73
 | 
5.51e-01
 | 
4.04e-02
 | 
8.38e-01
 | 
| 
GO:0000979 RNA polymerase II core
promoter sequence-specific DNA binding
 | 
12
 | 
8.09e-01
 | 
-4.02e-02
 | 
9.38e-01
 | 
| 
GO:0030139 endocytic vesicle
 | 
37
 | 
6.73e-01
 | 
-4.02e-02
 | 
9.00e-01
 | 
| 
GO:0070534 protein K63-linked
ubiquitination
 | 
31
 | 
7.00e-01
 | 
-4.00e-02
 | 
9.11e-01
 | 
| 
GO:0004519 endonuclease activity
 | 
14
 | 
7.96e-01
 | 
4.00e-02
 | 
9.34e-01
 | 
| 
GO:0051059 NF-kappaB binding
 | 
22
 | 
7.47e-01
 | 
3.98e-02
 | 
9.20e-01
 | 
| 
GO:0005682 U5 snRNP
 | 
10
 | 
8.28e-01
 | 
-3.97e-02
 | 
9.44e-01
 | 
| 
GO:0000712 resolution of meiotic
recombination intermediates
 | 
14
 | 
7.97e-01
 | 
3.97e-02
 | 
9.34e-01
 | 
| 
GO:0006351 DNA-templated
transcription
 | 
36
 | 
6.81e-01
 | 
-3.96e-02
 | 
9.02e-01
 | 
| 
GO:0030307 positive regulation of
cell growth
 | 
36
 | 
6.85e-01
 | 
-3.91e-02
 | 
9.03e-01
 | 
| 
GO:0051787 misfolded protein
binding
 | 
12
 | 
8.15e-01
 | 
-3.91e-02
 | 
9.38e-01
 | 
| 
GO:0032869 cellular response to
insulin stimulus
 | 
33
 | 
6.99e-01
 | 
3.89e-02
 | 
9.11e-01
 | 
| 
GO:0120163 negative regulation of
cold-induced thermogenesis
 | 
21
 | 
7.59e-01
 | 
-3.87e-02
 | 
9.20e-01
 | 
| 
GO:1901224 positive regulation of
non-canonical NF-kappaB signal transduction
 | 
21
 | 
7.60e-01
 | 
-3.85e-02
 | 
9.20e-01
 | 
| 
GO:0030246 carbohydrate binding
 | 
40
 | 
6.75e-01
 | 
-3.83e-02
 | 
9.00e-01
 | 
| 
GO:0034113 heterotypic cell-cell
adhesion
 | 
12
 | 
8.19e-01
 | 
3.81e-02
 | 
9.41e-01
 | 
| 
GO:0016477 cell migration
 | 
136
 | 
4.49e-01
 | 
3.77e-02
 | 
7.84e-01
 | 
| 
GO:0032543 mitochondrial
translation
 | 
22
 | 
7.60e-01
 | 
3.77e-02
 | 
9.20e-01
 | 
| 
GO:0030970 retrograde protein
transport, ER to cytosol
 | 
12
 | 
8.22e-01
 | 
3.76e-02
 | 
9.42e-01
 | 
| 
GO:0031418 L-ascorbic acid binding
 | 
14
 | 
8.09e-01
 | 
-3.74e-02
 | 
9.38e-01
 | 
| 
GO:0071233 cellular response to
L-leucine
 | 
10
 | 
8.39e-01
 | 
3.71e-02
 | 
9.44e-01
 | 
| 
GO:0007010 cytoskeleton
organization
 | 
51
 | 
6.47e-01
 | 
-3.70e-02
 | 
8.90e-01
 | 
| 
GO:0012505 endomembrane system
 | 
97
 | 
5.30e-01
 | 
3.69e-02
 | 
8.26e-01
 | 
| 
GO:0031122 cytoplasmic microtubule
organization
 | 
28
 | 
7.37e-01
 | 
-3.67e-02
 | 
9.20e-01
 | 
| 
GO:0048787 presynaptic active zone
membrane
 | 
10
 | 
8.41e-01
 | 
3.66e-02
 | 
9.44e-01
 | 
| 
GO:0060070 canonical Wnt signaling
pathway
 | 
58
 | 
6.31e-01
 | 
3.65e-02
 | 
8.79e-01
 | 
| 
GO:0007160 cell-matrix adhesion
 | 
41
 | 
6.86e-01
 | 
-3.65e-02
 | 
9.03e-01
 | 
| 
GO:0003824 catalytic activity
 | 
10
 | 
8.42e-01
 | 
3.65e-02
 | 
9.44e-01
 | 
| 
GO:0070588 calcium ion
transmembrane transport
 | 
45
 | 
6.73e-01
 | 
3.64e-02
 | 
9.00e-01
 | 
| 
GO:0090090 negative regulation of
canonical Wnt signaling pathway
 | 
71
 | 
5.97e-01
 | 
-3.63e-02
 | 
8.59e-01
 | 
| 
GO:2000134 negative regulation of
G1/S transition of mitotic cell cycle
 | 
23
 | 
7.64e-01
 | 
-3.62e-02
 | 
9.20e-01
 | 
| 
GO:0000387 spliceosomal snRNP
assembly
 | 
17
 | 
7.97e-01
 | 
3.60e-02
 | 
9.34e-01
 | 
| 
GO:0140664 ATP-dependent DNA damage
sensor activity
 | 
14
 | 
8.16e-01
 | 
3.59e-02
 | 
9.39e-01
 | 
| 
GO:0043161 proteasome-mediated
ubiquitin-dependent protein catabolic process
 | 
156
 | 
4.41e-01
 | 
-3.58e-02
 | 
7.82e-01
 | 
| 
GO:0051216 cartilage development
 | 
21
 | 
7.77e-01
 | 
3.58e-02
 | 
9.25e-01
 | 
| 
GO:0098978 glutamatergic synapse
 | 
231
 | 
3.51e-01
 | 
3.57e-02
 | 
7.29e-01
 | 
| 
GO:0001662 behavioral fear response
 | 
12
 | 
8.31e-01
 | 
3.55e-02
 | 
9.44e-01
 | 
| 
GO:0005884 actin filament
 | 
43
 | 
6.87e-01
 | 
3.55e-02
 | 
9.04e-01
 | 
| 
GO:0001578 microtubule bundle
formation
 | 
15
 | 
8.13e-01
 | 
-3.54e-02
 | 
9.38e-01
 | 
| 
GO:0030324 lung development
 | 
35
 | 
7.17e-01
 | 
3.54e-02
 | 
9.17e-01
 | 
| 
GO:0030507 spectrin binding
 | 
12
 | 
8.33e-01
 | 
-3.52e-02
 | 
9.44e-01
 | 
| 
GO:0034976 response to endoplasmic
reticulum stress
 | 
34
 | 
7.24e-01
 | 
3.50e-02
 | 
9.18e-01
 | 
| 
GO:0098719 sodium ion import across
plasma membrane
 | 
10
 | 
8.48e-01
 | 
3.50e-02
 | 
9.47e-01
 | 
| 
GO:0045672 positive regulation of
osteoclast differentiation
 | 
11
 | 
8.42e-01
 | 
-3.48e-02
 | 
9.44e-01
 | 
| 
GO:0005525 GTP binding
 | 
212
 | 
3.85e-01
 | 
3.47e-02
 | 
7.50e-01
 | 
| 
GO:0043025 neuronal cell body
 | 
85
 | 
5.81e-01
 | 
3.47e-02
 | 
8.53e-01
 | 
| 
GO:0000956 nuclear-transcribed mRNA
catabolic process
 | 
12
 | 
8.35e-01
 | 
-3.47e-02
 | 
9.44e-01
 | 
| 
GO:0007346 regulation of mitotic
cell cycle
 | 
31
 | 
7.38e-01
 | 
3.47e-02
 | 
9.20e-01
 | 
| 
GO:0016055 Wnt signaling pathway
 | 
77
 | 
6.01e-01
 | 
3.45e-02
 | 
8.59e-01
 | 
| 
GO:0003785 actin monomer binding
 | 
14
 | 
8.23e-01
 | 
3.45e-02
 | 
9.42e-01
 | 
| 
GO:0008203 cholesterol metabolic
process
 | 
28
 | 
7.55e-01
 | 
-3.41e-02
 | 
9.20e-01
 | 
| 
GO:0031146 SCF-dependent
proteasomal ubiquitin-dependent protein catabolic process
 | 
28
 | 
7.55e-01
 | 
-3.41e-02
 | 
9.20e-01
 | 
| 
GO:0003688 DNA replication origin
binding
 | 
12
 | 
8.38e-01
 | 
-3.41e-02
 | 
9.44e-01
 | 
| 
GO:0001778 plasma membrane repair
 | 
16
 | 
8.14e-01
 | 
-3.41e-02
 | 
9.38e-01
 | 
| 
GO:0001889 liver development
 | 
30
 | 
7.48e-01
 | 
3.39e-02
 | 
9.20e-01
 | 
| 
GO:0007288 sperm axoneme assembly
 | 
18
 | 
8.03e-01
 | 
-3.39e-02
 | 
9.36e-01
 | 
| 
GO:0008340 determination of adult
lifespan
 | 
21
 | 
7.89e-01
 | 
3.38e-02
 | 
9.29e-01
 | 
| 
GO:0008270 zinc ion binding
 | 
399
 | 
2.52e-01
 | 
-3.36e-02
 | 
6.33e-01
 | 
| 
GO:0042470 melanosome
 | 
27
 | 
7.63e-01
 | 
3.35e-02
 | 
9.20e-01
 | 
| 
GO:0031594 neuromuscular junction
 | 
34
 | 
7.36e-01
 | 
3.35e-02
 | 
9.20e-01
 | 
| 
GO:0005881 cytoplasmic microtubule
 | 
30
 | 
7.54e-01
 | 
3.31e-02
 | 
9.20e-01
 | 
| 
GO:0099072 regulation of
postsynaptic membrane neurotransmitter receptor levels
 | 
16
 | 
8.19e-01
 | 
3.30e-02
 | 
9.41e-01
 | 
| 
GO:0007416 synapse assembly
 | 
25
 | 
7.76e-01
 | 
-3.29e-02
 | 
9.25e-01
 | 
| 
GO:1904047 S-adenosyl-L-methionine
binding
 | 
13
 | 
8.37e-01
 | 
-3.29e-02
 | 
9.44e-01
 | 
| 
GO:0007519 skeletal muscle tissue
development
 | 
17
 | 
8.14e-01
 | 
3.29e-02
 | 
9.38e-01
 | 
| 
GO:0032588 trans-Golgi network
membrane
 | 
27
 | 
7.67e-01
 | 
3.29e-02
 | 
9.23e-01
 | 
| 
GO:0004674 protein serine/threonine
kinase activity
 | 
204
 | 
4.21e-01
 | 
-3.28e-02
 | 
7.73e-01
 | 
| 
GO:0043235 receptor complex
 | 
75
 | 
6.25e-01
 | 
3.27e-02
 | 
8.76e-01
 | 
| 
GO:0006887 exocytosis
 | 
44
 | 
7.08e-01
 | 
-3.26e-02
 | 
9.14e-01
 | 
| 
GO:0048821 erythrocyte development
 | 
15
 | 
8.27e-01
 | 
-3.25e-02
 | 
9.44e-01
 | 
| 
GO:0051457 maintenance of protein
location in nucleus
 | 
10
 | 
8.59e-01
 | 
-3.25e-02
 | 
9.53e-01
 | 
| 
GO:0030145 manganese ion binding
 | 
45
 | 
7.09e-01
 | 
-3.21e-02
 | 
9.14e-01
 | 
| 
GO:0010811 positive regulation of
cell-substrate adhesion
 | 
13
 | 
8.41e-01
 | 
-3.21e-02
 | 
9.44e-01
 | 
| 
GO:0001673 male germ cell nucleus
 | 
27
 | 
7.74e-01
 | 
3.19e-02
 | 
9.25e-01
 | 
| 
GO:0140823 histone H2BS36 kinase
activity
 | 
31
 | 
7.59e-01
 | 
3.19e-02
 | 
9.20e-01
 | 
| 
GO:0009636 response to toxic
substance
 | 
15
 | 
8.31e-01
 | 
-3.18e-02
 | 
9.44e-01
 | 
| 
GO:0007283 spermatogenesis
 | 
100
 | 
5.84e-01
 | 
3.17e-02
 | 
8.55e-01
 | 
| 
GO:0031593 polyubiquitin
modification-dependent protein binding
 | 
19
 | 
8.11e-01
 | 
-3.17e-02
 | 
9.38e-01
 | 
| 
GO:0035402 histone H3T11 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0044022 histone H3S28 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0044023 histone H4S1 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0044024 histone H2AS1 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0044025 histone H2BS14 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0072371 histone H2AS121 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0140855 histone H3S57 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0140857 histone H3T45 kinase
activity
 | 
30
 | 
7.65e-01
 | 
3.16e-02
 | 
9.20e-01
 | 
| 
GO:0060586 multicellular
organismal-level iron ion homeostasis
 | 
15
 | 
8.32e-01
 | 
-3.16e-02
 | 
9.44e-01
 | 
| 
GO:0016328 lateral plasma membrane
 | 
24
 | 
7.89e-01
 | 
-3.16e-02
 | 
9.29e-01
 | 
| 
GO:0016197 endosomal transport
 | 
27
 | 
7.77e-01
 | 
3.15e-02
 | 
9.25e-01
 | 
| 
GO:0043542 endothelial cell
migration
 | 
14
 | 
8.39e-01
 | 
-3.14e-02
 | 
9.44e-01
 | 
| 
GO:0030308 negative regulation of
cell growth
 | 
42
 | 
7.25e-01
 | 
-3.14e-02
 | 
9.18e-01
 | 
| 
GO:0001755 neural crest cell
migration
 | 
25
 | 
7.86e-01
 | 
-3.14e-02
 | 
9.28e-01
 | 
| 
GO:0030217 T cell differentiation
 | 
18
 | 
8.19e-01
 | 
-3.12e-02
 | 
9.41e-01
 | 
| 
GO:0046326 positive regulation of
D-glucose import
 | 
15
 | 
8.35e-01
 | 
3.10e-02
 | 
9.44e-01
 | 
| 
GO:0060391 positive regulation of
SMAD protein signal transduction
 | 
13
 | 
8.47e-01
 | 
3.09e-02
 | 
9.47e-01
 | 
| 
GO:0045944 positive regulation of
transcription by RNA polymerase II
 | 
528
 | 
2.30e-01
 | 
-3.07e-02
 | 
6.06e-01
 | 
| 
GO:0005262 calcium channel activity
 | 
22
 | 
8.04e-01
 | 
3.06e-02
 | 
9.36e-01
 | 
| 
GO:0006446 regulation of
translational initiation
 | 
17
 | 
8.28e-01
 | 
-3.04e-02
 | 
9.44e-01
 | 
| 
GO:0120162 positive regulation of
cold-induced thermogenesis
 | 
28
 | 
7.81e-01
 | 
3.03e-02
 | 
9.26e-01
 | 
| 
GO:0008013 beta-catenin binding
 | 
46
 | 
7.23e-01
 | 
3.03e-02
 | 
9.18e-01
 | 
| 
GO:0001818 negative regulation of
cytokine production
 | 
11
 | 
8.62e-01
 | 
-3.02e-02
 | 
9.55e-01
 | 
| 
GO:0044297 cell body
 | 
25
 | 
7.94e-01
 | 
3.02e-02
 | 
9.34e-01
 | 
| 
GO:0019843 rRNA binding
 | 
22
 | 
8.07e-01
 | 
-3.02e-02
 | 
9.37e-01
 | 
| 
GO:0000724 double-strand break
repair via homologous recombination
 | 
71
 | 
6.61e-01
 | 
-3.02e-02
 | 
8.99e-01
 | 
| 
GO:0005923 bicellular tight
junction
 | 
50
 | 
7.14e-01
 | 
3.00e-02
 | 
9.16e-01
 | 
| 
GO:0050767 regulation of
neurogenesis
 | 
14
 | 
8.46e-01
 | 
-3.00e-02
 | 
9.47e-01
 | 
| 
GO:0042802 identical protein
binding
 | 
663
 | 
1.93e-01
 | 
2.99e-02
 | 
5.66e-01
 | 
| 
GO:0019722 calcium-mediated
signaling
 | 
31
 | 
7.76e-01
 | 
-2.96e-02
 | 
9.25e-01
 | 
| 
GO:0062023 collagen-containing
extracellular matrix
 | 
74
 | 
6.61e-01
 | 
2.95e-02
 | 
8.99e-01
 | 
| 
GO:0005112 Notch binding
 | 
13
 | 
8.54e-01
 | 
2.94e-02
 | 
9.51e-01
 | 
| 
GO:0045121 membrane raft
 | 
74
 | 
6.64e-01
 | 
2.93e-02
 | 
8.99e-01
 | 
| 
GO:0005543 phospholipid binding
 | 
37
 | 
7.60e-01
 | 
-2.90e-02
 | 
9.20e-01
 | 
| 
GO:0005847 mRNA cleavage and
polyadenylation specificity factor complex
 | 
11
 | 
8.69e-01
 | 
-2.88e-02
 | 
9.55e-01
 | 
| 
GO:0003007 heart morphogenesis
 | 
16
 | 
8.42e-01
 | 
2.88e-02
 | 
9.44e-01
 | 
| 
GO:0009952 anterior/posterior
pattern specification
 | 
42
 | 
7.47e-01
 | 
2.88e-02
 | 
9.20e-01
 | 
| 
GO:0006884 cell volume homeostasis
 | 
14
 | 
8.53e-01
 | 
-2.87e-02
 | 
9.51e-01
 | 
| 
GO:0050821 protein stabilization
 | 
109
 | 
6.06e-01
 | 
-2.86e-02
 | 
8.59e-01
 | 
| 
GO:0010467 gene expression
 | 
83
 | 
6.55e-01
 | 
2.84e-02
 | 
8.96e-01
 | 
| 
GO:0010575 positive regulation of
vascular endothelial growth factor production
 | 
13
 | 
8.60e-01
 | 
2.83e-02
 | 
9.53e-01
 | 
| 
GO:0032991 protein-containing
complex
 | 
206
 | 
4.85e-01
 | 
2.83e-02
 | 
8.02e-01
 | 
| 
GO:0065003 protein-containing
complex assembly
 | 
38
 | 
7.64e-01
 | 
-2.82e-02
 | 
9.20e-01
 | 
| 
GO:0005484 SNAP receptor activity
 | 
26
 | 
8.04e-01
 | 
-2.81e-02
 | 
9.36e-01
 | 
| 
GO:0071007 U2-type catalytic step 2
spliceosome
 | 
24
 | 
8.12e-01
 | 
-2.81e-02
 | 
9.38e-01
 | 
| 
GO:0016251 RNA polymerase II
general transcription initiation factor activity
 | 
22
 | 
8.20e-01
 | 
-2.81e-02
 | 
9.41e-01
 | 
| 
GO:0038109 Kit signaling pathway
 | 
14
 | 
8.56e-01
 | 
-2.81e-02
 | 
9.52e-01
 | 
| 
GO:0000463 maturation of LSU-rRNA
from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
 | 
12
 | 
8.66e-01
 | 
2.81e-02
 | 
9.55e-01
 | 
| 
GO:0071456 cellular response to
hypoxia
 | 
33
 | 
7.83e-01
 | 
2.77e-02
 | 
9.26e-01
 | 
| 
GO:0006284 base-excision repair
 | 
17
 | 
8.45e-01
 | 
-2.74e-02
 | 
9.46e-01
 | 
| 
GO:0001503 ossification
 | 
26
 | 
8.10e-01
 | 
-2.73e-02
 | 
9.38e-01
 | 
| 
GO:0019899 enzyme binding
 | 
110
 | 
6.22e-01
 | 
2.72e-02
 | 
8.74e-01
 | 
| 
GO:0016925 protein sumoylation
 | 
19
 | 
8.37e-01
 | 
-2.72e-02
 | 
9.44e-01
 | 
| 
GO:0005829 cytosol
 | 
2016
 | 
5.00e-02
 | 
2.72e-02
 | 
3.16e-01
 | 
| 
GO:0046332 SMAD binding
 | 
23
 | 
8.22e-01
 | 
-2.70e-02
 | 
9.42e-01
 | 
| 
GO:0051604 protein maturation
 | 
20
 | 
8.34e-01
 | 
-2.70e-02
 | 
9.44e-01
 | 
| 
GO:0015630 microtubule cytoskeleton
 | 
69
 | 
6.99e-01
 | 
2.70e-02
 | 
9.11e-01
 | 
| 
GO:0050731 positive regulation of
peptidyl-tyrosine phosphorylation
 | 
30
 | 
8.00e-01
 | 
2.67e-02
 | 
9.35e-01
 | 
| 
GO:0070085 glycosylation
 | 
14
 | 
8.63e-01
 | 
2.66e-02
 | 
9.55e-01
 | 
| 
GO:0048538 thymus development
 | 
22
 | 
8.30e-01
 | 
-2.65e-02
 | 
9.44e-01
 | 
| 
GO:0099170 postsynaptic modulation
of chemical synaptic transmission
 | 
13
 | 
8.69e-01
 | 
-2.64e-02
 | 
9.55e-01
 | 
| 
GO:0042734 presynaptic membrane
 | 
35
 | 
7.87e-01
 | 
-2.64e-02
 | 
9.28e-01
 | 
| 
GO:0007186 G protein-coupled
receptor signaling pathway
 | 
92
 | 
6.64e-01
 | 
-2.63e-02
 | 
8.99e-01
 | 
| 
GO:0007015 actin filament
organization
 | 
71
 | 
7.03e-01
 | 
2.62e-02
 | 
9.12e-01
 | 
| 
GO:0005085 guanyl-nucleotide
exchange factor activity
 | 
143
 | 
5.90e-01
 | 
-2.62e-02
 | 
8.58e-01
 | 
| 
GO:0005179 hormone activity
 | 
12
 | 
8.77e-01
 | 
2.59e-02
 | 
9.59e-01
 | 
| 
GO:0004679 AMP-activated protein
kinase activity
 | 
32
 | 
8.02e-01
 | 
2.57e-02
 | 
9.35e-01
 | 
| 
GO:0030332 cyclin binding
 | 
20
 | 
8.43e-01
 | 
2.56e-02
 | 
9.45e-01
 | 
| 
GO:0003730 mRNA 3’-UTR binding
 | 
51
 | 
7.52e-01
 | 
2.56e-02
 | 
9.20e-01
 | 
| 
GO:0009954 proximal/distal pattern
formation
 | 
14
 | 
8.70e-01
 | 
-2.53e-02
 | 
9.56e-01
 | 
| 
GO:0004181 metallocarboxypeptidase
activity
 | 
12
 | 
8.81e-01
 | 
-2.50e-02
 | 
9.60e-01
 | 
| 
GO:0048741 skeletal muscle fiber
development
 | 
16
 | 
8.63e-01
 | 
-2.49e-02
 | 
9.55e-01
 | 
| 
GO:0038063 collagen-activated
tyrosine kinase receptor signaling pathway
 | 
16
 | 
8.65e-01
 | 
-2.46e-02
 | 
9.55e-01
 | 
| 
GO:0002244 hematopoietic progenitor
cell differentiation
 | 
35
 | 
8.01e-01
 | 
-2.46e-02
 | 
9.35e-01
 | 
| 
GO:0045880 positive regulation of
smoothened signaling pathway
 | 
23
 | 
8.39e-01
 | 
-2.45e-02
 | 
9.44e-01
 | 
| 
GO:0090575 RNA polymerase II
transcription regulator complex
 | 
53
 | 
7.58e-01
 | 
-2.45e-02
 | 
9.20e-01
 | 
| 
GO:0042752 regulation of circadian
rhythm
 | 
27
 | 
8.27e-01
 | 
-2.44e-02
 | 
9.44e-01
 | 
| 
GO:0035023 regulation of Rho
protein signal transduction
 | 
16
 | 
8.67e-01
 | 
-2.41e-02
 | 
9.55e-01
 | 
| 
GO:0005007 fibroblast growth factor
receptor activity
 | 
13
 | 
8.81e-01
 | 
2.40e-02
 | 
9.60e-01
 | 
| 
GO:1990573 potassium ion import
across plasma membrane
 | 
18
 | 
8.60e-01
 | 
-2.40e-02
 | 
9.53e-01
 | 
| 
GO:0106310 protein serine kinase
activity
 | 
38
 | 
7.98e-01
 | 
2.40e-02
 | 
9.35e-01
 | 
| 
GO:0030326 embryonic limb
morphogenesis
 | 
14
 | 
8.77e-01
 | 
2.39e-02
 | 
9.59e-01
 | 
| 
GO:0044877 protein-containing
complex binding
 | 
105
 | 
6.73e-01
 | 
2.39e-02
 | 
9.00e-01
 | 
| 
GO:0046540 U4/U6 x U5 tri-snRNP
complex
 | 
23
 | 
8.45e-01
 | 
-2.36e-02
 | 
9.46e-01
 | 
| 
GO:0098552 side of membrane
 | 
16
 | 
8.71e-01
 | 
-2.35e-02
 | 
9.56e-01
 | 
| 
GO:0051017 actin filament bundle
assembly
 | 
12
 | 
8.88e-01
 | 
2.34e-02
 | 
9.64e-01
 | 
| 
GO:0090398 cellular senescence
 | 
19
 | 
8.61e-01
 | 
-2.32e-02
 | 
9.54e-01
 | 
| 
GO:0019216 regulation of lipid
metabolic process
 | 
10
 | 
8.99e-01
 | 
-2.32e-02
 | 
9.69e-01
 | 
| 
GO:0019905 syntaxin binding
 | 
25
 | 
8.41e-01
 | 
2.31e-02
 | 
9.44e-01
 | 
| 
GO:0009897 external side of plasma
membrane
 | 
108
 | 
6.80e-01
 | 
2.30e-02
 | 
9.02e-01
 | 
| 
GO:0048013 ephrin receptor
signaling pathway
 | 
24
 | 
8.47e-01
 | 
-2.27e-02
 | 
9.47e-01
 | 
| 
GO:0048012 hepatocyte growth factor
receptor signaling pathway
 | 
17
 | 
8.73e-01
 | 
-2.25e-02
 | 
9.57e-01
 | 
| 
GO:1990244 histone H2AT120 kinase
activity
 | 
31
 | 
8.29e-01
 | 
2.24e-02
 | 
9.44e-01
 | 
| 
GO:0006611 protein export from
nucleus
 | 
22
 | 
8.56e-01
 | 
-2.23e-02
 | 
9.52e-01
 | 
| 
GO:0035371 microtubule plus-end
 | 
12
 | 
8.94e-01
 | 
2.22e-02
 | 
9.67e-01
 | 
| 
GO:0005524 ATP binding
 | 
894
 | 
2.73e-01
 | 
-2.19e-02
 | 
6.58e-01
 | 
| 
GO:0050727 regulation of
inflammatory response
 | 
26
 | 
8.48e-01
 | 
2.17e-02
 | 
9.47e-01
 | 
| 
GO:0007219 Notch signaling pathway
 | 
41
 | 
8.12e-01
 | 
2.15e-02
 | 
9.38e-01
 | 
| 
GO:0031167 rRNA methylation
 | 
11
 | 
9.04e-01
 | 
2.11e-02
 | 
9.72e-01
 | 
| 
GO:0010468 regulation of gene
expression
 | 
58
 | 
7.83e-01
 | 
2.09e-02
 | 
9.26e-01
 | 
| 
GO:0043204 perikaryon
 | 
36
 | 
8.28e-01
 | 
2.09e-02
 | 
9.44e-01
 | 
| 
GO:0060324 face development
 | 
14
 | 
8.93e-01
 | 
-2.08e-02
 | 
9.67e-01
 | 
| 
GO:0031116 positive regulation of
microtubule polymerization
 | 
11
 | 
9.05e-01
 | 
-2.08e-02
 | 
9.72e-01
 | 
| 
GO:0043525 positive regulation of
neuron apoptotic process
 | 
18
 | 
8.80e-01
 | 
-2.06e-02
 | 
9.60e-01
 | 
| 
GO:0051607 defense response to
virus
 | 
56
 | 
7.91e-01
 | 
-2.05e-02
 | 
9.31e-01
 | 
| 
GO:0044389 ubiquitin-like protein
ligase binding
 | 
16
 | 
8.87e-01
 | 
-2.05e-02
 | 
9.64e-01
 | 
| 
GO:0005875 microtubule associated
complex
 | 
10
 | 
9.12e-01
 | 
-2.02e-02
 | 
9.76e-01
 | 
| 
GO:0005912 adherens junction
 | 
68
 | 
7.74e-01
 | 
-2.01e-02
 | 
9.25e-01
 | 
| 
GO:0005911 cell-cell junction
 | 
77
 | 
7.61e-01
 | 
-2.01e-02
 | 
9.20e-01
 | 
| 
GO:0042995 cell projection
 | 
54
 | 
7.99e-01
 | 
2.01e-02
 | 
9.35e-01
 | 
| 
GO:0070936 protein K48-linked
ubiquitination
 | 
68
 | 
7.77e-01
 | 
1.99e-02
 | 
9.25e-01
 | 
| 
GO:0045785 positive regulation of
cell adhesion
 | 
15
 | 
8.94e-01
 | 
1.99e-02
 | 
9.67e-01
 | 
| 
GO:0051289 protein
homotetramerization
 | 
35
 | 
8.42e-01
 | 
-1.95e-02
 | 
9.44e-01
 | 
| 
GO:0030890 positive regulation of B
cell proliferation
 | 
21
 | 
8.78e-01
 | 
1.94e-02
 | 
9.60e-01
 | 
| 
GO:0060337 type I
interferon-mediated signaling pathway
 | 
10
 | 
9.16e-01
 | 
-1.93e-02
 | 
9.77e-01
 | 
| 
GO:1990138 neuron projection
extension
 | 
10
 | 
9.17e-01
 | 
1.91e-02
 | 
9.77e-01
 | 
| 
GO:0030659 cytoplasmic vesicle
membrane
 | 
43
 | 
8.28e-01
 | 
1.91e-02
 | 
9.44e-01
 | 
| 
GO:0043588 skin development
 | 
23
 | 
8.75e-01
 | 
1.89e-02
 | 
9.59e-01
 | 
| 
GO:0030154 cell differentiation
 | 
141
 | 
7.00e-01
 | 
-1.88e-02
 | 
9.11e-01
 | 
| 
GO:0035175 histone H3S10 kinase
activity
 | 
31
 | 
8.58e-01
 | 
1.86e-02
 | 
9.53e-01
 | 
| 
GO:0072354 histone H3T3 kinase
activity
 | 
31
 | 
8.58e-01
 | 
1.86e-02
 | 
9.53e-01
 | 
| 
GO:0005019 platelet-derived growth
factor beta-receptor activity
 | 
13
 | 
9.08e-01
 | 
-1.85e-02
 | 
9.73e-01
 | 
| 
GO:0003697 single-stranded DNA
binding
 | 
67
 | 
7.95e-01
 | 
1.84e-02
 | 
9.34e-01
 | 
| 
GO:0019005 SCF ubiquitin ligase
complex
 | 
43
 | 
8.36e-01
 | 
-1.83e-02
 | 
9.44e-01
 | 
| 
GO:0032874 positive regulation of
stress-activated MAPK cascade
 | 
11
 | 
9.16e-01
 | 
1.83e-02
 | 
9.77e-01
 | 
| 
GO:0030165 PDZ domain binding
 | 
29
 | 
8.65e-01
 | 
-1.83e-02
 | 
9.55e-01
 | 
| 
GO:0030032 lamellipodium assembly
 | 
21
 | 
8.85e-01
 | 
-1.82e-02
 | 
9.63e-01
 | 
| 
GO:0051015 actin filament binding
 | 
118
 | 
7.34e-01
 | 
-1.81e-02
 | 
9.20e-01
 | 
| 
GO:0008021 synaptic vesicle
 | 
47
 | 
8.30e-01
 | 
1.81e-02
 | 
9.44e-01
 | 
| 
GO:0043066 negative regulation of
apoptotic process
 | 
151
 | 
7.02e-01
 | 
1.81e-02
 | 
9.12e-01
 | 
| 
GO:0055085 transmembrane transport
 | 
88
 | 
7.70e-01
 | 
1.81e-02
 | 
9.24e-01
 | 
| 
GO:0008233 peptidase activity
 | 
10
 | 
9.23e-01
 | 
-1.77e-02
 | 
9.79e-01
 | 
| 
GO:0016301 kinase activity
 | 
14
 | 
9.09e-01
 | 
-1.77e-02
 | 
9.73e-01
 | 
| 
GO:0043065 positive regulation of
apoptotic process
 | 
122
 | 
7.36e-01
 | 
1.77e-02
 | 
9.20e-01
 | 
| 
GO:0038062 protein tyrosine kinase
collagen receptor activity
 | 
13
 | 
9.13e-01
 | 
-1.75e-02
 | 
9.76e-01
 | 
| 
GO:0001223 transcription
coactivator binding
 | 
21
 | 
8.90e-01
 | 
-1.74e-02
 | 
9.65e-01
 | 
| 
GO:0098761 cellular response to
interleukin-7
 | 
10
 | 
9.25e-01
 | 
1.73e-02
 | 
9.80e-01
 | 
| 
GO:0045296 cadherin binding
 | 
28
 | 
8.75e-01
 | 
1.72e-02
 | 
9.59e-01
 | 
| 
GO:0051082 unfolded protein binding
 | 
56
 | 
8.24e-01
 | 
-1.72e-02
 | 
9.42e-01
 | 
| 
GO:0043162 ubiquitin-dependent
protein catabolic process via the multivesicular body sorting pathway
 | 
16
 | 
9.06e-01
 | 
-1.71e-02
 | 
9.73e-01
 | 
| 
GO:0031267 small GTPase binding
 | 
166
 | 
7.07e-01
 | 
1.69e-02
 | 
9.14e-01
 | 
| 
GO:0008625 extrinsic apoptotic
signaling pathway via death domain receptors
 | 
18
 | 
9.01e-01
 | 
1.69e-02
 | 
9.71e-01
 | 
| 
GO:0006635 fatty acid
beta-oxidation
 | 
26
 | 
8.83e-01
 | 
1.66e-02
 | 
9.62e-01
 | 
| 
GO:0005634 nucleus
 | 
2132
 | 
2.22e-01
 | 
-1.65e-02
 | 
5.97e-01
 | 
| 
GO:0005685 U1 snRNP
 | 
12
 | 
9.21e-01
 | 
-1.64e-02
 | 
9.78e-01
 | 
| 
GO:0016042 lipid catabolic process
 | 
29
 | 
8.79e-01
 | 
-1.63e-02
 | 
9.60e-01
 | 
| 
GO:0035855 megakaryocyte
development
 | 
10
 | 
9.29e-01
 | 
1.62e-02
 | 
9.80e-01
 | 
| 
GO:0072332 intrinsic apoptotic
signaling pathway by p53 class mediator
 | 
11
 | 
9.26e-01
 | 
1.61e-02
 | 
9.80e-01
 | 
| 
GO:0060339 negative regulation of
type I interferon-mediated signaling pathway
 | 
13
 | 
9.21e-01
 | 
1.60e-02
 | 
9.78e-01
 | 
| 
GO:0042130 negative regulation of T
cell proliferation
 | 
12
 | 
9.26e-01
 | 
1.56e-02
 | 
9.80e-01
 | 
| 
GO:0004222 metalloendopeptidase
activity
 | 
50
 | 
8.50e-01
 | 
-1.55e-02
 | 
9.48e-01
 | 
| 
GO:0008083 growth factor activity
 | 
39
 | 
8.68e-01
 | 
1.54e-02
 | 
9.55e-01
 | 
| 
GO:0000175 3’-5’-RNA exonuclease
activity
 | 
21
 | 
9.04e-01
 | 
-1.53e-02
 | 
9.72e-01
 | 
| 
GO:0048675 axon extension
 | 
16
 | 
9.16e-01
 | 
1.52e-02
 | 
9.77e-01
 | 
| 
GO:0070527 platelet aggregation
 | 
16
 | 
9.18e-01
 | 
-1.48e-02
 | 
9.78e-01
 | 
| 
GO:0071806 protein transmembrane
transport
 | 
12
 | 
9.30e-01
 | 
1.47e-02
 | 
9.80e-01
 | 
| 
GO:0000278 mitotic cell cycle
 | 
53
 | 
8.53e-01
 | 
1.47e-02
 | 
9.51e-01
 | 
| 
GO:0032436 positive regulation of
proteasomal ubiquitin-dependent protein catabolic process
 | 
43
 | 
8.69e-01
 | 
-1.45e-02
 | 
9.55e-01
 | 
| 
GO:0090141 positive regulation of
mitochondrial fission
 | 
16
 | 
9.20e-01
 | 
1.45e-02
 | 
9.78e-01
 | 
| 
GO:0043491 phosphatidylinositol
3-kinase/protein kinase B signal transduction
 | 
35
 | 
8.84e-01
 | 
-1.42e-02
 | 
9.63e-01
 | 
| 
GO:0006879 intracellular iron ion
homeostasis
 | 
31
 | 
8.91e-01
 | 
1.42e-02
 | 
9.66e-01
 | 
| 
GO:0006890 retrograde
vesicle-mediated transport, Golgi to endoplasmic reticulum
 | 
32
 | 
8.90e-01
 | 
-1.41e-02
 | 
9.65e-01
 | 
| 
GO:0005200 structural constituent
of cytoskeleton
 | 
28
 | 
8.98e-01
 | 
1.40e-02
 | 
9.69e-01
 | 
| 
GO:0007528 neuromuscular junction
development
 | 
14
 | 
9.28e-01
 | 
1.40e-02
 | 
9.80e-01
 | 
| 
GO:0008344 adult locomotory
behavior
 | 
23
 | 
9.08e-01
 | 
-1.39e-02
 | 
9.73e-01
 | 
| 
GO:0003690 double-stranded DNA
binding
 | 
35
 | 
8.88e-01
 | 
-1.38e-02
 | 
9.64e-01
 | 
| 
GO:0000978 RNA polymerase II
cis-regulatory region sequence-specific DNA binding
 | 
394
 | 
6.43e-01
 | 
-1.37e-02
 | 
8.88e-01
 | 
| 
GO:0006783 heme biosynthetic
process
 | 
10
 | 
9.40e-01
 | 
1.37e-02
 | 
9.83e-01
 | 
| 
GO:0016446 somatic hypermutation of
immunoglobulin genes
 | 
10
 | 
9.41e-01
 | 
1.35e-02
 | 
9.83e-01
 | 
| 
GO:0003756 protein disulfide
isomerase activity
 | 
10
 | 
9.41e-01
 | 
-1.35e-02
 | 
9.83e-01
 | 
| 
GO:0001843 neural tube closure
 | 
48
 | 
8.72e-01
 | 
-1.34e-02
 | 
9.57e-01
 | 
| 
GO:0030335 positive regulation of
cell migration
 | 
107
 | 
8.14e-01
 | 
1.32e-02
 | 
9.38e-01
 | 
| 
GO:0005080 protein kinase C binding
 | 
16
 | 
9.28e-01
 | 
-1.31e-02
 | 
9.80e-01
 | 
| 
GO:0097110 scaffold protein binding
 | 
27
 | 
9.07e-01
 | 
-1.30e-02
 | 
9.73e-01
 | 
| 
GO:0035979 histone H2AXS139 kinase
activity
 | 
32
 | 
8.99e-01
 | 
-1.30e-02
 | 
9.69e-01
 | 
| 
GO:0002053 positive regulation of
mesenchymal cell proliferation
 | 
11
 | 
9.41e-01
 | 
-1.29e-02
 | 
9.83e-01
 | 
| 
GO:0042407 cristae formation
 | 
11
 | 
9.41e-01
 | 
1.28e-02
 | 
9.83e-01
 | 
| 
GO:0007286 spermatid development
 | 
25
 | 
9.13e-01
 | 
1.26e-02
 | 
9.76e-01
 | 
| 
GO:2000737 negative regulation of
stem cell differentiation
 | 
12
 | 
9.40e-01
 | 
-1.26e-02
 | 
9.83e-01
 | 
| 
GO:0051881 regulation of
mitochondrial membrane potential
 | 
14
 | 
9.36e-01
 | 
-1.25e-02
 | 
9.83e-01
 | 
| 
GO:0061564 axon development
 | 
13
 | 
9.38e-01
 | 
1.24e-02
 | 
9.83e-01
 | 
| 
GO:0001678 intracellular glucose
homeostasis
 | 
17
 | 
9.30e-01
 | 
1.24e-02
 | 
9.80e-01
 | 
| 
GO:0043524 negative regulation of
neuron apoptotic process
 | 
51
 | 
8.81e-01
 | 
-1.21e-02
 | 
9.60e-01
 | 
| 
GO:0030521 androgen receptor
signaling pathway
 | 
12
 | 
9.42e-01
 | 
1.21e-02
 | 
9.83e-01
 | 
| 
GO:0008045 motor neuron axon
guidance
 | 
12
 | 
9.44e-01
 | 
1.18e-02
 | 
9.83e-01
 | 
| 
GO:0001541 ovarian follicle
development
 | 
19
 | 
9.30e-01
 | 
1.16e-02
 | 
9.80e-01
 | 
| 
GO:0045862 positive regulation of
proteolysis
 | 
12
 | 
9.45e-01
 | 
1.15e-02
 | 
9.83e-01
 | 
| 
GO:0046676 negative regulation of
insulin secretion
 | 
10
 | 
9.50e-01
 | 
-1.15e-02
 | 
9.84e-01
 | 
| 
GO:0032526 response to retinoic
acid
 | 
15
 | 
9.39e-01
 | 
-1.14e-02
 | 
9.83e-01
 | 
| 
GO:0000460 maturation of 5.8S rRNA
 | 
11
 | 
9.50e-01
 | 
1.10e-02
 | 
9.84e-01
 | 
| 
GO:0070059 intrinsic apoptotic
signaling pathway in response to endoplasmic reticulum stress
 | 
15
 | 
9.42e-01
 | 
-1.08e-02
 | 
9.83e-01
 | 
| 
GO:0008286 insulin receptor
signaling pathway
 | 
49
 | 
8.96e-01
 | 
1.08e-02
 | 
9.67e-01
 | 
| 
GO:0001702 gastrulation with mouth
forming second
 | 
10
 | 
9.53e-01
 | 
-1.08e-02
 | 
9.84e-01
 | 
| 
GO:0022904 respiratory electron
transport chain
 | 
14
 | 
9.45e-01
 | 
-1.07e-02
 | 
9.83e-01
 | 
| 
GO:0006310 DNA recombination
 | 
23
 | 
9.29e-01
 | 
-1.07e-02
 | 
9.80e-01
 | 
| 
GO:0016529 sarcoplasmic reticulum
 | 
13
 | 
9.47e-01
 | 
1.06e-02
 | 
9.84e-01
 | 
| 
GO:0000118 histone deacetylase
complex
 | 
22
 | 
9.33e-01
 | 
1.03e-02
 | 
9.81e-01
 | 
| 
GO:0070062 extracellular exosome
 | 
39
 | 
9.14e-01
 | 
-1.00e-02
 | 
9.76e-01
 | 
| 
GO:0007189 adenylate
cyclase-activating G protein-coupled receptor signaling pathway
 | 
33
 | 
9.22e-01
 | 
9.90e-03
 | 
9.78e-01
 | 
| 
GO:0007254 JNK cascade
 | 
26
 | 
9.30e-01
 | 
-9.89e-03
 | 
9.80e-01
 | 
| 
GO:0005201 extracellular matrix
structural constituent
 | 
13
 | 
9.51e-01
 | 
9.84e-03
 | 
9.84e-01
 | 
| 
GO:0035556 intracellular signal
transduction
 | 
186
 | 
8.18e-01
 | 
-9.82e-03
 | 
9.41e-01
 | 
| 
GO:0001822 kidney development
 | 
51
 | 
9.04e-01
 | 
-9.77e-03
 | 
9.72e-01
 | 
| 
GO:0004672 protein kinase activity
 | 
64
 | 
8.96e-01
 | 
9.49e-03
 | 
9.67e-01
 | 
| 
GO:0031297 replication fork
processing
 | 
26
 | 
9.34e-01
 | 
-9.45e-03
 | 
9.81e-01
 | 
| 
GO:0006298 mismatch repair
 | 
16
 | 
9.49e-01
 | 
-9.31e-03
 | 
9.84e-01
 | 
| 
GO:0014032 neural crest cell
development
 | 
11
 | 
9.58e-01
 | 
9.18e-03
 | 
9.84e-01
 | 
| 
GO:0097550 transcription
preinitiation complex
 | 
12
 | 
9.56e-01
 | 
-9.14e-03
 | 
9.84e-01
 | 
| 
GO:0031463 Cul3-RING ubiquitin
ligase complex
 | 
41
 | 
9.20e-01
 | 
-9.09e-03
 | 
9.78e-01
 | 
| 
GO:0004535 poly(A)-specific
ribonuclease activity
 | 
10
 | 
9.60e-01
 | 
9.05e-03
 | 
9.85e-01
 | 
| 
GO:0042149 cellular response to
glucose starvation
 | 
29
 | 
9.33e-01
 | 
9.00e-03
 | 
9.81e-01
 | 
| 
GO:0098656 monoatomic anion
transmembrane transport
 | 
18
 | 
9.48e-01
 | 
8.88e-03
 | 
9.84e-01
 | 
| 
GO:0005006 epidermal growth factor
receptor activity
 | 
14
 | 
9.55e-01
 | 
8.78e-03
 | 
9.84e-01
 | 
| 
GO:0045773 positive regulation of
axon extension
 | 
10
 | 
9.62e-01
 | 
8.66e-03
 | 
9.86e-01
 | 
| 
GO:1904263 positive regulation of
TORC1 signaling
 | 
35
 | 
9.33e-01
 | 
-8.16e-03
 | 
9.81e-01
 | 
| 
GO:0045765 regulation of
angiogenesis
 | 
11
 | 
9.63e-01
 | 
7.98e-03
 | 
9.86e-01
 | 
| 
GO:0047496 vesicle transport along
microtubule
 | 
11
 | 
9.64e-01
 | 
7.97e-03
 | 
9.86e-01
 | 
| 
GO:0051209 release of sequestered
calcium ion into cytosol
 | 
20
 | 
9.52e-01
 | 
-7.70e-03
 | 
9.84e-01
 | 
| 
GO:0051496 positive regulation of
stress fiber assembly
 | 
31
 | 
9.41e-01
 | 
-7.67e-03
 | 
9.83e-01
 | 
| 
GO:0042552 myelination
 | 
28
 | 
9.44e-01
 | 
-7.61e-03
 | 
9.83e-01
 | 
| 
GO:0032154 cleavage furrow
 | 
28
 | 
9.45e-01
 | 
-7.55e-03
 | 
9.83e-01
 | 
| 
GO:0009411 response to UV
 | 
23
 | 
9.51e-01
 | 
-7.45e-03
 | 
9.84e-01
 | 
| 
GO:0031252 cell leading edge
 | 
20
 | 
9.55e-01
 | 
7.31e-03
 | 
9.84e-01
 | 
| 
GO:0005506 iron ion binding
 | 
64
 | 
9.20e-01
 | 
-7.24e-03
 | 
9.78e-01
 | 
| 
GO:0031464 Cul4A-RING E3 ubiquitin
ligase complex
 | 
10
 | 
9.70e-01
 | 
6.98e-03
 | 
9.88e-01
 | 
| 
GO:0005876 spindle microtubule
 | 
20
 | 
9.57e-01
 | 
6.95e-03
 | 
9.84e-01
 | 
| 
GO:1900087 positive regulation of
G1/S transition of mitotic cell cycle
 | 
26
 | 
9.51e-01
 | 
-6.95e-03
 | 
9.84e-01
 | 
| 
GO:0005763 mitochondrial small
ribosomal subunit
 | 
21
 | 
9.59e-01
 | 
-6.55e-03
 | 
9.84e-01
 | 
| 
GO:0051301 cell division
 | 
144
 | 
8.94e-01
 | 
6.41e-03
 | 
9.67e-01
 | 
| 
GO:0004722 protein serine/threonine
phosphatase activity
 | 
33
 | 
9.50e-01
 | 
6.32e-03
 | 
9.84e-01
 | 
| 
GO:0030501 positive regulation of
bone mineralization
 | 
14
 | 
9.67e-01
 | 
-6.31e-03
 | 
9.88e-01
 | 
| 
GO:0010507 negative regulation of
autophagy
 | 
22
 | 
9.59e-01
 | 
-6.28e-03
 | 
9.84e-01
 | 
| 
GO:0038084 vascular endothelial
growth factor signaling pathway
 | 
23
 | 
9.59e-01
 | 
-6.18e-03
 | 
9.84e-01
 | 
| 
GO:0055013 cardiac muscle cell
development
 | 
11
 | 
9.72e-01
 | 
6.13e-03
 | 
9.88e-01
 | 
| 
GO:0046580 negative regulation of
Ras protein signal transduction
 | 
13
 | 
9.70e-01
 | 
6.11e-03
 | 
9.88e-01
 | 
| 
GO:0001228 DNA-binding
transcription activator activity, RNA polymerase II-specific
 | 
183
 | 
8.88e-01
 | 
6.05e-03
 | 
9.64e-01
 | 
| 
GO:0004677 DNA-dependent protein
kinase activity
 | 
31
 | 
9.54e-01
 | 
5.97e-03
 | 
9.84e-01
 | 
| 
GO:0035116 embryonic hindlimb
morphogenesis
 | 
12
 | 
9.72e-01
 | 
5.80e-03
 | 
9.88e-01
 | 
| 
GO:0043488 regulation of mRNA
stability
 | 
16
 | 
9.69e-01
 | 
-5.67e-03
 | 
9.88e-01
 | 
| 
GO:0043124 negative regulation of
canonical NF-kappaB signal transduction
 | 
36
 | 
9.54e-01
 | 
-5.58e-03
 | 
9.84e-01
 | 
| 
GO:0000981 DNA-binding
transcription factor activity, RNA polymerase II-specific
 | 
348
 | 
8.65e-01
 | 
5.33e-03
 | 
9.55e-01
 | 
| 
GO:0005819 spindle
 | 
54
 | 
9.47e-01
 | 
-5.24e-03
 | 
9.84e-01
 | 
| 
GO:0033173 calcineurin-NFAT
signaling cascade
 | 
10
 | 
9.78e-01
 | 
5.14e-03
 | 
9.92e-01
 | 
| 
GO:0051225 spindle assembly
 | 
21
 | 
9.68e-01
 | 
5.11e-03
 | 
9.88e-01
 | 
| 
GO:0005834 heterotrimeric G-protein
complex
 | 
19
 | 
9.70e-01
 | 
5.04e-03
 | 
9.88e-01
 | 
| 
GO:0016579 protein deubiquitination
 | 
28
 | 
9.64e-01
 | 
-4.93e-03
 | 
9.86e-01
 | 
| 
GO:0030522 intracellular receptor
signaling pathway
 | 
18
 | 
9.71e-01
 | 
4.87e-03
 | 
9.88e-01
 | 
| 
GO:0046835 carbohydrate
phosphorylation
 | 
20
 | 
9.71e-01
 | 
-4.67e-03
 | 
9.88e-01
 | 
| 
GO:0005657 replication fork
 | 
20
 | 
9.71e-01
 | 
4.67e-03
 | 
9.88e-01
 | 
| 
GO:0036342 post-anal tail
morphogenesis
 | 
11
 | 
9.79e-01
 | 
4.66e-03
 | 
9.92e-01
 | 
| 
GO:0006417 regulation of
translation
 | 
44
 | 
9.58e-01
 | 
-4.54e-03
 | 
9.84e-01
 | 
| 
GO:0005737 cytoplasm
 | 
2177
 | 
7.80e-01
 | 
3.75e-03
 | 
9.26e-01
 | 
| 
GO:0016323 basolateral plasma
membrane
 | 
94
 | 
9.54e-01
 | 
-3.43e-03
 | 
9.84e-01
 | 
| 
GO:0060021 roof of mouth
development
 | 
36
 | 
9.73e-01
 | 
-3.26e-03
 | 
9.88e-01
 | 
| 
GO:0090263 positive regulation of
canonical Wnt signaling pathway
 | 
62
 | 
9.69e-01
 | 
2.84e-03
 | 
9.88e-01
 | 
| 
GO:0000902 cell morphogenesis
 | 
55
 | 
9.76e-01
 | 
-2.33e-03
 | 
9.91e-01
 | 
| 
GO:0016538 cyclin-dependent protein
serine/threonine kinase regulator activity
 | 
20
 | 
9.87e-01
 | 
2.12e-03
 | 
9.97e-01
 | 
| 
GO:0043001 Golgi to plasma membrane
protein transport
 | 
21
 | 
9.87e-01
 | 
2.04e-03
 | 
9.97e-01
 | 
| 
GO:0019900 kinase binding
 | 
48
 | 
9.81e-01
 | 
1.96e-03
 | 
9.93e-01
 | 
| 
GO:0046427 positive regulation of
receptor signaling pathway via JAK-STAT
 | 
13
 | 
9.90e-01
 | 
1.91e-03
 | 
9.99e-01
 | 
| 
GO:0008543 fibroblast growth factor
receptor signaling pathway
 | 
36
 | 
9.85e-01
 | 
-1.85e-03
 | 
9.95e-01
 | 
| 
GO:0005770 late endosome
 | 
75
 | 
9.79e-01
 | 
1.77e-03
 | 
9.92e-01
 | 
| 
GO:0000165 MAPK cascade
 | 
46
 | 
9.84e-01
 | 
-1.75e-03
 | 
9.95e-01
 | 
| 
GO:0006606 protein import into
nucleus
 | 
62
 | 
9.81e-01
 | 
1.75e-03
 | 
9.93e-01
 | 
| 
GO:0007020 microtubule nucleation
 | 
14
 | 
9.91e-01
 | 
-1.72e-03
 | 
9.99e-01
 | 
| 
GO:0048863 stem cell
differentiation
 | 
22
 | 
9.89e-01
 | 
-1.65e-03
 | 
9.98e-01
 | 
| 
GO:0009566 fertilization
 | 
12
 | 
9.94e-01
 | 
-1.34e-03
 | 
9.99e-01
 | 
| 
GO:0030490 maturation of SSU-rRNA
 | 
12
 | 
9.94e-01
 | 
-1.33e-03
 | 
9.99e-01
 | 
| 
GO:0045599 negative regulation of
fat cell differentiation
 | 
21
 | 
9.92e-01
 | 
-1.23e-03
 | 
9.99e-01
 | 
| 
GO:1990498 mitotic spindle
microtubule
 | 
10
 | 
9.96e-01
 | 
-8.89e-04
 | 
9.99e-01
 | 
| 
GO:0051537 2 iron, 2 sulfur cluster
binding
 | 
17
 | 
9.95e-01
 | 
-8.79e-04
 | 
9.99e-01
 | 
| 
GO:0000124 SAGA complex
 | 
15
 | 
9.96e-01
 | 
8.02e-04
 | 
9.99e-01
 | 
| 
GO:0032418 lysosome localization
 | 
23
 | 
9.96e-01
 | 
-6.14e-04
 | 
9.99e-01
 | 
| 
GO:0031526 brush border membrane
 | 
12
 | 
9.97e-01
 | 
6.02e-04
 | 
9.99e-01
 | 
| 
GO:0007173 epidermal growth factor
receptor signaling pathway
 | 
38
 | 
9.96e-01
 | 
-4.65e-04
 | 
9.99e-01
 | 
| 
GO:0045499 chemorepellent activity
 | 
18
 | 
9.97e-01
 | 
-4.56e-04
 | 
9.99e-01
 | 
| 
GO:0031290 retinal ganglion cell
axon guidance
 | 
11
 | 
9.99e-01
 | 
-2.97e-04
 | 
1.00e+00
 | 
| 
GO:0045211 postsynaptic membrane
 | 
54
 | 
9.97e-01
 | 
2.71e-04
 | 
9.99e-01
 | 
| 
GO:0005868 cytoplasmic dynein
complex
 | 
14
 | 
9.99e-01
 | 
1.69e-04
 | 
1.00e+00
 | 
| 
GO:0003743 translation initiation
factor activity
 | 
39
 | 
1.00e+00
 | 
-2.68e-05
 | 
1.00e+00
 |